Science.gov

Sample records for agreement mta confidential

  1. 40 CFR 2.215 - Confidentiality agreements.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 1 2010-07-01 2010-07-01 false Confidentiality agreements. 2.215 Section 2.215 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY GENERAL PUBLIC INFORMATION Confidentiality of Business Information § 2.215 Confidentiality agreements. (a) No EPA officer,...

  2. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 6 2012-10-01 2012-10-01 false Project employee... Clauses 1552.227-76 Project employee confidentiality agreement. As prescribed in 1527.409, insert the following clause: Project Employee Confidentiality Agreement (MAY 1994) (a) The Contractor recognizes...

  3. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 6 2014-10-01 2014-10-01 false Project employee... Clauses 1552.227-76 Project employee confidentiality agreement. As prescribed in 1527.409, insert the following clause: Project Employee Confidentiality Agreement (MAY 1994) (a) The Contractor recognizes...

  4. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 6 2011-10-01 2011-10-01 false Project employee... Clauses 1552.227-76 Project employee confidentiality agreement. As prescribed in 1527.409, insert the following clause: Project Employee Confidentiality Agreement (MAY 1994) (a) The Contractor recognizes...

  5. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 6 2013-10-01 2013-10-01 false Project employee... Clauses 1552.227-76 Project employee confidentiality agreement. As prescribed in 1527.409, insert the following clause: Project Employee Confidentiality Agreement (MAY 1994) (a) The Contractor recognizes...

  6. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 6 2010-10-01 2010-10-01 true Project employee... Clauses 1552.227-76 Project employee confidentiality agreement. As prescribed in 1527.409, insert the following clause: Project Employee Confidentiality Agreement (MAY 1994) (a) The Contractor recognizes...

  7. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 30 Mineral Resources 1 2010-07-01 2010-07-01 false Confidentiality agreement and remedies. 47.85 Section 47.85 Mineral Resources MINE SAFETY AND HEALTH ADMINISTRATION, DEPARTMENT OF LABOR EDUCATION AND TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement and remedies. (a) The...

  8. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  9. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  10. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  11. MTA: A Clinical Review

    PubMed Central

    Tawil, Peter Z; Duggan, Derek J.; Galicia, Johnah C.

    2016-01-01

    MTA has been a revolutionary material in endodontics. Since it’s introduction in the 1990’s several studies have demonstrated its use in several clinical applications. MTA has been extensively studied and is currently used for perforation repairs, apexifications, regenerative procedures, apexogenesis, pulpotomies & pulp capping. This article will review the history, composition, research findings and clinical applications of this versatile material. PMID:25821936

  12. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... stations using any frequency identified in their spectrum block anywhere within their authorized MTA... rules and international agreements that restrict use of frequencies identified in their spectrum block... for a previously authorized co-channel station within the MTA licensee's authorized spectrum block...

  13. Confidential Searches.

    ERIC Educational Resources Information Center

    Kenney, Linda Chion

    2003-01-01

    Will the stealth superintendent hunt in Cincinnati become tomorrow's standard approach? Search consultants and superintendents offer their views on how far confidentiality should go. Also includes a search firm's process for shielding identities and a confidentiality pledge. (MLF)

  14. MTA applications in pediatric dentistry

    PubMed Central

    MATURO, P.; COSTACURTA, M.; BARTOLINO, M.; DOCIMO, R.

    2010-01-01

    SUMMARY The aim of this paper is to show and asses the clinical applications of the Mineral Trioxide Aggregate (MTA) in pediatric dentistry, either on primary teeth or on immature apex permanent teeth. We have described the primary tooth pulpotomy technique using MTA, that is characterized by a superior biocompatibility and a sealing ability that make it a more suitable compound compared to other materials in terms of result prediction on a long-term basis. We have also reported the direct capping technique using MTA on immature apex teeth; in these particular cases, MTA is undoubtedly preferable to conventional materials, especially in what its sealing characteristics concern. Furthermore, we have explained the apexogenesis clinical procedure, in which after a chamber pulpotomy on incomplete root development teeth, MTA is used in direct contact with the pulpar stump in order to save the root pulp vitality, allowing the apex and relative canal walls physiological maturation to take place. In case of necrotic teeth with immature apex, we describe the possibility of using MTA as an apical barrier making the apexification treatment faster and predictable, taking profit from its biocompatibility quality, its sealing ability and setting characteristic in humid environments. In all described applications, MTA has demonstrated to be a very versatile and extremely trustworthy material. Either literature and results obtained from the present experience, show how the use of MTA in Pediatric Dentistry, compared to commonly used materials, translates into pulp or periapical tissues being less swollen and, thus, guaranteeing a higher prediction of the therapeutic result on a short-term basis and on a long-term one. PMID:23285367

  15. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential...

  16. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential...

  17. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential...

  18. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential...

  19. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed....

  20. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed....

  1. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed....

  2. MTA Computer Based Evaluation System.

    ERIC Educational Resources Information Center

    Brenner, Lisa P.; And Others

    The MTA PLATO-based evaluation system, which has been implemented by a consortium of schools of medical technology, is designed to be general-purpose, modular, data-driven, and interactive, and to accommodate other national and local item banks. The system provides a comprehensive interactive item-banking system in conjunction with online student…

  3. Livin' with the MTA

    ERIC Educational Resources Information Center

    Mirowski, Philip

    2008-01-01

    Although the push to get universities to accumulate IP by commercializing their scientific research was a conscious movement, dealing with the blowback in the form of contracts over the transfer of research tools and inputs, called materials transfer agreements (MTAs), was greeted by universities as an afterthought. Faculty often regarded them as…

  4. Structure, expression and functions of MTA genes.

    PubMed

    Kumar, Rakesh; Wang, Rui-An

    2016-05-15

    Metastatic associated proteins (MTA) are integrators of upstream regulatory signals with the ability to act as master coregulators for modifying gene transcriptional activity. The MTA family includes three genes and multiple alternatively spliced variants. The MTA proteins neither have their own enzymatic activity nor have been shown to directly interact with DNA. However, MTA proteins interact with a variety of chromatin remodeling factors and complexes with enzymatic activities for modulating the plasticity of nucleosomes, leading to the repression or derepression of target genes or other extra-nuclear and nucleosome remodeling and histone deacetylase (NuRD)-complex independent activities. The functions of MTA family members are driven by the steady state levels and subcellular localization of MTA proteins, the dynamic nature of modifying signals and enzymes, the structural features and post-translational modification of protein domains, interactions with binding proteins, and the nature of the engaged and resulting features of nucleosomes in the proximity of target genes. In general, MTA1 and MTA2 are the most upregulated genes in human cancer and correlate well with aggressive phenotypes, therapeutic resistance, poor prognosis and ultimately, unfavorable survival of cancer patients. Here we will discuss the structure, expression and functions of the MTA family of genes in the context of cancer cells. PMID:26869315

  5. Confidential information.

    PubMed

    Deitch, Rodney

    1983-01-29

    The British Medical Association is described as very concerned that two Government-sponsored bills in Parliament pose a threat to the customary secrecy of medical records. The Association has garnered support only from opposition parties in its efforts to incorporate confidentiality safeguards into the Police and Criminal Evidence Bill, which would permit police to seize patient records if a warrant had been issued, and the Data Protection Bill, intended to prevent tapping of computerized files. PMID:11644250

  6. Collective Bargaining Agreement between Board of Trustees of the University of Massachusetts and the Massachusetts Society of Professors, Faculty Staff Union, MTA/NEA, July 1, 1983-June 30, 1986.

    ERIC Educational Resources Information Center

    National Education Association, Washington, DC.

    The collective bargaining agreement between the Board of Trustees of the University of Massachusetts and the Massachusetts Society of Professors, Faculty Staff Union (1,643 members) of the National Education Association, covering the period July 1, 1983-June 30, 1986 is presented. Items covered in the agreement include: unit recognition,…

  7. Agreement between the Board of Trustees of the University of Massachusetts on Behalf of the Board of Regents of Higher Education and the Massachusetts Society of Professors Faculty Staff Union/MTA/NEA.

    ERIC Educational Resources Information Center

    National Education Association, Washington, DC.

    The collective bargaining agreement between the Board of Trustees of the University of Massachusetts and the Board of Regents of Higher Education and the Massachusetts Society of Professors, an affiliate of the National Education Association, covering the period July 1, 1986-June 30, 1987, is presented. Items covered in the agreement include: unit…

  8. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 19 Customs Duties 3 2014-04-01 2014-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING ARTICLE 1904 OF THE NORTH AMERICAN FREE TRADE AGREEMENT Violation of a Protective Order or a Disclosure Undertaking § 356.29 Confidentiality. (a)...

  9. 7 CFR 900.407 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... to the Agricultural Marketing Agreement Act of 1937, as Amended § 900.407 Confidential information... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.407 Section 900.407 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE...

  10. 7 CFR 900.309 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... to Agricultural Marketing Agreement Act of 1937, as Amended § 900.309 Confidential information. The... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.309 Section 900.309 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE...

  11. Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus

    PubMed Central

    Ha, William Nguyen; Shakibaie, Fardad; Kahler, Bill; Walsh, Laurence James

    2016-01-01

    Abstract Objective Mineral trioxide aggregate (MTA) cements contain two types of particles, namely Portland cement (PC) (nominally 80% w/w) and bismuth oxide (BO) (20%). This study aims to determine the particle size distribution (PSD) of PC and BO found in MTA. Materials and methods The PSDs of ProRoot MTA (MTA-P) and MTA Angelus (MTA-A) powder were determined using laser diffraction, and compared to samples of PC (at three different particle sizes) and BO. The non-linear least squares method was used to deconvolute the PSDs into the constituents. MTA-P and MTA-A powders were also assessed with scanning electron microscopy. Results BO showed a near Gaussian distribution for particle size, with a mode distribution peak at 10.48 μm. PC samples milled to differing degrees of fineness had mode distribution peaks from 19.31 down to 4.88 μm. MTA-P had a complex PSD composed of both fine and large PC particles, with BO at an intermediate size, whereas MTA-A had only small BO particles and large PC particles. Conclusions The PSD of MTA cement products is bimodal or more complex, which has implications for understanding how particle size influences the overall properties of the material. Smaller particles may be reactive PC or unreactive radiopaque agent. Manufacturers should disclose particle size information for PC and radiopaque agents to prevent simplistic conclusions being drawn from statements of average particle size for MTA materials. PMID:27335899

  12. X-ray diffraction analysis of MTA-Plus, MTA-Angelus and DiaRoot BioAggregate

    PubMed Central

    Guven, Yeliz; Tuna, Elif Bahar; Dincol, Muzaffer Emin; Aktoren, Oya

    2014-01-01

    Objective: The purpose of this study was to investigate and compare the crystalline structures of recently released MTA Plus (MTA-P), MTA Angelus (MTA-A), DiaRoot BioAggregate (BA) by X-ray diffraction (XRD) analysis. Materials and Methods: Phase analysis was carried out on powder and set forms of tested materials. The powder specimens placed into sample holders that were packed with a glass slide and the set samples prepared according to the manufacturer's instructions were placed into molds. The samples after being set for three days at 37°C and 100% humidity in an incubator were mounted onto the XRD machine and phase identification was accomplished using a search-match software program. Results: XRD findings indicated that major constituents of MTA-P were bismuth oxide, portlandite, dicalcium silicate and tricalcium silicate. The crystal structure of MTA-A were similar to those of MTA-P except for the absence of portlandite. Additionally, MTA-A had tricalcium aluminate differing from MTA-P. BA mainly differed from MTA-P and MTA-A by the radiopacifier (tantalum oxide-TO) in its composition. Conclusions: The majority of constituents of the tested materials have shown similarity except for the presence of tricalcium aluminate in MTA-A and the inclusion of TO in BA. In addition, set MTA-P showed a strong peak of portlandite. PMID:24966772

  13. Can MTA be: Miracle trioxide aggregate?

    PubMed Central

    Naik, Reshma M; Pudakalkatti, Pushpa S; Hattarki, Sanjeevini A

    2014-01-01

    Mineral trioxide aggregate (MTA) has been used for more than 10 years in the dental community and has often been thought of as a material of choice for the endodontist. The dental pulp is closely related to periodontal tissues through apical foramina, accessory canals, and dentinal tubules. Due to this interrelationship, pulpal diseases may influence periodontal health and periodontal infections may affect pulpal integrity. It is estimated that pulpal and periodontal problems are responsible for more than 50% of tooth mortality. Thus, these associations recommend an interdisciplinary approach. MTA appears to exhibit significant results even in periodontal procedures as it is the first restorative material that consistently allows for over-growth of cementum and may facilitate periodontal tissue regeneration. Thus, in the present review, an attempt is made to discuss the clinical applications of MTA as an interdisciplinary approach. PMID:24744536

  14. 46 CFR 535.608 - Confidentiality of submitted material.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 9 2010-10-01 2010-10-01 false Confidentiality of submitted material. 535.608 Section... on Agreements § 535.608 Confidentiality of submitted material. (a) Except for an agreement filed under section 5 of the Act (46 U.S.C. 40301(d)-(e), 40302-40303, 40305), all information submitted...

  15. Role of MTA1 in Cancer Progression and Metastasis

    PubMed Central

    Sen, Nirmalya; Gui, Bin; Kumar, Rakesh

    2014-01-01

    The MTA1 protein contributes to the process of cancer progression and metastasis through multiple genes and protein targets and interacting proteins with roles in transformation, anchorage-independent growth, invasion, survival, DNA-repair, angiogenesis, hormone-independence, metastasis and therapeutic resistance. MTA proteins control a spectrum of cancer promoting processes by modulating the expression of target genes and/or the activity of MTA-interacting proteins. In the case of MTA1, these functions are manifested through post-translational modifications of MTA1 in response to upstream signals, MTA1 interaction with binding proteins and the expression of target gene products. The MTA1 coregulator interacts with nucleosomes through modified histones and is an integrator of extracellular signaling and gene activator. Studies delineating the molecular basis of dual functionality of MTA1 reveal that the functions of MTA1-chromatin modifying complexes in the context of target gene regulation are dynamic in nature. The nature and targets of MTA1-chromatin modifying complexes are also governed by the dynamic plasticity of the nucleosome landscape as well as kinetics of activation and inactivation of enzymes responsible for post-translational modifications on the MTA1 protein. These broadly applicable functions also explain why MTA1 may be a ‘hub’ gene, whose current understanding is limited to selective influences on gene with roles in cancer but further research may reveal a more global influence. Because the deregulation of enzymes and their substrates with roles in MTA1-biology is not necessarily limited to cancer, we speculate that the lessons from MTA1 as a prototype dual master coregulator will be relevant for other human diseases. In this context, the concept of the dynamic nature of corepressor versus coactivator complexes and the MTA1 proteome as a function of time to signal is likely to be generally applicable to other multi-proteins regulatory complexes

  16. Loop parallelism on Tera MTA using SISAL

    SciTech Connect

    Mitrovic, S.

    1995-11-01

    The difficulty of programming parallel computers has impeded their wide-spread use. The problems are caused by existing hardware and software tools. The software problems on shared-memory and vector computers can be solved by using deterministic high-performance functional languages like SISAL. Distributed-memory computers have even more obstacles than shared-memory parallel machines. Research indicates that multithreaded architectures can hide long latency of distributed memories and that they can solve the problems of locality. Tera`s MTA multiprocessor is based on the concept of multithreading and provides the programmer with a real shared-memory model. This paper investigates the performance of parallel loops written in SISAL and executed on the Tera MTA using the Livermore Loops benchmarks.

  17. The nature of confidentiality.

    PubMed Central

    Thompson, I E

    1979-01-01

    This paper examines confidentiality and its nature and analyses the guidelines laid down by the Hippocratic Oath as well as the British and World Medical Associations for maintaining such confidentiality between doctor and patient. There are exceptions to practically any code of rules and this is true also for confidentiality. Some of these exceptions make it appear that very little is confidential. The three values implicit in confidentiality would seem to be privacy, confidence and secrecy. Each of these values is discussed and developed in this paper. In conclusion, the question is suggested that maybe in the face of death, doctor and patient need to re-examine the pre-suppositions of privacy, confidence and secrecy on which the confidential relationship is based. PMID:469872

  18. Confidentiality and death.

    PubMed

    Ong, B B; Kaur, S

    1997-12-01

    The duty of confidentiality in the normal doctor-patient relationship is well recognized. However, the duty of confidentiality between the pathologist who performs the autopsy and the requesting authorities and the next-of-kin is not as clearly spelt out. This article discusses the problems faced by the pathologist with regards to hospital and medico-legal autopsies in Malaysia. A proposed ethical guideline is included on how to deal with peculiar issues regarding confidentiality and the pathologist. PMID:10879250

  19. Respecting patient confidentiality.

    PubMed

    Price, Bob

    2015-02-01

    Nurses face a particular challenge in respecting the confidentiality of patients in a world where information is quickly shared and where information about illness can be sensitive. We have a duty of care towards patients. That duty includes maintaining privacy (protecting them from undue intrusion), and confidentiality (by the discreet management of information about themselves that they share with us). Legislation on confidentiality comes from different sources and should be interpreted in the clinical setting. This article summarises the principal requirements set out in the legislation and directs readers to questions and tools designed to help them explore the extent to which patient confidentiality is respected where they work. PMID:25627535

  20. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 19 Customs Duties 2 2012-04-01 2012-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of...

  1. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 2 2013-04-01 2013-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of...

  2. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 2 2011-04-01 2011-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of...

  3. Working with the NCL - Material Transfer Agreement - Nanotechnology Characterization Laboratory

    Cancer.gov

    To share and safeguard Research Material, intellectual property and proprietary information, the NCL's interaction with extramural researchers and vendors will normally be conducted under a Material Transfer Agreement (MTA).

  4. Medical confidentiality: an intransigent and absolute obligation.

    PubMed Central

    Kottow, M H

    1986-01-01

    Clinicians' work depends on sincere and complete disclosures from their patients; they honour this candidness by confidentially safeguarding the information received. Breaching confidentiality causes harms that are not commensurable with the possible benefits gained. Limitations or exceptions put on confidentiality would destroy it, for the confider would become suspicious and un-co-operative, the confidant would become untrustworthy and the whole climate of the clinical encounter would suffer irreversible erosion. Excusing breaches of confidence on grounds of superior moral values introduces arbitrariness and ethical unreliability into the medical context. Physicians who breach the agreement of confidentiality are being unfair, thus opening the way for, and becoming vulnerable to, the morally obtuse conduct of others. Confidentiality should not be seen as the cosy but dispensable atmosphere of clinical settings; rather, it constitutes a guarantee of fairness in medical actions. Possible perils that might accrue to society are no greater than those accepted when granting inviolable custody of information to priests, lawyers and bankers. To jeopardize the integrity of confidential medical relationships is too high a price to pay for the hypothetical benefits this might bring to the prevailing social order. PMID:3761330

  5. North Adams State College Institutional Self-Evaluation Study Report, Vol. 2. Appendix 1: Agreement Between the Board of Trustees of State Colleges and North Adams State College Association, Massachusetts; Appendix 2: Agreement Between The Board of Trustees of State Colleges and the North Adams State College Mark Hopkins Faculty Association-MTA/NEA.

    ERIC Educational Resources Information Center

    Massachusetts State Coll. System, Boston.

    The two agreements included in this document are in effect until June 30, 1976 and June 30, 1977, respectively. Articles cover: recognition and definitions, relationship between the board and the association, use of college facilities, faculty fringe benefits, statement on academic freedom, responsibilities of department chairmen, participation in…

  6. MTA1 Expression in Benign and Malignant Salivary gland Tumors

    PubMed Central

    Andisheh-Tadbir, Azadeh; Dehghani-Nazhvani, Ali; Ashraf, Mohammad Javad; Khademi, Bijan; Mirhadi, Hosein; Torabi-Ardekani, Shima

    2016-01-01

    Introduction: Salivary gland tumors (SGTs) are important parts of human neoplasms. The most common SGT is pleomorphic adenoma and the most common malignant SGTs are mucoepidermoid carcinoma and adenoid cystic carcinoma (ACC). Metastasis-associated genes 1 (MTA1), a member of the nucleosome remodeling and histone deacetylation complex, is one newly discovered gene which recruits histone deacetylation, causing ATP-dependent chromosome remodeling, and regulating transcription. MTA1 had been shown to be overexpressed in malignant tumors with the enhancement of invasion and metastasis. Materials and Methods: Fifty-six samples of salivary gland tumors from the Khalili Hospital archive, including 20 cases of pleomorphic adenoma, 17 cases of mucoepidermoid carcinoma, 19 cases of ACC, and 23 cases of normal salivary gland tissues were chosen for immunohistochemical analysis of MTA1. Results: MTA1 expression in the malignant tumors was significantly higher than that in pleomorphic adenoma (P<0.001), and higher in pleomorphic adenoma than the normal salivary glands(P< 0.001). In total, 69.6% of normal salivary gland tissues showed MTA1, but all cases of salivary gland tumors were positive for MTA1. High nuclear expression of MTA1 was detected in 83.3% (30/36) of the malignant salivary gland tumors and 45% (9/20) of pleomorphic adenoma, while low MTA1 expression was seen in all of the normal salivary gland tissues. No statistically significant correlation was found between MTA1 protein expression and any clinicopathological features (P>0.05). Conclusion: Our findings demonstrate that MTA1 was significantly overexpressed in malignant salivary gland neoplasm in comparison to a lower level in benign pleomorphic adenoma, suggesting that MTA1 protein might be involved in carcinogenesis. PMID:26878004

  7. MTA3 regulates CGB5 and Snail genes in trophoblast

    SciTech Connect

    Chen, Ying; Miyazaki, Jun; Nishizawa, Haruki; Kurahashi, Hiroki; Leach, Richard; Wang, Kai

    2013-04-19

    Highlights: •Impaired MTA3, raised CGB5 and Snail expression are associated with preeclampsia. •Knock-down of MTA3 causes up-regulation of CGB5 and Snail genes in BeWo cells. •MTA3 occupies CGB5 and Snail gene promoters in BeWo cells. -- Abstract: Secreted by the placental trophoblast, human chorionic gonadotropin (hCG) is an important hormone during pregnancy and is required for the maintenance of pregnancy. Previous studies have shown that dys-regulation of hCG expression is associated with preeclampsia. However, the exact relationship between altered hCG levels and development of preeclampsia is unknown. Metastasis associated protein 3 (MTA3), a chromatin remodeling protein, is abundantly expressed in the placental trophoblasts, but its function is unknown. In breast cancer, MTA3 has been shown to repress the expression of Snail and cell migration. However, whether MTA3 acts similarly in the trophoblast has not been investigated. In the present study, we examined the role of MTA3 in regulating the hCG β-subunit gene (gene name: CGB5) and Snail expression in the trophoblast cell line, BeWo, as well as its relevance to the high hCG expression levels seen in preeclampsia. First, we investigated MTA3 expression in preeclamptic placenta as compared to normal control placenta via gene expression microarray and qRT-PCR and found that MTA3 was significantly down-regulated, whereas both CGB5 and Snail were up-regulated in preeclamptic placenta. Secondly, we knocked down MTA3 gene in trophoblast cell line BeWo and found Snail and hCG were both up-regulated, suggesting that MTA3 represses Snail and hCG gene expression in trophoblasts. Next, we cloned the CGB5 and Snail promoters into the pGL3-basic vector individually and found that silencing of MTA3 by siRNA resulted in an increase of both CGB5 and Snail promoter activities. To confirm that this MTA3 inhibition is a direct effect, we performed a chromatin immune-precipitation (ChIP) assay and found that MTA3

  8. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MILK), DEPARTMENT OF AGRICULTURE DAIRY PROMOTION PROGRAM Dairy Promotion and...

  9. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  10. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  11. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  12. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  13. 7 CFR 1219.108 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1219.108 Section 1219.108 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HASS AVOCADO PROMOTION,...

  14. 7 CFR 1219.108 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1219.108 Section 1219.108 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HASS AVOCADO PROMOTION,...

  15. 7 CFR 1245.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1245.107 Section 1245.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE U.S. HONEY PRODUCER...

  16. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  17. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  18. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  19. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  20. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  1. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  2. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  3. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  4. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1210.607 Section 1210.607 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH...

  5. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  6. 7 CFR 985.63 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 985.63 Section 985.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE MARKETING ORDER REGULATING...

  7. 7 CFR 989.75 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 989.75 Section 989.75 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE RAISINS PRODUCED FROM...

  8. 7 CFR 989.75 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 989.75 Section 989.75 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE RAISINS PRODUCED FROM...

  9. 7 CFR 989.75 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 989.75 Section 989.75 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE RAISINS PRODUCED FROM...

  10. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  11. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  12. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  13. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  14. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES...

  15. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES...

  16. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES...

  17. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES...

  18. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE EGG RESEARCH AND PROMOTION Egg Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a) All... information furnished by any person, (2) the publication, by direction of the Secretary, of general...

  19. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE COTTON RESEARCH AND PROMOTION Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment. All... cotton, which statements do not identify the information furnished by any person, or (b) The...

  20. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential treatment... Plan, which statements do not identify the information furnished by any person; or (b) The...

  1. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE BEEF PROMOTION AND RESEARCH Beef Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All information... identify the information furnished by any person; and (b) The publication, by direction of the...

  2. 7 CFR 1210.352 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND PROMOTION PLAN Watermelon Research and Promotion Plan Reports, Books, and Records § 1210.352 Confidential... identify the information furnished by any person; or (2) The publication by direction of the Secretary...

  3. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE...

  4. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE...

  5. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE...

  6. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY...

  7. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY...

  8. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY...

  9. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY...

  10. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  11. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  12. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  13. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  14. 3-Year Follow-up of the NIMH MTA Study

    ERIC Educational Resources Information Center

    Jensen, Peter S.; Arnold, L. Eugene; Swanson, James M.; Vitiello, Benedetto; Abikoff, Howard B.; Greenhill, Laurence L.; Hechtman, Lily; Hinshaw, Stephen P.; Pelham, William E.; Wells, Karen C.; Conners, C. Keith; Elliott, Glen R.; Epstein, Jeffery N.; Hoza, Betsy; March, John S.; Molina, Brooke S. G.; Newcorn, Jeffrey H.; Severe, Joanne B.; Wigal, Timothy; Gibbons, Robert D.; Hur, Kwan

    2007-01-01

    Objective: In the intent-to-treat analysis of the Multimodal Treatment Study of Children With ADHD (MTA), the effects of medication management (MedMgt), behavior therapy (Beh), their combination (Comb), and usual community care (CC) differed at 14 and 24 months due to superiority of treatments that used the MTA medication algorithm (Comb+MedMgt)…

  15. Boon of MTA Apexification in Young Permanent Posterior Teeth.

    PubMed

    Kumar, Vinod; Zameer, Mohammed; Prasad, Vijaya; Mahantesh, T

    2014-01-01

    Single visit apexification using mineral trioxide aggregate (MTA) is a new boon in effective management of nonvital tooth with an open apex which has steadily gained popularity with clinicians; also it shortens the treatment period and improves patient compliance. Importance of this approach lies in expedient cleaning and shaping of the root canal system, followed by its apical seal with MTA. There are several case reports available describing the use of MTA as an apexification agent in incisors and premolar, but presented cases are the unique case reports demonstrating successful apexification procedure using MTA in young permanent mandibular molars. After eight-month follow-up, teeth were without any abnormal clinical symptoms; rather there were radiographic resolution of the periapical lesion and induction of root end closure with new hard tissue formation over MTA. PMID:25431690

  16. Boon of MTA Apexification in Young Permanent Posterior Teeth

    PubMed Central

    Kumar, Vinod; Prasad, Vijaya; Mahantesh, T.

    2014-01-01

    Single visit apexification using mineral trioxide aggregate (MTA) is a new boon in effective management of nonvital tooth with an open apex which has steadily gained popularity with clinicians; also it shortens the treatment period and improves patient compliance. Importance of this approach lies in expedient cleaning and shaping of the root canal system, followed by its apical seal with MTA. There are several case reports available describing the use of MTA as an apexification agent in incisors and premolar, but presented cases are the unique case reports demonstrating successful apexification procedure using MTA in young permanent mandibular molars. After eight-month follow-up, teeth were without any abnormal clinical symptoms; rather there were radiographic resolution of the periapical lesion and induction of root end closure with new hard tissue formation over MTA. PMID:25431690

  17. Confidentiality: a modified value.

    PubMed Central

    Emson, H E

    1988-01-01

    In its original expression as a medical value confidentiality may have been absolute; this concept has become eroded by patient consent, legal actions and change in the climate of public opinion. In particular requirements arising out of legal statutes and common law judgements have greatly modified the confidentiality of the doctor-patient relationship in societies deriving their law from English origins. Despite this, confidentiality remains a value which the physician must strive to preserve. He cannot however do this without considering its effect upon possible innocent third parties. PMID:3392723

  18. Confidentiality and the courts.

    PubMed

    1982-12-11

    Three cases reported by medical defense societies from Great Britain, South Africa, and New Zealand are presented to illustrate legal difficulties which can arise from the conflict between the duty to preserve confidentiality in the physician patient relationship and legal requests for information. The first case illustrates how not to treat confidential information; the second presents a model of professional propriety; the third resolves a difficult problem sensibly and satisfactorily. PMID:11652382

  19. 47 CFR 90.665 - Authorization, construction and implementation of MTA licenses.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... of MTA licenses. 90.665 Section 90.665 Telecommunication FEDERAL COMMUNICATIONS COMMISSION (CONTINUED... Licensing and Use of Mta-Based Smr Systems in the 896-901/935-940 Mhz Band § 90.665 Authorization, construction and implementation of MTA licenses. (a) MTA licenses in the 896-901/935-940 MHz band will...

  20. Spheroid model study comparing the biocompatibility of Biodentine and MTA.

    PubMed

    Pérard, Matthieu; Le Clerc, Justine; Watrin, Tanguy; Meary, Fleur; Pérez, Fabienne; Tricot-Doleux, Sylvie; Pellen-Mussi, Pascal

    2013-06-01

    The primary objective of this study was to assess the biological effects of a new dentine substitute based on Ca₃SiO₅ (Biodentine™) for use in pulp-capping treatment, on pseudo-odontoblastic (MDPC-23) and pulp (Od-21) cells. The secondary objective was to evaluate the effects of Biodentine and mineral trioxide aggregate (MTA) on gene expression in cultured spheroids. We used the acid phosphatase assay to compare the biocompatibility of Biodentine and MTA. Cell differentiation was investigated by RT-qPCR. We investigated the expression of genes involved in odontogenic differentiation (Runx2), matrix secretion (Col1a1, Spp1) and mineralisation (Alp). ANOVA and PLSD tests were used for data analysis. MDPC-23 cells cultured in the presence of MTA had higher levels of viability than those cultured in the presence of Biodentine and control cells on day 7 (P = 0.0065 and P = 0.0126, respectively). For Od-21 cells, proliferation rates on day 7 were significantly lower in the presence of Biodentine or MTA than for control (P < 0.0001). Col1a1 expression levels were slightly lower in cells cultured in the presence of MTA than in those cultured in the presence of Biodentine and in control cells. Biodentine and MTA may modify the proliferation of pulp cell lines. Their effects may fluctuate over time, depending on the cell line considered. The observed similarity between Biodentine and MTA validates the indication for direct pulp-capping claimed by the manufacturers. PMID:23515903

  1. Structure of the corrinoid:coenzyme M methyltransferase MtaA from Methanosarcina mazei.

    PubMed

    Hoeppner, Astrid; Thomas, Frank; Rueppel, Alma; Hensel, Reinhard; Blankenfeldt, Wulf; Bayer, Peter; Faust, Annette

    2012-11-01

    The zinc-containing corrinoid:coenzyme M methyltransferase MtaA is part of the methanol-coenzyme M-methyltransferase complex of Methanosarcina mazei. The whole complex consists of three subunits: MtaA, MtaB and MtaC. The MtaB-MtaC complex catalyses the cleavage of methanol (bound to MtaB) and the transfer of the methyl group onto the cobalt of cob(I)alamin (bound to MtaC). The MtaA-MtaC complex catalyses methyl transfer from methyl-cob(III)alamin (bound to MtaC) to coenzyme M (bound to MtaA). The crystal structure of the MtaB-MtaC complex from M. barkeri has previously been determined. Here, the crystal structures of MtaA from M. mazei in a substrate-free but Zn(2+)-bound state and in complex with Zn(2+) and coenzyme M (HS-CoM) are reported at resolutions of 1.8 and 2.1 Å, respectively. A search for homologous proteins revealed that MtaA exhibits 23% sequence identity to human uroporphyrinogen III decarboxylase, which has also the highest structural similarity (r.m.s.d. of 2.03 Å for 306 aligned amino acids). The main structural feature of MtaA is a TIM-barrel-like fold, which is also found in all other zinc enzymes that catalyse thiol-group alkylation. The active site of MtaA is situated at the narrow bottom of a funnel such that the thiolate group of HS-CoM points towards the Zn(2+) ion. The Zn(2+) ion in the active site of MtaA is coordinated tetrahedrally via His240, Cys242 and Cys319. In the substrate-free form the fourth ligand is Glu263. Binding of HS-CoM leads to exchange of the O-ligand of Glu263 for the S-ligand of HS-CoM with inversion of the zinc geometry. The interface between MtaA and MtaC for transfer of the methyl group from MtaC-bound methylcobalamin is most likely to be formed by the core complex of MtaB-MtaC and the N-terminal segment (a long loop containing three α-helices and a β-hairpin) of MtaA, which is not part of the TIM-barrel core structure of MtaA. PMID:23090404

  2. Confidentiality and medical records

    PubMed Central

    Jones, R. V. H.; Richards, S. Jane

    1978-01-01

    Protecting confidential information disclosed to doctors has been one of the most important ethical traditions of the medical profession. However, the patient's right to such confidentiality is threatened because it is legally unclear how far ownership by Government of the paper on which NHS records are kept or of the computer system in which they are stored confers right of access. We hope the medical profession will examine this problem urgently and offer some suggestions as to how patients' confidences can continue to be protected in the future. PMID:702427

  3. Cryogenics for the MuCool Test Area (MTA)

    SciTech Connect

    Darve, Christine; Norris, Barry; Pei, Liu-Jin; /Fermilab

    2005-09-01

    MuCool Test Area (MTA) is a complex of buildings at Fermi National Accelerator Laboratory, which are dedicated to operate components of a cooling cell to be used for Muon Collider and Neutrino Factory R&D. The long-term goal of this facility is to test ionization cooling principles by operating a 25-liter liquid hydrogen (LH{sub 2}) absorber embedded in a 5 Tesla superconducting solenoid magnet. The MTA solenoid magnet will be used with RF cavities exposed to a high intensity beam. Cryogens used at the MTA include LHe, LN{sub 2} and LH{sub 2}. The latter dictates stringent system design for hazardous locations. The cryogenic plant is a modified Tevatron refrigerator based on the Claude cycle. The implementation of an in-house refrigerator system and two 300 kilowatt screw compressors is under development. The helium refrigeration capacity is 500 W at 14 K. In addition the MTA solenoid magnet will be batch-filled with LHe every 2 days using the same cryo-plant. This paper reviews cryogenic systems used to support the Muon Collider and Neutrino Factory R&D programs and emphasizes the feasibility of handling cryogenic equipment at MTA in a safe manner.

  4. Cryogenics for the MuCool Test Area (MTA)

    NASA Astrophysics Data System (ADS)

    Darve, Christine; Norris, Barry; Pei, Liujin

    2006-03-01

    MuCool Test Area (MTA) is a complex of buildings at Fermi National Accelerator Laboratory, which are dedicated to operate components of a cooling cell to be used for Muon Collider and Neutrino Factory R&D. The long-term goal of this facility is to test ionization cooling principles by operating a 25-liter liquid hydrogen (LH2) absorber embedded in a 5 Tesla superconducting solenoid magnet. The MTA solenoid magnet will be used with RF cavities exposed to a high intensity beam. Cryogens used at the MTA include LHe, LN2 and LH2. The latter dictates stringent system design for hazardous locations. The cryogenic plant is a modified Tevatron refrigerator based on the Claude cycle. The implementation of an in-house refrigerator system and two 300 kilowatt screw compressors is under development. The helium refrigeration capacity is 500 W at 14 K. In addition the MTA solenoid magnet will be batch-filled with LHe every 2 days using the same cryo-plant. This paper reviews cryogenic systems used to support the Muon Collider and Neutrino Factory R&D programs and emphasizes the feasibility of handling cryogenic equipment at MTA in a safe manner.

  5. Cryogenics for the MuCool Test Area (MTA)

    SciTech Connect

    Darve, Christine; Norris, Barry; Pei, Liujin

    2006-03-20

    MuCool Test Area (MTA) is a complex of buildings at Fermi National Accelerator Laboratory, which are dedicated to operate components of a cooling cell to be used for Muon Collider and Neutrino Factory R and D. The long-term goal of this facility is to test ionization cooling principles by operating a 25-liter liquid hydrogen (LH2) absorber embedded in a 5 Tesla superconducting solenoid magnet. The MTA solenoid magnet will be used with RF cavities exposed to a high intensity beam. Cryogens used at the MTA include LHe, LN2 and LH2. The latter dictates stringent system design for hazardous locations. The cryogenic plant is a modified Tevatron refrigerator based on the Claude cycle. The implementation of an in-house refrigerator system and two 300 kilowatt screw compressors is under development. The helium refrigeration capacity is 500 W at 14 K. In addition the MTA solenoid magnet will be batch-filled with LHe every 2 days using the same cryo-plant. This paper reviews cryogenic systems used to support the Muon Collider and Neutrino Factory R and D programs and emphasizes the feasibility of handling cryogenic equipment at MTA in a safe manner.

  6. 47 CFR 90.661 - MTA-based SMR service areas.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 47 Telecommunication 5 2010-10-01 2010-10-01 false MTA-based SMR service areas. 90.661 Section 90..., 851-869, 896-901, and 935-940 MHz Bands Policies Governing the Licensing and Use of Mta-Based Smr Systems in the 896-901/935-940 Mhz Band § 90.661 MTA-based SMR service areas. MTA licenses for...

  7. Case studies in confidentiality.

    PubMed

    Lowenthal, David

    2002-05-01

    Although a fundamental principle of psychiatric practice in general and psychotherapy in particular is that interactions and communications between clinician and patient are private, there are certain instances in which there is an affirmative obligation to break confidentiality, or in which such a breach is at least legally (if not ethically) permitted. The author examines the various situations in which a psychiatrist's obligation to maintain confidentiality is modified or even completely overridden by some other competing clinical, legal, or ethical principle or obligation. He reviews the duty to protect third parties (Tarasoff warnings), situations in which a psychiatrist's loyalties are divided between the patient and some other entity, person, or principle (dual agency issues), the release of information in emergencies, and the reporting of abuse. He also discusses the circle of confidentiality and which individuals are deemed to be inside and outside that circle. Guidelines for the use of clinical material in presentations and publications are reviewed. The author also considers how psychiatrists should deal with knowledge of past criminal behavior that they may obtain during the course of treatment. Finally, the author discusses the need to carefully document the rationale for whatever course of action is taken. PMID:15985872

  8. Parallelizing a DNA simulation code for the Cray MTA-2.

    PubMed

    Bokhari, Shahid H; Glaser, Matthew A; Jordan, Harry F; Lansac, Yves; Sauer, Jon R; Van Zeghbroeck, Bart

    2002-01-01

    The Cray MTA-2 (Multithreaded Architecture) is an unusual parallel supercomputer that promises ease of use and high performance. We describe our experience on the MTA-2 with a molecular dynamics code, SIMU-MD, that we are using to simulate the translocation of DNA through a nanopore in a silicon based ultrafast sequencer. Our sequencer is constructed using standard VLSI technology and consists of a nanopore surrounded by Field Effect Transistors (FETs). We propose to use the FETs to sense variations in charge as a DNA molecule translocates through the pore and thus differentiate between the four building block nucleotides of DNA. We were able to port SIMU-MD, a serial C code, to the MTA with only a modest effort and with good performance. Our porting process needed neither a parallelism support platform nor attention to the intimate details of parallel programming and interprocessor communication, as would have been the case with more conventional supercomputers. PMID:15838145

  9. MTA1 regulation of ERβ pathway in salivary gland carcinoma cells

    SciTech Connect

    Ohshiro, Kazufumi Kumar, Rakesh

    2015-09-04

    Abstracts: Although Metastatic-tumor antigen 1 (MTA1) is differentially expressed in metastatic cancer and coregulates the status and activity of nuclear receptors, its role upon estrogen receptor β (ERβ) – a potent tumor suppressor, remains poorly understood. Here we investigated whether MTA1 regulates the expression and functions of ERβ, an ER isoform predominantly expressed in salivary gland cancer cells. We found that the depletion of the endogenous MTA1 in the HSG and HSY salivary duct carcinoma cell lines enhances the expression of ERβ while MTA1 overexpression augmented the expression of ERβ in salivary duct carcinoma cells. Furthermore, MTA1 knockdown inhibited the proliferations and invasion of HSG and HSY cells. The noted ERβ downregulation by MTA1 overexpression involves the process of proteasomal degradation, as a proteasome inhibitor could block it. In addition, both MTA1 knockdown and ERβ overexpression attenuated the cell migration and inhibited the ERK1/2 signaling in the both cell lines. These findings imply that MTA1 dysregulation in a subset of salivary gland cancer might promote aggressive phenotypes by compromising the tumor suppressor activity of ERβ, and hence, MTA1-ERβ axis might serve a new therapeutic target for the salivary gland cancer. - Highlights: • MTA1 silencing upregulates ERβ expression in salivary gland carcinoma cells. • MTA1 overexpression downregulates ERβ expression via proteasomal degradation. • Upregulation of ERβ expression inhibits cell migration and ERK signaling. • MTA1 knockdown inhibits cell proliferation and invasion.

  10. 40 CFR 1036.815 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Reference Information § 1036.815 Confidential information. The provisions of 40 CFR 1068.10 apply for information you consider confidential. ... 40 Protection of Environment 34 2012-07-01 2012-07-01 false Confidential information....

  11. Gene Profiling of Mta1 Identifies Novel Gene Targets and Functions

    PubMed Central

    Eswaran, Jeyanthy; Kumar, Rakesh

    2011-01-01

    Background Metastasis-associated protein 1 (MTA1), a master dual co-regulatory protein is found to be an integral part of NuRD (Nucleosome Remodeling and Histone Deacetylation) complex, which has indispensable transcriptional regulatory functions via histone deacetylation and chromatin remodeling. Emerging literature establishes MTA1 to be a valid DNA-damage responsive protein with a significant role in maintaining the optimum DNA-repair activity in mammalian cells exposed to genotoxic stress. This DNA-damage responsive function of MTA1 was reported to be a P53-dependent and independent function. Here, we investigate the influence of P53 on gene regulation function of Mta1 to identify novel gene targets and functions of Mta1. Methods Gene expression analysis was performed on five different mouse embryonic fibroblasts (MEFs) samples (i) the Mta1 wild type, (ii) Mta1 knock out (iii) Mta1 knock out in which Mta1 was reintroduced (iv) P53 knock out (v) P53 knock out in which Mta1 was over expressed using Affymetrix Mouse Exon 1.0 ST arrays. Further Hierarchical Clustering, Gene Ontology analysis with GO terms satisfying corrected p-value<0.1, and the Ingenuity Pathway Analysis were performed. Finally, RT-qPCR was carried out on selective candidate genes. Significance/Conclusion This study represents a complete genome wide screen for possible target genes of a coregulator, Mta1. The comparative gene profiling of Mta1 wild type, Mta1 knockout and Mta1 re-expression in the Mta1 knockout conditions define “bona fide” Mta1 target genes. Further extensive analyses of the data highlights the influence of P53 on Mta1 gene regulation. In the presence of P53 majority of the genes regulated by Mta1 are related to inflammatory and anti-microbial responses whereas in the absence of P53 the predominant target genes are involved in cancer signaling. Thus, the presented data emphasizes the known functions of Mta1 and serves as a rich resource which could help us identify novel Mta

  12. Confidentiality in Childbirth Education

    PubMed Central

    Philipsen, Nayna C.

    2010-01-01

    Protecting the confidentiality of the personal information that childbirth educators receive from their clients is crucial. Without this respect for privacy, educators will not be able to get the information essential to meeting their objectives. Childbirth educators who work in schools may come under federal law that protects individual student records (Family Educational Rights and Privacy Act, or FERPA). Childbirth educators who are employed in a health-care facility may come under federal law that protects individual health information (Health Insurance Portability and Accountability Act, or HIPAA). All childbirth educators must be thoughtful advocates of the rights to privacy and self-determination of expectant parents. PMID:21358833

  13. Unifying Theories of Confidentiality

    NASA Astrophysics Data System (ADS)

    Banks, Michael J.; Jacob, Jeremy L.

    This paper presents a framework for reasoning about the security of confidential data within software systems. A novelty is that we use Hoare and He's Unifying Theories of Programming (UTP) to do so and derive advantage from this choice. We identify how information flow between users can be modelled in the UTP and devise conditions for verifying that system designs may not leak secret information to untrusted users. We also investigate how these conditions can be combined with existing notions of refinement to produce refinement relations suitable for deriving secure implementations of systems.

  14. Prognostic correlation between MTA2 expression level and colorectal cancer

    PubMed Central

    Ding, Weijun; Hu, Wei; Yang, Haihua; Ying, Ting; Tian, Ye

    2015-01-01

    Objectives: Association of MTA2 expression with presence, development, metastasis and prognosis of colorectal cancer (CRC) was investigated. Methods: 90 CRC-related cases with follow-up information were made into tissue microarrays according to the paired principle of cancer tissues and the adjacent tissues. Subsequently, the expression of MAT2 was detected with immunohistochemical analysis and SPSS software was finally utilized to analyze the relationships between experimental data and clinical indicatives. Results: Expression of MTA2 in CRC tissues were notably higher than their adjacent tissues (P < 0.001) and showed significant positive correlation with tumor grade (r2 > 0, P < 0.01). Moreover, survival analysis indicated that MTA2 expression in cancer tissues, serving as an independent correlation factor, was significantly correlated with poor prognosis (P = 0.004). Conclusions: MTA2 is a crucial biomarker that is closely related with prognosis of CRC and also a potential molecular target for evaluating the prognosis and treatment of CRC. PMID:26261611

  15. Delayed tooth replantation: MTA as root canal filling.

    PubMed

    Panzarini, Sônia Regina; Sonoda, Celso Koogi; Saito, Célia Tomiko Matida Hamata; Hamanaka, Elizane Ferreira; Poi, Wilson Roberto

    2014-01-01

    MTA has been investigated as a root-end filling material. Its mechanism of action has some similarities to that of Ca(OH)2. The purpose of this study was to evaluate the repair process taking place in the delayed replantation of monkey teeth using calcium hydroxide and MTA as root canal filling materials. Five monkeys had their lateral incisors extracted and bench-dried for 60 minutes. After root canal preparation, the teeth were assigned to two groups according to root canal filling material: I, calcium hydroxide; and II, MTA. The same treatment sequence was followed for both groups: coronal seal, periodontal ligament removal, immersion of the tooth in 2% acidulated-phosphate sodium fluoride, irrigation of the socket with saline and replantation. Both groups exhibited replacement resorption, areas of ankylosis and absence of inflammatory root resorption. Statistically similar results (p > 0.05) were observed for both groups regarding replacement root resorption, but the groups differed significantly (p < 0.05) regarding the occurrence of ankylosis. MTA may be a viable clinical option for filling teeth submitted to delayed replantation, and is an acceptable option for treating replanted permanent teeth in order to prevent tooth resorption, particularly when dressing changes are not possible. PMID:25337936

  16. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis

    PubMed Central

    Shi, Wei; Hu, Jiangfeng; Zhu, Shizhang; Shen, Xiaoying; Zhang, Xiaoyan; Yang, Changqing; Gao, Hengjun; Zhang, Hao

    2015-01-01

    The aim of this study was to investigate the relationship among MTA2, Ki-67 and HCC patient prognosis. Tissue microarray and immunohistochemistry were used to detect the expression of MTA2 and Ki-67 in HCC samples and corresponding adjacent samples. We found MTA2 and Ki-67 were both increased in HCC tissues than those in adjacent tissues and nuclear MTA2 was associated with Ki-67 (P = 0.019). Moreover, nuclear MTA2 was a risk factor of distant metastasis in patients with HCC andKi-67 showed a negative correlation with histological grade (P < 0.05, P < 0.01, respectively). Multivariate Cox model analysis revealed that Ki-67 expression was an independent prognosis factor in HCC patients (P = 0.020). These results indicated there might be a tight correlation among MTA2, Ki-67 and HCC prognosis. MTA2 combined with Ki-67 might be used to predict HCC patient prognosis. PMID:26722504

  17. Postmortem Confidentiality: An Ethical Issue

    ERIC Educational Resources Information Center

    Bradley, Loretta J.; Hendricks, Bret; Kabell, Douglas R.

    2011-01-01

    In an era of increased need and expectation for confidentiality, the counseling record of the deceased client challenges confidentiality. Using ethical codes and legal mandates, the authors explore whether the counseling record of a deceased client should be released when the client's will and the client's counseling records are silent on this…

  18. An In Vitro Comparison of Marginal Adaptation of MTA and MTA-Like Materials in the Presence of PBS at One-Week and Two-Month Intervals

    PubMed Central

    Ghorbanzadeh, Abdollah; Shokouhinejad, Noushin; Fathi, Bita; Raoof, Maryam; Khoshkhounejad, Mehrfam

    2014-01-01

    Objective: This study compared the marginal adaptation of mineral trioxide aggregate (MTA) and MTA-like materials as root-end fillings after incubation in phosphate buffer saline (PBS), a synthetic tissue fluid, for either 1 week or 2 months. Materials and Methods: In this experimental study, seventy-two extracted human single-rooted teeth were prepared and obturated with gutta-percha and AH26 sealer. The apical 3 mm of the roots were resected. Root-end cavities were prepared with an ultrasonic retrotip. The specimens were randomly divided into three groups (n=24) and filled with either ProRoot MTA, OrthoMTA, or RetroMTA. Half of the specimens in each group were stored in PBS for 1 week the other half for 2 months. Epoxy resin replicas from the resected root-end surfaces and longitudinally sectioned roots were fabricated. The gaps at the material/dentin interface were measured using a scanning electron microscope (SEM). Transversal, longitudinal, and overall gap sizes were measured. The data were analyzed using Kruskal-Wallis and Mann-Whitney tests. The significance level was set at p < 0.05. Results: There were no significant differences between the marginal adaptation of ProRoot MTA, RetroMTA, and OrthoMTA in both transverse and longitudinal sections after incubation for either 1 week or 2 months (p > 0.05). In addition, the test groups were not significantly different regarding the overall mean gap values (p > 0.05). Conclusion: Under the conditions of this study, there was no difference between the marginal adaptation of ProRoot MTA, OrthoMTA, and RetroMTA as root-end filling materials after exposure to PBS for either 1 week or 2 months. PMID:25628683

  19. Evaluation of Antibacterial Efficacy of MTA with and without Additives Like Silver Zeolite and Chlorhexidine

    PubMed Central

    Patil, Anand; Giriyappa, Ramesh Halebathi; Singh, Thakur Veerandar; Jyotsna, Sistla Venkata; Rairam, Surabhi

    2016-01-01

    Introduction Microorganisms, predominantly Enterococcus faecalis are found responsible in the progression of pulpal, periradicular diseases and in endodontic failures. Unsuccessful conventional treatment might necessitate the need for a surgical approach; where in retrograde restorative materials are used to seal the apex. Among the root end filling materials, Mineral Trioxide Aggregate (MTA) is considered biocompatible and is most commonly used in clinical applications but it has limited antibacterial activity. Metallic silver and chlorhexidine have been added into various dental materials to enhance the antibacterial activity. Aim This study aimed to compare the antibacterial effect of MTA, MTA mixed with silver zeolite and MTA mixed with chlorhexidine against Enterococcus faecalis. Materials and Methods Test materials used in the study were divided into three groups namely Group 1- MTA, Group 2-MTA + Silver Zeolite, Group 3-MTA + Chlorhexidine. Direct contact test was done by placing a standardized suspension of Enterococcus faecalis on the test materials in a 96 well microtiter plate. The bacterial growth was measured spectrophotometrically using ELISA reader at intervals of one, three and seven days. Statistical Analysis Data was collected by recording the optical density and analyzed using two-way ANOVA and Tukey’s multiple post hoc test followed by paired-t test. Results and Conclusion All test groups showed antibacterial activity against Enterococcus faecalis at day one, three and seven. MTA with silver zeolite showed the maximum antibacterial activity followed by MTA with 2% chlorhexidine. The least antibacterial effect was shown by MTA mixed with sterile water. PMID:27504400

  20. PROTECTING CONFIDENTIALITY IN ESTABLISHMENT SURVEYS

    EPA Science Inventory

    This invited chapter for an International Monograph on Survey Methods inEstablishment Surveys summarizes methods for protecting respondent confidentiality in establishment surveys and includes open research problems and an extensive bibliography. t will be summarized in an invite...

  1. MTA resorption and periradicular healing in an open-apex incisor: A case report

    PubMed Central

    Asgary, Saeed; Ehsani, Sara

    2011-01-01

    This case report describes the periradicular healing and resorption of an unintentional extrusion of mineral trioxide aggregate (MTA) in an open-apex central incisor. A 22-year old female with a symptomatic open-apex right maxillary central incisor associated with a periradicular lesion was referred for evaluation and treatment. After chemomechanical debridement, the apical third of the root canal was filled with MTA to create an apical plug. Postoperative radiographs showed the extrusion of MTA into the periradicular lesion. The tooth was then restored with a post and crown. At the 2-year follow-up, the tooth was asymptomatic and radiographs revealed complete healing of the periradicular area. At the 7-year follow-up, complete resorption of the extruded MTA was evident. The results of this case study indicate that complete resorption of extruded MTA is possible in the long term; however, the extrusion of MTA in open-apex tooth should still be avoided. PMID:23960529

  2. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 47 Telecommunication 5 2010-10-01 2010-10-01 false MTA-based SMR system operations. 90.663 Section... 806-824, 851-869, 896-901, and 935-940 MHz Bands Policies Governing the Licensing and Use of Mta-Based Smr Systems in the 896-901/935-940 Mhz Band § 90.663 MTA-based SMR system operations. (a)...

  3. Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor.

    PubMed

    Kumar, Arathy S; Jagadeeshan, Sankar; Subramanian, Anirudh; Chidambaram, Saravana Babu; Surabhi, Rohan Prasad; Singhal, Mahak; Bhoopalan, Hemadev; Sekar, Sathiya; Pitani, Ravi Shankar; Duvuru, Prathiba; Venkatraman, Ganesh; Rayala, Suresh K

    2016-06-01

    Parkinson disease (PD) is a neurodegenerative disorder with loss of dopaminergic neurons of the brain, which results in insufficient synthesis and action of dopamine. Metastasis-associated protein 1 (MTA1) is an upstream modulator of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, and hence MTA1 plays a significant role in PD pathogenesis. To impart functional and clinical significance to MTA1, we analyzed MTA1 and TH levels in the substantia nigra region of a large cohort of human brain tissue samples by Western blotting, quantitative PCR, and immunohistochemistry. Our results showed that MTA1 and TH levels were significantly down-regulated in PD samples as compared with normal brain tissue. Correspondingly, immunohistochemistry analysis for MTA1 in substantia nigra sections revealed that 74.1% of the samples had a staining intensity of <6 in the PD samples as compared with controls, 25.9%, with an odds ratio of 8.54. Because of the clinical importance of MTA1 established in PD, we looked at agents to modulate MTA1 expression in neuronal cells, and granulocyte colony-stimulating factor (G-CSF) was chosen, due to its clinically proven neurogenic effects. Treatment of the human neuronal cell line KELLY and acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model with G-CSF showed significant induction of MTA1 and TH with rescue of phenotype in the mouse model. Interestingly, the observed induction of TH was compromised on silencing of MTA1. The underlying molecular mechanism of MTA1 induction by G-CSF was proved to be through induction of c-Fos and its recruitment to the MTA1 promoter. PMID:27044752

  4. A laboratory assessment of bacterial leakage in MTA apical plugs exposed to phosphate-buffered saline.

    PubMed

    de Almeida, Josiane; Pimenta, Andrea L; Felippe, Wilson T

    2015-08-01

    This study evaluated the influence of the exposure of mineral trioxide aggregate (MTA) - with and without calcium chloride (CaCl2) -to phosphate-buffered saline (PBS) on apical microleakage. Sixty root segments were divided into 4 experimental groups (n=15). Apical cavities were filled with MTA with or without CaCl2, and the root canals dressed with a moistened cotton pellet or PBS: 1) MTA/cotton pellet; 2) MTA/PBS; 3) MTA+ 10%CaCl2/cotton pellet; 4) MTA+10%CaCl2/PBS. After 2 months, E. faecalis penetration was analyzed along the apical plugs. Samples were observed weekly for 70 days, and leakage was detected by turbidity of the medium in contact with the root segment. Teeth in the control groups (n=2) were either made completely impermeable or kept without an apical plug. The Kaplan-Meier method was used to analyze survival and the Logrank test was used to compare the survival curves (p<0.05). All specimens in the positive control group showed evidence of leakage within 24h, while none in the negative control group showed leakage up to 70 days. There was no statistically significant difference among the experimental groups (p=0.102). The use of PBS as intracanal dressing may improve MTA sealing ability, but cannot prevent bacterial leakage. The addition of CaCl2 to the MTA did not improve MTA sealing ability. PMID:26355884

  5. 20 CFR 603.10 - What are the requirements for agreements?

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... INFORMATION Confidentiality and Disclosure Requirements § 603.10 What are the requirements for agreements? (a) Requirements. (1) For disclosures of confidential UC information under § 603.5(d)(2) (to a third party (other... agreement with any agency or entity requesting disclosure(s) of such information. The agreement must...

  6. Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth

    PubMed Central

    2010-01-01

    Background Melanoma is the most deadly form of skin cancer without effective treatment. Methylthioadenosine (MTA) is a naturally occurring nucleoside with differential effects on normal and transformed cells. MTA has been widely demonstrated to promote anti-proliferative and pro-apoptotic responses in different cell types. In this study we have assessed the therapeutic potential of MTA in melanoma treatment. Methods To investigate the therapeutic potential of MTA we performed in vitro proliferation and viability assays using six different mouse and human melanoma cell lines wild type for RAS and BRAF or harboring different mutations in RAS pathway. We also have tested its therapeutic capabilities in vivo in a xenograft mouse melanoma model and using variety of molecular techniques and tissue culture we investigated its anti-proliferative and pro-apoptotic properties. Results In vitro experiments showed that MTA treatment inhibited melanoma cell proliferation and viability in a dose dependent manner, where BRAF mutant melanoma cell lines appear to be more sensitive. Importantly, MTA was effective inhibiting in vivo tumor growth. The molecular analysis of tumor samples and in vitro experiments indicated that MTA induces cytostatic rather than pro-apoptotic effects inhibiting the phosphorylation of Akt and S6 ribosomal protein and inducing the down-regulation of cyclin D1. Conclusions MTA inhibits melanoma cell proliferation and in vivo tumor growth particularly in BRAF mutant melanoma cells. These data reveal a naturally occurring drug potentially useful for melanoma treatment. PMID:20529342

  7. Dietary Pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Dietary nutrients with ability to reverse adverse epigenetic events have great potential for cancer chemoprevention. Overexpression of the epigenetic modifier metastasis-associated protein 1 (MTA1) is associated with aggressive human prostate cancer. The purpose of this study was to determine MTA1-d...

  8. Data Confidentiality Challenges in Big Data Applications

    SciTech Connect

    Yin, Jian; Zhao, Dongfang

    2015-12-15

    In this paper, we address the problem of data confidentiality in big data analytics. In many fields, much useful patterns can be extracted by applying machine learning techniques to big data. However, data confidentiality must be protected. In many scenarios, data confidentiality could well be a prerequisite for data to be shared. We present a scheme to provide provable secure data confidentiality and discuss various techniques to optimize performance of such a system.

  9. Sealing ability of ProRoot MTA and MTA-Angelus simulating a one-step apical barrier technique--an in vitro study.

    PubMed

    Lolayekar, Nikita; Bhat, Sham S; Hegde, Sundeep

    2009-01-01

    Endodontic treatment of the pulpless tooth with an immature root apex poses a special challenge for the clinician due to lack of an apical stop against which to compact an interim dressing of calcium hydroxide, or the final obturation material. A one-visit apexification protocol with MTA (Mineral Trioxide Aggregate) has be seen as an alternative to the traditional treatment practices with calcium hydroxide [Ca(OH)2]. The aim of this study was to investigate the use of MTA as a 5mm apical barrier by comparing sealing ability of ProRoot MTA to that of MTA-Angelus. 50 freshly extracted Maxillary and Mandibular single canal sound human incisor teeth were used in this study, which were decoronated to standardized 10mm root lengths. The root segments were prepared to simulate the clinical situation of an open apex with Gates Glidden burs # 51 and randomly assigned into 2 experimental groups of 20 samples each (Group A: ProRoot MTA, Group B: MTA-Angelus) and 10 root segments were used as control (Group C) where no apical barrier was used. After obturation the coronal portion of all samples were sealed with Glass Ionomer and stored at 37 degrees C and 100% humidity for 4 weeks. The root segments were then double coated with nail varnish except for the apical 1mm and apical ends of all root segments were suspended vertically in methylene blue dye for 48 hours at room temperature. After removal from the dye, the samples were sectioned longitudinally and linear dye penetration was measured using a Grid and stereomicroscope. The measurements were tabulated and statistically analyzed. The mean percentage of dye leakage for Group A was 55.5% and for Group B was 53.25%. The results showed no statistically significant difference in the sealing ability of ProRoot MTA and MTA-Angelus when used as apical barriers. PMID:19725236

  10. Sealing Ability of MTA Used in Perforation Repair of Permanent Teeth; Literature Review

    PubMed Central

    Baroudi, Kusai; Samir, Samah

    2016-01-01

    There were several materials used to seal different types of perforation defects. MTA is one of these restorative materials that is considered the most effective, biocompatible, non-toxic, and non-irritant; promote bone healing and cementum regeneration. The objective of this article was to review and summarize the sealing ability of MTA compared with the other materials used for sealing different types of root perforations of permanent teeth. A literature search was conducted using Medline, accessed via the National Library of Medicine Pub Med from 2005 to 2015 searching for articles related to sealing ability of MTA. This study found that factors affecting prognosis are the size, site of the perforation and time elapsed as well as the repair material. MTA is an important filling material to be used for sealing different types of perforations when perforated sites sealed immediately with MTA. PMID:27347231

  11. Sealing Ability of MTA Used in Perforation Repair of Permanent Teeth; Literature Review.

    PubMed

    Baroudi, Kusai; Samir, Samah

    2016-01-01

    There were several materials used to seal different types of perforation defects. MTA is one of these restorative materials that is considered the most effective, biocompatible, non-toxic, and non-irritant; promote bone healing and cementum regeneration. The objective of this article was to review and summarize the sealing ability of MTA compared with the other materials used for sealing different types of root perforations of permanent teeth. A literature search was conducted using Medline, accessed via the National Library of Medicine Pub Med from 2005 to 2015 searching for articles related to sealing ability of MTA. This study found that factors affecting prognosis are the size, site of the perforation and time elapsed as well as the repair material. MTA is an important filling material to be used for sealing different types of perforations when perforated sites sealed immediately with MTA. PMID:27347231

  12. 37 CFR 382.14 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 382... Confidential information. (a) Definition. For purposes of this subpart, “Confidential Information” shall include the statements of account and any information contained therein, including the amount of...

  13. 37 CFR 261.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 261... THE MAKING OF EPHEMERAL REPRODUCTIONS § 261.5 Confidential information. (a) For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein,...

  14. 37 CFR 384.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 384... BUSINESS ESTABLISHMENT SERVICES § 384.5 Confidential information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein,...

  15. 32 CFR 806b.9 - Confidentiality promises.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 32 National Defense 6 2010-07-01 2010-07-01 false Confidentiality promises. 806b.9 Section 806b.9 National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE ADMINISTRATION PRIVACY ACT PROGRAM Obtaining Law Enforcement Records and Confidentiality Promises § 806b.9 Confidentiality...

  16. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... the trade secret chemical identity to the health purposes indicated in the written statement of need... designated representative, or the health professional to disclose the trade secret chemical identity to MSHA... professional inform the operator who provided the trade secret chemical identity prior to or at the same...

  17. College Confidential: A Field Guide

    ERIC Educational Resources Information Center

    Hoover, Eric

    2013-01-01

    Day and night the locals chatter. They counsel and console, bicker and rant. Their questions are endless. Though often hopeful, they never stop pounding the drums of worry. This is College Confidential, a vast virtual realm where visitors can find the best and worst of human nature. Here, in moderated discussion forums, people help strangers. They…

  18. Confidential Training Needs Assessment Report.

    ERIC Educational Resources Information Center

    Williams, Jean; Ingram, Cynthia

    In 1988, Patrick Henry Community College (PHCC), in cooperation with Virginia Polytechnic Institute and State University, conducted a confidential survey of members of the Henry County Sheriff's Department and the Martinsville Police Department to determine training needs. Groups of between 1 and 15 employees from all shifts and departments were…

  19. Confidential inquiry into malaria deaths.

    PubMed Central

    Dürrheim, D. N.; Frieremans, S.; Kruger, P.; Mabuza, A.; de Bruyn, J. C.

    1999-01-01

    The results of a confidential inquiry into mortality attributed to malaria in South Africa's Mpumalanga Province are being used to guide the design of strategies for improving the management of cases and reducing the probability of deaths from the disease. PMID:10212518

  20. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer

    PubMed Central

    Zhang, Liangfen; Rimando, Agnes M.; Lage, Janice M.; Lewin, Jack R.; Atfi, Azeddine; Zhang, Xu; Levenson, Anait S.

    2016-01-01

    Overexpression of the epigenetic modifier metastasis-associated protein 1 (MTA1) is associated with aggressive human prostate cancer. The purpose of this study was to determine MTA1- targeted chemopreventive and therapeutic efficacy of pterostilbene, a natural potent analog of resveratrol, in pre-clinical models of prostate cancer. Here, we show that high levels of MTA1 expression in Pten-loss prostate cooperate with key oncogenes, including c-Myc and Akt among others, to promote prostate cancer progression. Loss-of-function studies using human prostate cancer cells indicated direct involvement of MTA1 in inducing inflammation and epithelial-to-mesenchymal transition. Importantly, pharmacological inhibition of MTA1 by pterostilbene resulted in decreased proliferation and angiogenesis and increased apoptosis. This restrained prostatic intraepithelial neoplasia (PIN) formation in prostate-specific Pten heterozygous mice and reduced tumor development and progression in prostate-specific Pten-null mice. Our findings highlight MTA1 as a key upstream regulator of prostate tumorigenesis and cancer progression. More significantly, it offers pre-clinical proof for pterostilbene as a promising lead natural agent for MTA1-targeted chemopreventive and therapeutic strategy to curb prostate cancer. PMID:26943043

  1. Comprehensive versus matched psychosocial treatment in the MTA study: conceptual and empirical issues.

    PubMed

    Wells, K C

    2001-03-01

    Addressed some factual inaccuracies and presented alternative positions on key issues raised in the article by Greene and Ablon (this issue) on the question, "What does the Multimodal Treatment Study (MTA) tell us about effective psychosocial treatment for attention deficit hyperactivity disorder (ADHD)?" The Greene and Ablon critique does not present for the reader's consideration the full range of findings from the MTA study, notably those most relevant to psychosocial treatment, and articulates a theoretical position that effective treatment requires matching treatment to children's assessed needs, an approach not taken in the MTA study. In this article, I present the full range of findings from the MTA study related to psychosocial treatment effects, correct the misperceptions that exist about the study based on limited reviews such as Greene and Ablon's, and review the empirical and experimental design issues that produced the decision by the MTA investigative team to study the effects of intensive, comprehensive psychosocial treatment. I argue that the questions asked by the MTA study about psychosocial treatment were important, relevant, and were addressed well in the MTA study design. PMID:11294072

  2. Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator*

    PubMed Central

    Bui-Nguyen, Tri M.; Pakala, Suresh B.; Sirigiri, Divijendranatha Reddy; Martin, Emil; Murad, Ferid; Kumar, Rakesh

    2010-01-01

    Nitric oxide has been implicated in the pathogenesis of inflammatory disorders, including hepatitis B virus-associated hepatocellular carcinoma. Transactivator protein HBx, a major regulator of cellular responses of hepatitis B virus, is known to induce the expression of MTA1 (metastasis-associated protein 1) coregulator via NF-κB signaling in hepatic cells. However, the underlying mechanism of HBx regulation of the inducible nitric-oxide synthase (iNOS) pathway remains unknown. Here we provide evidence that MTA1 is a positive regulator of iNOS transcription and plays a mechanistic role in HBx stimulation of iNOS expression and activity. We found that the HBx-MTA1 complex is recruited onto the human iNOS promoter in an NF-κB-dependent manner. Pharmacological inhibition of the NF-κB signaling prevented the ability of HBx to stimulate the transcription, the expression, and the activity of iNOS; nevertheless, these effects could be substantially rescued by MTA1 dysregulation. We further discovered that HBx-mediated stimulation of MTA1 is paralleled by the suppression of miR-661, a member of the small noncoding RNAs, recently shown to target MTA1. We observed that miR-661 controls of MTA1 expression contributed to the expression and activity of iNOS in HBx-expressing HepG2 cells. Accordingly, depletion of MTA1 by either miR-661 or siRNA in HBx-expressing cells severely impaired the ability of HBx to modulate the endogenous levels of iNOS and nitrite production. Together, these findings reveal an inherent role of MTA1 in HBx regulation of iNOS expression and consequently its function in the liver cancer cells. PMID:20022949

  3. Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE.

    PubMed

    Ghoddusi, Jamileh; Shahrami, Fatemeh; Alizadeh, Mahyareh; Kianoush, Kamyar; Forghani, Maryam

    2012-04-01

    The purpose of this study was to report the success rate of using mineral trioxide aggregate (MTA) and zinc oxide eugenol (ZOE) as vital pulp therapy agents in immature permanent teeth with carious or traumatic pulp exposure. Subjects were children with permanent teeth requiring pulpotomy (apexogenesis) and without systemic diseases. Both ZOE and MTA treatments as pulpotomy agents showed clinical and radiographic success in immature permanent teeth. Although MTA was more successful, it is more expensive, and dentin bridges may develop over canal orifices, complicating future root canal therapy. PMID:22803275

  4. Proposal for high pressure RF cavity test in the MTA

    SciTech Connect

    Yonehara, K.; /Fermilab

    2010-09-01

    In order to demonstrate the feasibility of high pressure hydrogen gas filled RF (HPRF) cavities for muon ionization cooling, an HPRF cavity must be tested with a high intensity charged beam. When an HPRF cavity is irradiated with an intense beam each incident particle generates about 1000 electrons and ions per cubic centimeter in a high pressure cavity via ionization. These ionization electrons are influenced by the RF field and the RF quality factor goes down. This Q factor reduction will be a problem with a multi bunch beam, e.g., a muon beam for a muon collider consists of a 12 to 20 bunch train beam with 5 ns timing gap. Thus, the RF field must recover in few nano seconds. We propose to use a 400 MeV proton beam in the MTA and measure a beam loading effect in the HPRF cavity and study the recovery mechanism of the RF field.

  5. Comparison of sealing ability of ProRoot MTA, RetroMTA, and Biodentine as furcation repair materials: An ultraviolet spectrophotometric analysis

    PubMed Central

    Sinkar, Roshan Chandrakant; Patil, Sanjay S; Jogad, Nitin P; Gade, Vandana J

    2015-01-01

    Aim: To evaluate the sealing ability of ProRooT MTA, RetroMTA, and Biodentine as furcation repair materials using dye extraction leakage method. Materials and Methods: Thirty-five mandibular molars were randomly divided into four groups according to the material used for perforation repair. Group I — ProRoot MTA (10 samples), Group II — RetroMTA (10 samples), Group III — Biodentine (10 samples), and Group IV (Control) — left unrepaired (5 samples). All samples were subjected to orthograde and retrograde Methylene blue dye challenge followed by dye extraction with concentration 65% nitric acid. Samples were then analyzed using ultraviolet-visible spectrophotometer using 550 nm wave lengths. Statistical Analysis: One-way analysis of variance, Tukey-Kramer multiple comparisons test. Results: Biodentine showed least dye absorbance while RetroMTA showed highest dye absorbance values when compared with other repair materials. Conclusion: Within the limitations of this study, it was observed that Biodentine showed better sealing ability when compared with other root repair materials. PMID:26752836

  6. Superintendent Searches: Public or Confidential? Why Confidentiality Contributes to Quality Searches

    ERIC Educational Resources Information Center

    Attea, William J.

    2010-01-01

    When a highly qualified candidate learns the search will be conducted confidentially, a positive response is almost certain, in the author's experience running superintendent searches since 1988. Just as likely, the prospective candidate responds negatively to being told the search process will not be confidential. Confidentiality is the item of…

  7. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 13 Business Credit and Assistance 1 2010-01-01 2010-01-01 false Confidentiality of Reports, Risk Ratings and related Confidential Information. 120.1060 Section 120.1060 Business Credit and Assistance SMALL BUSINESS ADMINISTRATION BUSINESS LOANS Risk-Based Lender Oversight Supervision § 120.1060 Confidentiality of Reports, Risk Ratings and...

  8. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 13 Business Credit and Assistance 1 2013-01-01 2013-01-01 false Confidentiality of Reports, Risk Ratings and related Confidential Information. 120.1060 Section 120.1060 Business Credit and Assistance... section. The Report, Risk Rating, and Confidential Information must not be relied upon for any...

  9. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 13 Business Credit and Assistance 1 2011-01-01 2011-01-01 false Confidentiality of Reports, Risk Ratings and related Confidential Information. 120.1060 Section 120.1060 Business Credit and Assistance... section. The Report, Risk Rating, and Confidential Information must not be relied upon for any...

  10. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 13 Business Credit and Assistance 1 2014-01-01 2014-01-01 false Confidentiality of Reports, Risk Ratings and related Confidential Information. 120.1060 Section 120.1060 Business Credit and Assistance... section. The Report, Risk Rating, and Confidential Information must not be relied upon for any...

  11. Bioinformatic exploration of MTA1-regulated gene networks in colon cancer.

    PubMed

    Li, Chunxiao; Wang, Haijuan; Lin, Feng; Li, Hui; Wen, Tao; Qian, Haili; Zhan, Qimin

    2016-06-01

    Metastasis-associated gene 1 (MTA1) controls a series of biological processes in tumor progression. Tumor progression is a complex process regulated by a gene network. The global cancer gene regulatory network must be analyzed to determine the position of MTA1 in the molecular network and its cooperative genes by further exploring the biological functions of this gene. We used TCGA data sets and GeneCards database to screen MTA1-related genes. GO and KEGG pathway analyses were conducted with DAVID and gene network analysis via STRING and Cytoscape. Results showed that in the development of colon cancer, MTA1 is linked to certain signal pathways, such as Wnt/Notch/nucleotide excision repair pathways. The findings also suggested that MTA1 demonstrates the closest relationship in a coregulation process with the key molecules AKT1, EP300, CREBBP, SMARCA4, RHOA, and CAD. These results lead MTA1 exploration to an in-depth investigation in different directions, such as Wnt, Notch, and DNA repair. PMID:27052252

  12. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression

    PubMed Central

    Wang, Jiang; Ren, Ye; Li, Mi; Li, Hao; Cai, Zhuo; Chu, Qian; Yang, Caihong

    2016-01-01

    The stress response gene activating transcription factor 4 (ATF4) is involved in metastatic behavior and cellular protection. Here we show that ATF4 is upregulated in osteosarcoma (OS) cell lines and patient clinical samples as compared to matched non-tumor tissue. Overexpression of ATF4 in OS cells promoted cell proliferation, migration and lung metastasis. Furthermore, the expression of ATF4 was markedly reduced in metastasis associated protein (MTA1) or histone deacetylase 1 (HDAC1) knockdown OS cells, but MTA1 overexpression increased the stability and activity of ATF4 protein via ATF4 deacetylation by HDAC1. ATF4 in turn enhanced the expression of MTA1 and HDAC1 at the transcription level, suggesting a positive feedback loop between ATF4 and MTA1/HDAC1. Clinically, the level of ATF4 was positively correlated with that of MTA1 in OS. Mice injected with ATF4-overexpressing cells exhibited a higher rate of tumor growth, and the average weight of these tumors was ×90% greater than the controls. Taken together, these data establish a direct correlation between ATF4-induced OS progression and MTA1/HDAC1-associated metastasis, and support the potential therapeutic value of targeting ATF4 in the treatment of OS. PMID:26797758

  13. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  14. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  15. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  16. 12 CFR 978.5 - Storage of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... confidential information in its possession; and (c) Establish an internal review of its procedures for storing confidential information and maintaining its confidentiality, as a part of its internal audit process....

  17. 12 CFR 978.5 - Storage of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... confidential information in its possession; and (c) Establish an internal review of its procedures for storing confidential information and maintaining its confidentiality, as a part of its internal audit process....

  18. 12 CFR 978.5 - Storage of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... confidential information in its possession; and (c) Establish an internal review of its procedures for storing confidential information and maintaining its confidentiality, as a part of its internal audit process....

  19. Confidentiality, ethics, and the law.

    PubMed

    1984-02-25

    This brief report discusses the British Medical Association's reservations concerning two bills pending in the House of Commons. Clauses in the Data Protection Bill pertaining to accessing and transferring computerized information could affect physicians' ability to protect the confidentiality of patients' records. A code of guidance proposed by the government would apply only within the National Health Service and not to outside data users. The Police and Criminal Evidence Bill is the second piece of legislation being monitored by the BMA. Its provision for intimate body searches of prisoners without consent has prompted the Home Office to request guidance from the BMA and the General Medical Council. PMID:11653572

  20. Confidentiality and American semen donors.

    PubMed

    Karow, A M

    1993-01-01

    Most American donor insemination programs include a policy of complete confidentiality concerning the donor of the semen. This is the result of a long legal tradition of American constitutional law. However, some slight abridgement of this body of legal decisions might be very much in the best interests of children arising from donor insemination, and even--in most cases, in fact--the donors themselves. With regard to the children, the factors involved are both those of genetic counseling, should the need arise, and psychological development. Of course, as at present, the donor must be relieved of all responsibility, both legal and financial. PMID:8348162

  1. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Confidentiality. 821.55 Section 821.55 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient receiving a device subject to...

  2. 40 CFR 57.606 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... section 114 of the Act and 40 CFR part 2 shall govern the confidentiality of any data or information... 40 Protection of Environment 5 2010-07-01 2010-07-01 false Confidentiality. 57.606 Section 57.606 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED)...

  3. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 4 2011-01-01 2011-01-01 false Confidential information. 406.117 Section 406.117 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a)...

  4. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 4 2010-01-01 2010-01-01 false Confidential information. 406.117 Section 406.117 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a)...

  5. 46 CFR 249.11 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 8 2010-10-01 2010-10-01 false Confidentiality. 249.11 Section 249.11 Shipping MARITIME ADMINISTRATION, DEPARTMENT OF TRANSPORTATION REGULATIONS AFFECTING SUBSIDIZED VESSELS AND OPERATORS APPROVAL OF UNDERWRITERS FOR MARINE HULL INSURANCE § 249.11 Confidentiality. (a) If the data submitted under this...

  6. 37 CFR 262.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 262... information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein, including the amount of royalty payments, and...

  7. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 49 Transportation 6 2010-10-01 2010-10-01 false Confidential information. 537.12 Section 537.12... ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential information. (a) Information made available under § 537.11 for public inspection does not include information...

  8. 37 CFR 380.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 380... information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account and any information contained therein, including the amount of royalty payments,...

  9. 7 CFR 1205.209 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1205.209 Section 1205.209... Confidential information. (a) The ballots cast or the manner in which any person voted and all information.... (b) The ballots and other information or reports that reveal, or tend to reveal, the vote of...

  10. 31 CFR 9.6 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... information obtained from a person and privileged, within the meaning of 5 U.S.C. 552 and 31 CFR part 1, will... 31 Money and Finance: Treasury 1 2013-07-01 2013-07-01 false Confidential information. 9.6 Section... ON THE NATIONAL SECURITY § 9.6 Confidential information. Information submitted in confidence...

  11. 40 CFR 1037.815 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Information § 1037.815 Confidential information. The provisions of 40 CFR 1068.10 apply for information you... 40 Protection of Environment 34 2012-07-01 2012-07-01 false Confidential information. 1037.815 Section 1037.815 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR...

  12. 7 CFR 1217.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1217.107 Section 1217.107..., PROMOTION, CONSUMER EDUCATION AND INDUSTRY INFORMATION ORDER Referendum Procedures § 1217.107 Confidential information. The ballots and other information or reports that reveal, or tend to reveal, the vote of...

  13. 7 CFR 1160.608 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential information. 1160.608 Section 1160.608... Referenda in Connection with a Fluid Milk Promotion Order § 1160.608 Confidential information. The ballots cast, the identity of any person who voted, or the manner in which any person voted and all...

  14. 7 CFR 1170.12 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential information. 1170.12 Section 1170.12... Confidential information. Except as otherwise directed by the Secretary or the Attorney General for enforcement... information, statistics, or documents obtained from or submitted by any person in compliance with the...

  15. 7 CFR 1222.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1222.107 Section 1222.107... PROMOTION, RESEARCH AND INFORMATION ORDER Referendum Procedures § 1222.107 Confidential information. The ballots and other information or reports that reveal, or tend to reveal, the vote of any person...

  16. 7 CFR 1218.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1218.107 Section 1218.107..., AND INFORMATION ORDER Procedure for the Conduct of Referenda in Connection with the Blueberry Promotion, Research, and Information Order § 1218.107 Confidential information. The ballots and...

  17. 7 CFR 1250.207 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1250.207 Section 1250.207... Referendum Procedures § 1250.207 Confidential information. The ballots cast or the manner in which any person voted and all information furnished to, compiled by, or in the possession of the referendum agent...

  18. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Confidentiality claims. 716.55 Section 716.55 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT HEALTH AND SAFETY DATA REPORTING General Provisions § 716.55 Confidentiality claims. (a)(1) Section 14(b) of TSCA provides that EPA may...

  19. 40 CFR 710.38 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT TSCA CHEMICAL INVENTORY REGULATIONS 2002 Inventory Update Reporting § 710.38 Confidentiality. (a) Any person... if the identity of that substance is treated as confidential in the Master Inventory File as of...

  20. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment...

  1. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 31 Money and Finance: Treasury 1 2010-07-01 2010-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information collected pursuant to the Act will be kept in...

  2. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1210.607 Section 1210.607 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... PROMOTION PLAN Referendum Procedures § 1210.607 Confidential information. All ballots cast and...

  3. 7 CFR 930.73 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 930.73 Section 930.73 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Handling Reports and Records § 930.73 Confidential information. All reports and records furnished...

  4. 7 CFR 1170.12 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential information. 1170.12 Section 1170.12 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Confidential information. Except as otherwise directed by the Secretary or the Attorney General for...

  5. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 983.65 Section 983.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing..., ARIZONA, AND NEW MEXICO Reports, Books and Records § 983.65 Confidential information. All reports...

  6. 7 CFR 900.352 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... Determining the Qualification of Cooperative Milk Marketing Associations § 900.352 Confidential information... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.352 Section 900.352 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE...

  7. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Regulating Handling Reports and Records § 932.63 Confidential information. All reports and...

  8. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... INFORMATION Referendum Procedures. § 1206.107 Confidential information. The ballots and other information...

  9. 7 CFR 996.72 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 996.72 Section 996.72 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Confidential information. All reports and records furnished or submitted by handlers and importers to...

  10. 7 CFR 989.75 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 989.75 Section 989.75 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... GROWN IN CALIFORNIA Order Regulating Handling Reports and Records § 989.75 Confidential information....

  11. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... WASHINGTON Order Regulating Handling Records and Reports § 982.70 Confidential information. All reports...

  12. 7 CFR 1219.108 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1219.108 Section 1219.108 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING..., AND INFORMATION Referendum Procedures § 1219.108 Confidential information. The list of...

  13. 7 CFR 1160.608 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential information. 1160.608 Section 1160.608 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Referenda in Connection with a Fluid Milk Promotion Order § 1160.608 Confidential information. The...

  14. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Regulating Handling Reports, Books, and Other Records § 984.79 Confidential information. All reports...

  15. 7 CFR 993.71 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 993.71 Section 993.71 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... CALIFORNIA Order Regulating Handling Reports and Books and Other Records § 993.71 Confidential...

  16. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Confidential information. All reports and records furnished or submitted by handlers to the committee and...

  17. 7 CFR 1205.209 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1205.209 Section 1205.209 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential information. (a) The ballots cast or the manner in which any person voted and all...

  18. 42 CFR 56.111 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 56.111 Section 56.111 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR MIGRANT HEALTH SERVICES General Provisions § 56.111 Confidentiality. All information as to personal facts...

  19. 42 CFR 56.111 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 56.111 Section 56.111 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR MIGRANT HEALTH SERVICES General Provisions § 56.111 Confidentiality. All information as to personal facts...

  20. 19 CFR 111.24 - Records confidential.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 1 2010-04-01 2010-04-01 false Records confidential. 111.24 Section 111.24 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY CUSTOMS BROKERS Duties and Responsibilities of Customs Brokers § 111.24 Records confidential....

  1. 28 CFR 0.29f - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 28 Judicial Administration 1 2013-07-01 2013-07-01 false Confidentiality. 0.29f Section 0.29f Judicial Administration DEPARTMENT OF JUSTICE ORGANIZATION OF THE DEPARTMENT OF JUSTICE 4-Office of the Inspector General § 0.29f Confidentiality. The Inspector General shall not, during the pendency of...

  2. 37 CFR 262.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... public knowledge. The Designated Agent that claims the benefit of this provision shall have the burden of proving that the disclosed information was public knowledge. (c) Use of Confidential Information. In no event shall the Designated Agent use any Confidential Information for any purpose other than...

  3. 37 CFR 380.24 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Collective are public knowledge. The party claiming the benefit of this provision shall have the burden of proving that the disclosed information was public knowledge. (c) Use of Confidential Information. In no event shall the Collective use any Confidential Information for any purpose other than...

  4. 15 CFR 806.5 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 15 Commerce and Foreign Trade 3 2011-01-01 2011-01-01 false Confidentiality. 806.5 Section 806.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF ECONOMIC ANALYSIS, DEPARTMENT OF COMMERCE DIRECT INVESTMENT SURVEYS § 806.5 Confidentiality....

  5. 10 CFR 431.407 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... OF ENERGY ENERGY CONSERVATION ENERGY EFFICIENCY PROGRAM FOR CERTAIN COMMERCIAL AND INDUSTRIAL EQUIPMENT General Provisions § 431.407 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11, any... confidential has been deleted. In accordance with the procedures established at 10 CFR 1004.11, the...

  6. 10 CFR 431.407 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... OF ENERGY ENERGY CONSERVATION ENERGY EFFICIENCY PROGRAM FOR CERTAIN COMMERCIAL AND INDUSTRIAL EQUIPMENT General Provisions § 431.407 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11, any... confidential has been deleted. In accordance with the procedures established at 10 CFR 1004.11, the...

  7. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality...

  8. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality...

  9. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality...

  10. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality...

  11. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 31 Money and Finance: Treasury 1 2013-07-01 2013-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance MONETARY OFFICES, DEPARTMENT OF THE TREASURY PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information...

  12. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 31 Money and Finance: Treasury 1 2014-07-01 2014-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance MONETARY OFFICES, DEPARTMENT OF THE TREASURY PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information...

  13. 29 CFR 1691.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1691.3 Section 1691.3 Labor Regulations Relating to Labor (Continued) EQUAL EMPLOYMENT OPPORTUNITY COMMISSION PROCEDURES FOR COMPLAINTS OF EMPLOYMENT DISCRIMINATION FILED AGAINST RECIPIENTS OF FEDERAL FINANCIAL ASSISTANCE § 1691.3 Confidentiality. When an agency receives information...

  14. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required...

  15. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  16. 7 CFR 1217.72 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1217.72 Section 1217.72 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Education, and Industry Information Order Reports, Books, and Records § 1217.72 Confidential treatment....

  17. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment....

  18. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All...

  19. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  20. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including...

  1. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All...

  2. 7 CFR 1221.127 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1221.127 Section 1221.127 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act and this...

  3. 7 CFR 1221.127 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1221.127 Section 1221.127 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act and this...

  4. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a)...

  5. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from...

  6. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including...

  7. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 3 2012-01-01 2012-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  8. 7 CFR 1217.72 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1217.72 Section 1217.72 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Education, and Industry Information Order Reports, Books, and Records § 1217.72 Confidential treatment....

  9. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from...

  10. 7 CFR 1208.62 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1208.62 Section 1208.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING..., Books, and Records § 1208.62 Confidential treatment. All information obtained from books, records,...

  11. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a)...

  12. 7 CFR 1221.127 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1221.127 Section 1221.127 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act and this...

  13. 7 CFR 1221.127 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1221.127 Section 1221.127 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act and this...

  14. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  15. 7 CFR 1208.62 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1208.62 Section 1208.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING..., Books, and Records § 1208.62 Confidential treatment. All information obtained from books, records,...

  16. 7 CFR 1215.62 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1215.62 Section 1215.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Records § 1215.62 Confidential treatment. (a) All information obtained from books, records, or...

  17. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  18. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All...

  19. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 3 2010-01-01 2010-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  20. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from...

  1. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required...

  2. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from...

  3. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 3 2013-01-01 2013-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  4. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All...

  5. 7 CFR 1215.62 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1215.62 Section 1215.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Records § 1215.62 Confidential treatment. (a) All information obtained from books, records, or...

  6. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a)...

  7. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 3 2014-01-01 2014-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  8. 7 CFR 1215.62 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1215.62 Section 1215.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Records § 1215.62 Confidential treatment. (a) All information obtained from books, records, or...

  9. 7 CFR 1217.72 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1217.72 Section 1217.72 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Education, and Industry Information Order Reports, Books, and Records § 1217.72 Confidential treatment....

  10. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  11. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including...

  12. 7 CFR 1215.62 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1215.62 Section 1215.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Records § 1215.62 Confidential treatment. (a) All information obtained from books, records, or...

  13. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment....

  14. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required...

  15. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment....

  16. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a)...

  17. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including...

  18. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment....

  19. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including...

  20. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required...

  1. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 3 2011-01-01 2011-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  2. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 59.11 Section 59.11 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR FAMILY PLANNING SERVICES Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal...

  3. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Confidentiality. 59.11 Section 59.11 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR FAMILY PLANNING SERVICES Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal...

  4. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 59.11 Section 59.11 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR FAMILY PLANNING SERVICES Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal...

  5. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 1 2011-10-01 2011-10-01 false Confidentiality. 59.11 Section 59.11 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR FAMILY PLANNING SERVICES Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal...

  6. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 49 Transportation 6 2013-10-01 2013-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  7. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 49 Transportation 6 2014-10-01 2014-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  8. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 49 Transportation 6 2011-10-01 2011-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  9. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 49 Transportation 6 2012-10-01 2012-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  10. Radiopacity evaluation of Portland and MTA-based cements by digital radiographic system

    PubMed Central

    BORGES, Alvaro Henrique; PEDRO, Fabio Luiz Miranda; SEMANOFF-SEGUNDO, Alex; MIRANDA, Carlos Eduardo Saraiva; PÉCORA, Jesus Djalma; CRUZ FILHO, Antônio Miranda

    2011-01-01

    Objective The aim of the present study was to evaluate the radiopacity of Portland and MTA-based cements using the Digora TM digital radiographic system. Material and Methods The performed tests followed specification number 57 from the American National Standard Institute/American Dental Association (2000) for endodontic sealing materials. The materials were placed in 5 acrylic plates, especially designed for this experiment, along with a graduated aluminum stepwedge varying from 1 to 10 mm in thickness. The set was radiographed at a 30 cm focus-object distance and with 0.2 s exposure time. After the radiographs were taken, the optical laser readings of radiographs were performed by Digora TM system. Five radiographic density readings were performed for each studied material and for each step of the aluminum scale. Results White ProRoot MTA (155.99±8.04), gray ProRoot MTA (155.96±16.30) and MTA BIO (143.13±16.94) presented higher radiopacity values (p<0.05), while white non-structural Portland (119.76±22.34), gray Portland (109.71±4.90) and white structural Portland (99.59±12.88) presented lower radiopacity values (p<0.05). Conclusions It was concluded that MTA-based cements were the only materials presenting radiopacity within the ANSI/ADA specifications. PMID:21625738

  11. Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial.

    PubMed

    Hilton, T J; Ferracane, J L; Mancl, L

    2013-07-01

    This practice-based, randomized clinical trial evaluated and compared the success of direct pulp capping in permanent teeth with MTA (mineral trioxide aggregate) or CaOH (calcium hydroxide). Thirty-five practices in Northwest PRECEDENT were randomized to perform direct pulp caps with either CaOH (16 practices) or MTA (19 practices). Three hundred seventy-six individuals received a direct pulp cap with CaOH (n = 181) or MTA (n = 195). They were followed for up to 2 yrs at regular recall appointments, or as dictated by tooth symptoms. The primary outcomes were the need for extraction or root canal therapy. Teeth were also evaluated for pulp vitality, and radiographs were taken at the dentist's discretion. The probability of failure at 24 mos was 31.5% for CaOH vs. 19.7% for MTA (permutation log-rank test, p = .046). This large randomized clinical trial provided confirmatory evidence for a superior performance with MTA as a direct pulp-capping agent as compared with CaOH when evaluated in a practice-based research network for up to 2 yrs. PMID:23690353

  12. Comparative Analysis of Selected Physicochemical Properties of Pozzolan Portland and MTA-Based Cements

    PubMed Central

    Dorileo, Maura Cristiane Gonçales Orçati; Villa, Ricardo Dalla; Guedes, Orlando Aguirre; Aranha, Andreza Maria Fábio; Semenoff-Segundo, Alex; Bandeca, Matheus Coelho; Borges, Alvaro Henrique

    2014-01-01

    Physicochemical properties of pozzolan Portland cement were compared to ProRoot MTA and MTA BIO. To test the pH, the samples were immersed in distilled water for different periods of time. After the pH analysis, the sample was retained in the plastic recipient, and the electrical conductivity of the solution was measured. The solubility and radiopacity properties were evaluated according to specification 57 of the American National Standard Institute/American Dental Association (ANSI/ADA). The statistical analyses were performed using ANOVA and Tukey's test at a 5% level of significance. Pozzolan Portland cement exhibited pH and electrical conductivity mean values similar to those of the MTA-based cements. The solubilities of all tested materials were in accordance with the ANSI/ADA standards. Only the MTA-based cements met the ANSI/ADA recommendations for radiopacity. It might be concluded that the pH and electrical conductivity of pozzolan Portland cement are similar to and comparable to those of MTA-based cements. PMID:27437473

  13. MTA apical barrier: In vitro study of the use of ultrasonic vibration

    PubMed Central

    Escribano-Escrivá, Begona; Manzano-Saiz, Alberto; Giner-Lluesma, Teresa; Collado-Castellanos, Nicolás; Muwaquet-Rodríguez, Susana

    2016-01-01

    Background The apexification is the first alternative treatment on a permanent tooth when, after a tooth trauma and in the presence of immature apex trauma, pulp necrosis occurs. Many studies have demonstrated the efficacy of mineral trioxide aggregate (MTA) as apical sealing material of choice in these cases, but has a degree of filtration as all other materials. The objective of this study was to analyze the seal ability of MTA on the duct walls in immature teeth unirradicular apexes, using indirect vibration. Material and Methods The study was conducted on 45 teeth divided into 3 groups: Group A or control group in which no vibration for placing the MTA was used, Group B and C or groups where indirect vibration analysis was used. All samples were immersed in methylene blue to assess filtration. After performing longitudinal cuts millimetric measuring were made of the degree of filtration, divided into 3 degrees (2mm each grade filtration). Results Results obtained confirm our hypothesis, obtaining lesser degree of filtration those groups in which indirect vibration (Groups B and C) was performed. It was shown that the degree of filtration is closely linked to the degree of adaptation. Conclusions MTA vibration offers better results in its adaptation to the canal walls, significantly reducing the degree of filtration. Key words:Apexification, MTA, filtration, indirect vibration. PMID:27398184

  14. Sealing ability of mineral trioxide aggregate (MTA) combined with distilled water, chlorhexidine, and doxycycline.

    PubMed

    Arruda, Roberta A A; Cunha, Rodrigo S; Miguita, Kenner B; Silveira, Cláudia F M; De Martin, Alexandre S; Pinheiro, Sérgio L; Rocha, Daniel G P; Bueno, Carlos E S

    2012-09-01

    The aim of this study was to evaluate the sealing ability of mineral trioxide aggregate (MTA Bio) combined with different mixing agents (distilled water, chlorhexidine, doxycycline), used as an apical root-end filling material. Forty-two extracted human teeth were divided into three groups (n = 12); six teeth were used as controls. Root-ends were resected at 90 degrees, 3 mm from the apex. Root-end cavities were prepared using ultrasonic tips and filled with MTA Bio plus distilled water, 2% chlorhexidine solution, or 10% doxycycline solution. Apical sealing was assessed by microleakage of 50% silver nitrate solution. Roots were longitudinally sectioned in a buccolingual plane and analyzed using an operating microscope (20× magnification). Depth of dye leakage into the dentinal walls was measured in millimeters. Results were analyzed using ANOVA and Tukey's test (P = 0.05). MTA Bio plus distilled water showed significantly higher mean leakage results (1.06 mm) when compared with MTA Bio plus doxycycline (0.61 mm), and higher, although not significant, results when compared with MTA Bio plus chlorhexidine (0.79 mm). In conclusion, replacing distilled water with two biologically active mixing agents (doxycycline and chlorhexidine) did not alter the sealing properties of MTABio. The antimicrobial properties of these combinations should be further investigated. PMID:23047034

  15. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... are privileged or confidential, as set forth in 5 U.S.C. 552(b) and 29 CFR part 70. (b) Identification... 29 Labor 1 2014-07-01 2013-07-01 true Confidential business information. 90.33 Section 90.33 Labor... General Provisions § 90.33 Confidential business information. (a) Definition. Confidential...

  16. 19 CFR 201.6 - Confidential business information.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 3 2013-04-01 2013-04-01 false Confidential business information. 201.6 Section... Miscellaneous § 201.6 Confidential business information. (a) Definitions—(1) Confidential business information... “confidential business information” includes “proprietary information” within the meaning of section 777(b)...

  17. 49 CFR 209.11 - Request for confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 49 Transportation 4 2010-10-01 2010-10-01 false Request for confidential treatment. 209.11 Section... confidential treatment. (a) This section governs the procedures for requesting confidential treatment of any... confidential treatment with respect to a document or portion thereof may be made on the basis that...

  18. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... are privileged or confidential, as set forth in 5 U.S.C. 552(b) and 29 CFR part 70. (b) Identification... 29 Labor 1 2010-07-01 2010-07-01 true Confidential business information. 90.33 Section 90.33 Labor... General Provisions § 90.33 Confidential business information. (a) Definition. Confidential...

  19. 40 CFR 94.517 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Line Testing Programs § 94.517 Treatment of confidential information. Except for information required... confidentiality made by the submitter. The provisions for treatment of confidential information described in §...

  20. 46 CFR 221.79 - Request for confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 46 Shipping 8 2011-10-01 2011-10-01 false Request for confidential treatment. 221.79 Section 221... INTERESTS Civil Penalties § 221.79 Request for confidential treatment. (a) In addition to information treated as confidential under § 221.77 of this subpart, a request for confidential treatment of a...

  1. 49 CFR 209.11 - Request for confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 49 Transportation 4 2011-10-01 2011-10-01 false Request for confidential treatment. 209.11 Section... confidential treatment. (a) This section governs the procedures for requesting confidential treatment of any... confidential treatment with respect to a document or portion thereof may be made on the basis that...

  2. 49 CFR 209.11 - Request for confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 49 Transportation 4 2012-10-01 2012-10-01 false Request for confidential treatment. 209.11 Section... confidential treatment. (a) This section governs the procedures for requesting confidential treatment of any... confidential treatment with respect to a document or portion thereof may be made on the basis that...

  3. Crystal structure of recombinant tyrosinase-binding protein MtaL at 1.35 Å resolution.

    PubMed

    Lai, Xuelei; Soler-Lopez, Montserrat; Ismaya, Wangsa T; Wichers, Harry J; Dijkstra, Bauke W

    2016-03-01

    Mushroom tyrosinase-associated lectin-like protein (MtaL) binds to mature Agaricus bisporus tyrosinase in vivo, but the exact physiological function of MtaL is unknown. In this study, the crystal structure of recombinant MtaL is reported at 1.35 Å resolution. Comparison of its structure with that of the truncated and cleaved MtaL present in the complex with tyrosinase directly isolated from mushroom shows that the general β-trefoil fold is conserved. However, differences are detected in the loop regions, particularly in the β2-β3 loop, which is intact and not cleaved in the recombinant MtaL. Furthermore, the N-terminal tail is rotated inwards, covering the tyrosinase-binding interface. Thus, MtaL must undergo conformational changes in order to bind mature mushroom tyrosinase. Very interestingly, the β-trefoil fold has been identified to be essential for carbohydrate interaction in other lectin-like proteins. Comparison of the structures of MtaL and a ricin-B-like lectin with a bound disaccharide shows that MtaL may have a similar carbohydrate-binding site that might be involved in glycoreceptor activity. PMID:26919530

  4. Cytotoxic effects of new MTA-based cement formulations on fibroblast-like MDPL-20 cells.

    PubMed

    Garcia, Lucas da Fonseca Roberti; Santos, Alailson Domingos dos; Moraes, João Carlos Silos; Costa, Carlos Alberto de Souza

    2016-01-01

    The present study aimed at evaluating the cytotoxic effects of a novel cement called CER on periodontal fibroblast-like cells of mice (MDPL-20), in comparison with different formulations of Mineral Trioxide Aggregate (MTA), by means of the cell viability test (MTT) and cell morphology analysis. Thirty-two round-shaped samples were fabricated with the following cements: white MTA, white and gray CER and experimental white MTA. The samples were immersed in serum-free culture medium for 24 hours or 7 days (n = 16). The extracts (culture medium + components released from the cements) were applied for 24 hours to previously cultured cells (40.000 cells/cm2) in the wells of 24-well plates. Cells seeded in complete culture medium were used as a negative control. Cell viability was assessed using the MTT assay. Two samples of each cement were used for cell morphology analysis by Scanning Electron Microscopy (SEM). The extracts obtained at the 7-day period presented higher cytotoxicity compared with the 24-hour period (p < 0.05). The gray CER obtained at 24 hours presented the highest cytotoxic effect, whereas the experimental white MTA presented the lowest, similar to the control (p > 0.05). However, at the 7-day period, the experimental white MTA presented no significant difference in comparison with the other cements (p > 0.05). At the 7-day period, CER cement presented cytotoxic effects on fibroblast-like cells, similar to different MTA formulations. However, the immersion period in the culture medium influenced the cytotoxicity of the cements, which was greater for CER cement at 24 hours. PMID:26981755

  5. A simplified technique of orthograde MTA obturation on the elected canals of posterior teeth: Two case reports

    PubMed Central

    Wahengbam, Brucelee; Wahengbam, Pragya; Tikku, Aseem Prakash

    2014-01-01

    This article suggests a simplified technique of orthograde MTA obturation in less accessible canal(s) of posteriors teeth without using costly ultrasonics or specialised carrier. Essentially few finger pluggers, absorbent points and a simple canal projection method were used. The orifice(s) of the elected canal(s) to be obturated with MTA were projected onto the external occlusal surface for easy delivery and predictive instrumentation. The idea was based on ‘easy access’, ‘working one canal with one mix at one time’, ‘thorough condensation’ and ‘removal of excess moisture’. In case I, palatal canal of tooth no. 2 with gross apical perforation and suspected VRF was obturated with MTA. And in Case II, tooth no. 19 presented with incomplete furcal fracture extending into the canal was obturated with MTA in all 3 canals unitarily. Dense homogenous MTA obturation was achieved and both cases healed uneventfully. PMID:24554868

  6. Biosafety data as confidential business information.

    PubMed

    Nielsen, Kaare M

    2013-01-01

    Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs. PMID:23472051

  7. 37 CFR 382.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... SATELLITE DIGITAL AUDIO RADIO SERVICES Preexisting Subscription Services § 382.5 Confidential information... RATES AND TERMS FOR STATUTORY LICENSES RATES AND TERMS FOR DIGITAL TRANSMISSIONS OF SOUND RECORDINGS...

  8. 37 CFR 382.5 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... SATELLITE DIGITAL AUDIO RADIO SERVICES Preexisting Subscription Services § 382.5 Confidential information... RATES AND TERMS FOR STATUTORY LICENSES RATES AND TERMS FOR DIGITAL TRANSMISSIONS OF SOUND RECORDINGS...

  9. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 716.55 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL... such studies would reveal— (i) Processes used in the manufacturing, importing, or processing of the... because disclosure would reveal a confidential process or quantitative mixture composition should...

  10. Law and ethics in conflict over confidentiality?

    PubMed

    Dickens, B M; Cook, R J

    2000-09-01

    Ethical principles that require the preservation of patients' confidential information are reinforced by principles found in several areas of law, such as law on contracts, negligence, defamation and fiduciary duty. However, laws sometimes compel disclosures of medical confidences, and more often may justify or excuse disclosures. Legally contentious issues concern patients' confidences regarding possible unlawful conduct, such as pregnancy termination, and the risk of spread of HIV and other infections. This article reviews the various legal bases of the duty of confidentiality, and legal challenges to the ethical obligation of non-disclosure. It addresses the justifications and limits of exchange of patients' health information among healthcare professionals and trainees, and considers legally recognized limits of confidential duties, and the scope of legitimate disclosure. An underlying theme is how to determine whether physicians are ethically justified in employing the discretion the law sometimes affords them to breach patients' expectations of confidentiality. PMID:10967176

  11. 37 CFR 380.14 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... information was public knowledge. (c) Use of Confidential Information. In no event shall the Collective use... include documents or information that at the time of delivery to the Collective are public knowledge....

  12. 37 CFR 380.5 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... public knowledge. The party claiming the benefit of this provision shall have the burden of proving that the disclosed information was public knowledge. (c) Use of Confidential Information. In no event...

  13. 15 CFR 806.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... ECONOMIC ANALYSIS, DEPARTMENT OF COMMERCE DIRECT INVESTMENT SURVEYS § 806.5 Confidentiality. Information... publish or make available to any other person any information collected under the Act in such a...

  14. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ...”, or “trade secret”. (c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will...

  15. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ...”, or “trade secret”. (c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will...

  16. Protecting Respondent Confidentiality in Qualitative Research

    PubMed Central

    Kaiser, Karen

    2009-01-01

    For qualitative researchers, maintaining respondent confidentiality while presenting rich, detailed accounts of social life presents unique challenges. These challenges are not adequately addressed in the literature on research ethics and research methods. Using an example from a study of breast cancer survivors, I argue that by carefully considering the audience for one’s research and by re-envisioning the informed consent process, qualitative researchers can avoid confidentiality dilemmas that might otherwise lead them not to report rich, detailed data. PMID:19843971

  17. Advanced technology and confidentiality in hand surgery.

    PubMed

    Naam, Nash H; Sanbar, Sandy

    2015-01-01

    Advanced technology has the potential to improve the quality of care for our patients, but it also poses new challenges, especially in maintaining patient confidentiality. The Health Insurance Portability and Accountability Act and the newly enacted Health Information Technology for Economic and Clinical Health Act provide certain guidelines governing patients' medical record confidentiality. This article discusses the other new challenges facing hand surgeons, such as the use of social media, telemedicine, e-mails, and the Internet. PMID:25189686

  18. [Retrograde obturation with MTA Cement and Super-EBA after apicoectomy. Sealing ability of MTA and Super-EBA in dye penetration tests].

    PubMed

    Schultz, Christoph B; Westhauser, Patrick; Nideröst, Beatrice; Klaus, W Grätz

    2005-01-01

    The present in vitro study investigated the sealing of retrograde fillings compounded of two different cements in consideration of cracking after root-end preparation of resected dental roots using diamond-coated ultrasonic retrotips. Root-end cavities were prepared in 32 resected roots using diamond-coated ultrasonic retrotips. The samples were divided into two groups. The first group was filled using zinc-oxide cement (Super-EBA-Cement), the second with mineral-trioxide-aggregate (Pro Root MTA). After resection, root-end preparation and retrograde filling, the samples were analysed using macro-zoom photography and scanning electron microscopy. The sealing quality of the filling materials was detected through dye penetration test. The average degree of penetration of the samples filled with Super-EBA-Cement was 2.19 and of the samples filled with Pro Root MTA 0.44 respectively. Accordingly the sealing of Pro Root MTA in vitro is superior to the sealing of Super-EBA-Cement. Retrograde conditioning of resected roots with ultrasonic retrotips represents an efficient and sparing alternative to conventional root-end preparation techniques. PMID:15960453

  19. Secondary Evaluations of MTA 36-Month Outcomes: Propensity Score and Growth Mixture Model Analyses

    ERIC Educational Resources Information Center

    Swanson, James M.; Hinshaw, Stephen P.; Arnold, L. Eugene; Gibbons, Robert D.; Marcus, Sue; Hur, Kwan; Jensen, Peter S.; Vitiello, Benedetto; Abikoff, Howard B.: Greenhill, Laurence L.; Hechtman, Lily; Pelham, William E.; Wells, Karen C.; Conners, C. Keith; March, John S.; Elliott, Glen R.; Epstein, Jeffery N.; Hoagwood, Kimberly; Hoza, Betsy; Molina, Brooke S. G.; Newcorn, Jeffrey H.; Severe, Joanne B.; Wigal, Timothy

    2007-01-01

    Objective: To evaluate two hypotheses: that self-selection bias contributed to lack of medication advantage at the 36-month assessment of the Multimodal Treatment Study of Children With ADHD (MTA) and that overall improvement over time obscured treatment effects in subgroups with different outcome trajectories. Method: Propensity score analyses,…

  20. Does MTA affect fiber post retention in repaired cervical root canal perforations?

    PubMed

    Pereira, Rodrigo Dantas; Brito-Júnior, Manoel; Faria-E-Silva, André Luis; Guimarães, Karine Rodrigues; Mendes, Laís de Oliveira; Soares, Carlos José; Sousa-Neto, Manoel Damião

    2016-06-14

    This study evaluated the effect of mineral trioxide aggregate (MTA) on the retention of fiber posts in repaired root canal perforations. Ten-millimeter post spaces were prepared in 60 endodontically treated bovine incisors. Root perforations were created in half of the root canals in the cervical area prior to being filled with white MTA-Angelus. Fiber posts were luted into the root canals with two self-adhesive (RelyX Unicem or Set) or self-etching (Panavia F) resin cements. The posts were submitted to a pull-out test, and the data were submitted to two-way ANOVA and Tukey's post hoc tests (α = 0.05). The fiber posts exhibited reduced retention in MTA-repaired root canal perforations, regardless of the type of resin cement that was used (p < 0.001). Self-adhesive resin cements provided higher bond strength values than Panavia F, while no difference was observed between RelyX Unicem and Set (p > 0.05). The presence of MTA in repaired root perforations negatively affected post retention. In addition, self-adhesive cements seemed to be the best option to lute fiber posts within a root canal in these cases. PMID:27305516

  1. Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures

    ERIC Educational Resources Information Center

    Arnold, L. Eugene; Chuang, Shirley; Davies, Mark; Abikoff, Howard B.; Conners, C. Keith; Elliott, Glen R.; Greenhill, Laurence L.; Hechtman, Lily; Hinshaw, Stephen P.; Hoza, Betsy; Jensen, Peter S.; Kraemer, Helena C.; Langworthy-Lam, Kristen S.; March, John S.; Newcorn, Jeffrey H.; Pelham, William E.; Severe, Joanne B.; Swanson, James M.; Vitiello, Benedetto; Wells, Karen C.; Wigal, Timothy

    2004-01-01

    We examined 9-month data from the 14-month NIMH Multimodal Treatment Study of Children with ADHD (the MTA) as a further check on the relative effect of medication (MedMgt) and behavioral treatment (Beh) for attention-deficit/hyperactivity disorder (ADHD) while Beh was still being delivered at greater intensity than at 14-month endpoint, and…

  2. Parent-Reported Homework Problems in the MTA Study: Evidence for Sustained Improvement with Behavioral Treatment

    ERIC Educational Resources Information Center

    Langberg, Joshua M.; Arnold, L. Eugene; Flowers, Amanda M.; Epstein, Jeffery N.; Altaye, Mekibib; Hinshaw, Stephen P.; Swanson, James M.; Kotkin, Ronald; Simpson, Stephen; Molina, Brooke S. G.; Jensen, Peter S.; Abikoff, Howard; Pelham, William E., Jr.; Vitiello, Benedetto; Wells, Karen C.; Hechtman, Lily

    2010-01-01

    Parent-report of child homework problems was examined as a treatment outcome variable in the MTA-Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (ADHD). Five hundred seventy-nine children ages 7.0 to 9.9 were randomly assigned to either medication management, behavioral treatment, combination treatment, or…

  3. Analysis of Metal Contents in Portland Type V and MTA-Based Cements

    PubMed Central

    Dorileo, Maura Cristiane Gonçales Orçati; Bandeca, Matheus Coelho; Pedro, Fábio Luis Miranda; Volpato, Luiz Evaristo Ricci; Guedes, Orlando Aguirre; Villa, Ricardo Dalla; Tonetto, Mateus Rodrigues; Borges, Alvaro Henrique

    2014-01-01

    The aim of this study was to determine, by Atomic Absorption Spectrometry (AAS), the concentration levels of 11 metals in Type V gray and structural white PC, ProRoot MTA, and MTA Bio. Samples, containing one gram of each tested cement, were prepared and transferred to a 100 mL Teflon tube with a mixture of 7.0 mL of nitric acid and 21 mL of hydrochloric acid. After the reaction, the mixture was filtered and then volumed to 50 mL of distilled water. For each metal, specific patterns were determined from universal standards. Arsenic quantification was performed by hydride generator. The analysis was performed five times and the data were statistically analyzed at 5% level of significance. Only the cadmium presented concentration levels of values lower than the quantification limit of the device. The AAS analysis showed increased levels of calcium, nickel, and zinc in structural white PC. Type V PC presented the greatest concentration levels of arsenic, chromium, copper, iron, lead, and manganese (P < 0.05). Bismuth was found in all cements, and the lowest concentration levels were observed in Portland cements, while the highest were observed in ProRoot MTA. Both PC and MTA-based cements showed evidence of metals inclusion. PMID:25436238

  4. Solubility and bacterial sealing ability of MTA and root-end filling materials

    PubMed Central

    ESPIR, Camila Galletti; GUERREIRO-TANOMARU, Juliane Maria; SPIN-NETO, Rubens; CHÁVEZ-ANDRADE, Gisselle Moraima; BERBERT, Fabio Luiz Camargo Villela; TANOMARU-FILHO, Mario

    2016-01-01

    ABSTRACT Objective To evaluate solubility and sealing ability of Mineral Trioxide Aggregate (MTA) and root-end filling materials. Material and Methods The materials evaluated were: MTA, Calcium Silicate Cement with zirconium oxide (CSC/ZrO2), and zinc oxide/eugenol (ZOE). Solubility test was performed according to ANSI/ADA. The difference between initial and final mass of the materials was analyzed after immersion in distilled water for 7 and 30 days. Retrograde cavities in human teeth with single straight root canal were performed by using ultrasonic tip CVD 9.5107-8. The cavities were filled with the evaluated materials to evaluate sealing ability using the bacterial leakage test with Enterococcus faecalis. Bacterial leakage was evaluated every 24 hours for six weeks observing the turbidity of Brain Heart infusion (BHI) medium in contact with root apex. Data were submitted to ANOVA followed by Tukey tests (solubility), and Kruskal-Wallis and Dunn tests (sealing ability) at a 5% significance level. Results For the 7-day period, ZOE presented highest solubility when compared with the other groups (p<0.05). For the 30-day period, no difference was observed among the materials. Lower bacterial leakage was observed for MTA and CSC/ZrO2, and both presented better results than ZOE (p<0.05). Conclusion MTA and CSC/ZrO2 presented better bacterial sealing capacity, which may be related to lower initial solubility observed for these materials in relation to ZOE. PMID:27119759

  5. [An 18 month evaluation of MM-MTA pulpotomy on primary decayed molars].

    PubMed

    Abou Chedid, J C; Mchayleh, N; Khalil, I; Melki, B; Hardan, L S

    2015-12-01

    Pulpotomy is the most performed and controversial therapeutic in pediatric dentistry. Formocresol is known to have a toxic effect on living tissues, a mutagenic and carcinogenic potential with a systemic uptake of formocresol via pulpotomized teeth, other alternative products have been investigated. 40 molars were pulpotomized using Micro Mega Mineral Trioxide Aggregate (MM-MTA), which eliminates the need for the use of formocresol. The effects of this material were evaluated both clinically and radiographically. Post-operative control examinations were performed at 1, 6, 12, and 18 months trying to detect spontaneous or stimulated pain, pathological tooth mobility, abscesses or fistulas, internal or external pathological tooth resorption, periapical bone destruction, or canal obliteration. Pain was absent at 18 months post operatively. Thirty six molar treated with the MM-MTA didn't show any mobility or pain, one molar presented a pathological resorption and one molar presented an abscess without a fistula at 12 month. The observations were compared to others related to formocresol, ferric sulfate, MTA, and laser pulpotomies, using the Chi-square test x2. The abundance of positive result strongly demonstrate that the MM-MTA pulpotomy on carious temporary molars is a promising technique. PMID:26939217

  6. Solubility and bacterial sealing ability of MTA and root-end filling materials.

    PubMed

    Espir, Camila Galletti; Guerreiro-Tanomaru, Juliane Maria; Spin-Neto, Rubens; Chávez-Andrade, Gisselle Moraima; Berbert, Fabio Luiz Camargo Villela; Tanomaru-Filho, Mario

    2016-04-01

    Objective To evaluate solubility and sealing ability of Mineral Trioxide Aggregate (MTA) and root-end filling materials. Material and Methods The materials evaluated were: MTA, Calcium Silicate Cement with zirconium oxide (CSC/ZrO2), and zinc oxide/eugenol (ZOE). Solubility test was performed according to ANSI/ADA. The difference between initial and final mass of the materials was analyzed after immersion in distilled water for 7 and 30 days. Retrograde cavities in human teeth with single straight root canal were performed by using ultrasonic tip CVD 9.5107-8. The cavities were filled with the evaluated materials to evaluate sealing ability using the bacterial leakage test with Enterococcus faecalis. Bacterial leakage was evaluated every 24 hours for six weeks observing the turbidity of Brain Heart infusion (BHI) medium in contact with root apex. Data were submitted to ANOVA followed by Tukey tests (solubility), and Kruskal-Wallis and Dunn tests (sealing ability) at a 5% significance level. Results For the 7-day period, ZOE presented highest solubility when compared with the other groups (p<0.05). For the 30-day period, no difference was observed among the materials. Lower bacterial leakage was observed for MTA and CSC/ZrO2, and both presented better results than ZOE (p<0.05). Conclusion MTA and CSC/ZrO2 presented better bacterial sealing capacity, which may be related to lower initial solubility observed for these materials in relation to ZOE. PMID:27119759

  7. Push-out bond strength of MTA HP, a new high-plasticity calcium silicate-based cement.

    PubMed

    Silva, Emmanuel Jnl; Carvalho, Nancy Kudsi; Zanon, Mayara; Senna, Plínio Mendes; DE-Deus, Gustavo; Zuolo, Mário Luis; Zaia, Alexandre Augusto

    2016-06-14

    This study was designed to investigate the resistance to dislodgment provided by MTA HP, a new high-plasticity calcium silicate-based cement. Biodentine and White MTA Angelus were used as reference materials for comparison. Three discs 1 ± 0.1 mm thick were obtained from the middle third of the roots of 5 maxillary canines. Three 0.8-mm-wide holes were drilled on the axial surface of each root disc. Standardized irrigation was performed. Then the holes were dried with paper points and filled with one of the three tested cements. The filled dental slices were immersed in a phosphate-buffered saline (PBS) solution (pH 7.2) for 7 days before the push-out assessment. The Kruskal-Wallis test was applied to assess the effect of each endodontic cement on the push-out bond strength. Mann-Whitney with Bonferroni correction was used to isolate the differences. The alpha-type error was set at 0.05. All specimens had measurable push-out values and no premature failure occurred. There were significant differences among the materials (p <0.05). The Biodentine specimens had the highest push-out bond strength values (p < 0.05). MTA HP had significantly higher bond strength than White MTA (p < 0.05). MTA HP showed better push-out bond strength than its predecessor, White MTA; however, Biodentine had higher dislodgment resistance than both MTA formulations. PMID:27305515

  8. Effect of acidic solutions on the microhardness of dentin and set OrthoMTA and their cytotoxicity on murine macrophage

    PubMed Central

    Shon, Won-Jun; Lee, Woocheol

    2016-01-01

    Objectives To evaluate the effects of three acids on the microhardness of set mineral trioxide aggregate (MTA) and root dentin, and cytotoxicity on murine macrophage. Materials and Methods OrthoMTA (BioMTA) was mixed and packed into the human root dentin blocks of 1.5 mm diameter and 5 mm height. Four groups, each of ten roots, were exposed to 10% citric acid (CA), 5% glycolic acid (GA), 17% ethylenediaminetetraacetic acid (EDTA), and saline for five minutes after setting of the OrthoMTA. Vickers surface microhardness of set MTA and dentin was measured before and after exposure to solutions, and compared between groups using one-way ANOVA with Tukey test. The microhardness value of each group was analyzed using student t test. Acid-treated OrthoMTA and dentin was examined by scanning electron microscope (SEM). Cell viability of tested solutions was assessed using WST-8 assay and murine macrophage. Results Three test solutions reduced microhardness of dentin. 17% EDTA demonstrated severe dentinal erosion, significantly reduced the dentinal microhardness compared to 10% CA (p = 0.034) or 5% GA (p = 0.006). 10% CA or 5% GA significantly reduced the surface microhardness of set MTA compared to 17% EDTA and saline (p < 0.001). Acid-treated OrthoMTA demonstrated microporous structure with destruction of globular crystal. EDTA exhibited significantly more cellular toxicity than the other acidic solutions at diluted concentrations (0.2, 0.5, 1.0%). Conclusions Tested acidic solutions reduced microhardness of root dentin. Five minute's application of 10% CA and 5% GA significantly reduced the microhardness of set OrthoMTA with lower cellular cytotoxicity compared to 17% EDTA. PMID:26877986

  9. Comparison of Microleakage of MTA and CEM Cement Apical Plugs in Three Different Media

    PubMed Central

    Ayatollahi, Fatemeh; Tabrizizadeh, Mahdi; Hazeri Baqdad Abad, Milad; Ayatollahi, Reza; Zarebidoki, Fatemeh

    2016-01-01

    Introduction: Microleakage is of the causes of endodontic treatment failure. The aim of this in vitro study, was to compare the microleakage of mineral trioxide aggregate (MTA) and calcium-enriched mixture (CEM) cement apical plugs in three environments. Methods and Materials: A total of 130 human extracted single rooted teeth were collected. After decoronation, preparation of the root canal space and simulation of open apices, 5 teeth were selected as positive and negative control groups and the rest of the samples were randomly divided into two groups (MTA plug and CEM cement plug) and each group was divided into 3 subgroups (dry, contaminated with saliva and contaminated with blood). In each group apical plug was placed into the canal. After full setting of the apical plug, microleakage of the samples were evaluated using fluid filtration method and the data were analyzed using two-way analysis of variance. Results: In dry and saliva contaminated environments, the leakage of MTA samples were 40.906±2.081 and 39.608±2.081, respectively which was significantly more than that of CEM cement samples (26.977±2.081 and 27.000±2.081, respectively). However, in blood-contaminated environments, the amount of leakage in MTA group (21.640±2.081) was significantly lower than CEM cement group (44.358±2.081). Conclusion: According to the results of this study, in dry and saliva-contaminated conditions CEM cement provides significantly better seal in comparison to MTA PMID:27471531

  10. Comparative study of MTA and other materials in retrofilling of pulpless dogs' teeth.

    PubMed

    Bernabé, Pedro Felício Estrada; Holland, Roberto; Morandi, Ricardo; de Souza, Valdir; Nery, Mauro Juvenal; Otoboni Filho, José Arlindo; Dezan Junior, Eloi; Gomes-Filho, João Eduardo

    2005-01-01

    This in vivo study compared the effect of mineral trioxide aggregate (MTA), IRM, Super EBA and ZOE in a puttylike consistency, used as retrofilling materials, in the healing process of periapical tissue of pulpless dogs' teeth submitted to a conventional retrofilling technique. Twenty-four premolars obtained from three dogs were used. At the first intervention, the animals were anesthetized, coronal access was obtained and pulpectomy was done. Root canals were kept open to the oral environment for 180 days to induce the formation of apical lesions. After surgical removal of the lesions with curettes, 2 mm of the apical root was cut out perpendicular to the long axis of the teeth, and root-end cavities were shaped with a low-speed round bur. The bone cavities were irrigated and dried, and the root-end cavities were filled with MTA, IRM, Super EBA and ZOE in a puttylike consistency. The bone cavities were passively filled with blood and flaps were sutured. The coronal access openings were cleaned and double-sealed with ZOE and amalgam. After 180 days, the animals were killed by anesthetic overdose, maxilla and mandible were removed and the pieces were processed for histomorphologic analysis. Data were evaluated blindly on the basis of several histopathologic events and the scores obtained were analyzed statistically using the Kruskal Wallis test. No significant differences were observed among MTA, Super EBA and IRM (p>0.05). However, ZOE had a significantly more negative influence on the apical healing (p<0.05). In conclusion, MTA, Super EBA and IRM had similar histopathologic effects among each other and better performance than ZOE used in a puttylike consistency. Furthermore, only MTA stimulated hard tissue deposition in direct contact with the retrofilling material, even when it was inserted under critical conditions. PMID:16475611

  11. Bioactivity, physical and chemical properties of MTA mixed with propylene glycol

    PubMed Central

    NATU, Vaishali Prakash; DUBEY, Nileshkumar; LOKE, Gerald Choon Leong; Teng Seng, TAN; Wee Hsuan, NG; YONG, Chee Weng; Tong, CAO; ROSA, Vinicius

    2015-01-01

    Objective To investigate the physical (setting time, hardness, flowability, microstructure) and chemical (pH change, calcium release, crystallinity) properties and the biological outcomes (cell survival and differentiation) of mineral trioxide aggregate (MTA) mixed using different proportions of propylene glycol (PG) and water. Material and Methods White MTA was mixed with different water/PG ratios (100/0, 80/20 and 50/50). Composition (XRD), microstructure (SEM), setting time (ASTM C266-13), flowability (ANSI/ADA 57-2000), Knoop hardness (100 g/10 s) and chemical characteristics (pH change and Ca2+ release for 7 days) were evaluated. Cell proliferation, osteo/odontoblastic gene expression and mineralization induced by MTA mixed with PG were evaluated. MTA discs (5 mm in diameter, 2 mm thick) were prepared and soaked in culture medium for 7 days. Next, the discs were removed and the medium used to culture dental pulp stem cells (DPSC) for 28 days. Cells survival was evaluated using MTS assay (24, 72 and 120 h) and differentiation with RT-PCR (ALP, OCN, Runx2, DSPP and MEPE) and alizarin red staining (7 and 14 days). Data were analysed using one-way ANOVA and Tukey’s post-hoc analysis (a=0.05). Results The addition of PG significantly increased setting time, flowability and Ca2+ release, but it compromised the hardness of the material. SEM showed that 50/50 group resulted porous material after setting due to the incomplete setting reaction, as shown by XRD analysis. The addition of PG (80/20 and 50/50) was not capable to improve cell proliferation or to enhance gene expression, and mineralized deposition of DPSC after 7 and 14 days as compared to the 100/0. Conclusion Except for flowability, the addition of PG did not promote further improvements on the chemical and physical properties evaluated, and it was not capable of enhancing the bioactivity of the MTA. PMID:26398513

  12. Influence of 2% chlorhexidine on pH, calcium release and setting time of a resinous MTA-based root-end filling material.

    PubMed

    Jacinto, Rogério Castilho; Linhares-Farina, Giane; Sposito, Otávio da Silva; Zanchi, César Henrique; Cenci, Maximiliano Sérgio

    2015-01-01

    The addition of chlorhexidine (CHX) to a resinous experimental Mineral Trioxide Aggregate (E-MTA) based root-end filling material is an alternative to boost its antimicrobial activity. However, the influence of chlorhexidine on the properties of this material is unclear. The aim of this study was to evaluate the influence of 2% chlorhexidine on the pH, calcium ion release and setting time of a Bisphenol A Ethoxylate Dimethacrylate/Mineral Trioxide Aggregate (Bis-EMA/MTA) based dual-cure experimental root-end filling material (E-MTA), in comparison with E-MTA without the addition of CHX and with conventional white MTA (W-MTA). The materials were placed in polyethylene tubes, and immersed in deionized water to determine pH (digital pH meter) and calcium ion release (atomic absorption spectrometry technique). The setting time of each material was analyzed using Gilmore needles. The data were statistically analyzed at a significance level of 5%. E-MTA + CHX showed an alkaline pH in the 3 h period of evaluation, the alkalinity of which decreased but remained as such for 15 days. The pH of E-MTA + CHX was higher than the other two materials after 7 days, and lower after 30 days (p < 0.05). All of the materials were found to release calcium ions throughout the 30 days of the study. The addition of CHX increased the calcium ion release of E-MTA to levels statistically similar to W-MTA. E-MTA showed shorter initial and final setting time, compared with W-MTA (p < 0.05). The addition of 2% CHX to MTA prevented setting of the material. The addition of CHX to E-MTA increased its pH and calcium ion release. However, it also prevented setting of the material. PMID:25715035

  13. Confidentiality--An analysis of the issue.

    PubMed

    Von Kanel, R L

    1997-01-01

    Today, in the high-tech, fast-paced health care arena in which professionals practice, confidential information and the right to privacy in one's personal life have become very basic concerns of society. Among the general public, a genuine interest exists about potential invasions of privacy and the undermining of confidentiality. Members of society are more educated concerning rights as the result of multimedia and education presented by health care professionals. New challenges for the professional attending to the health needs of society will be encountered as the complexity of health care increases (Pohlman, 1988). One must remember that the most intensely private and personal moments of an individual's life are revealed in hospital settings. Health care professionals have a duty at all times to diligently protect the confidence of each patient unless specific criteria is met so that disclosure is warranted. Dilemmas encountered often are complex and require a certain degree of expertise for resolution to occur. If ethical theory and principles are used in combination with some of the specific guidelines apropos to resolving confidentiality issues, creative solutions can be devised. Professionals, by the very nature of their experience and education, possess the talent to achieve this goal. Consequently, when guidelines for confidential treatment of information are followed, public trust of professionals will be ensured. Once trust is established, a significant step will have been taken toward the solution of problems of confidentiality in modern day health care. PMID:9393042

  14. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... person and are privileged or confidential, as set forth in 5 U.S.C. 552(b) and 29 CFR part 70. (b... confidential shall be submitted on separate sheets each clearly marked at the top, “Business...

  15. 46 CFR 221.79 - Request for confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... treated as confidential under § 221.77 of this subpart, a request for confidential treatment of a document... result in a document being considered as nonconfidential and subject to release. (c)...

  16. 33 CFR 1.07-35 - Request for confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... request for confidential treatment of a document or portion thereof may be made by the person supplying... document being considered as nonconfidential and subject to release. (c) Confidential material is...

  17. The History of Confidentiality in Medicine

    PubMed Central

    Higgins, Gerald L.

    1989-01-01

    The author of this article reviews the history of the confidentiality of medical information relating to patients from its roots in the Hippocratic Oath to the current codes of medical ethics. There has been an important shift in the basis for the demand for confidentiality, from a physician-based commitment to a professional ideal that will improve the physician-patient relationship and thus the physician's therapeutic effectiveness, and replace it with a patientbased right arising from individual autonomy instead of a Hippocratic paternalistic privilege. PMID:11650274

  18. Altered Apical Morphology (Reverse Architecture): Use of Indirect Ultrasonic Technique for Orthograde MTA Placement in Maxillary Premolars

    PubMed Central

    Sonali, Kapoor; Suresh, Agrawal Vineet; Abhishek, Patel; Jenish, Patel

    2016-01-01

    Aim. To report the management and orthograde technique of MTA placement in case of reverse architecture maxillary premolars. Summary. Two cases of 17-year-old and 21-year-old female patients were referred to endodontic speciality for management of maxillary premolar having reverse architecture with wide immature open apex like a bell mouth. In both the cases, after control of intraradicular infection, it was decided to use MTA for apexification and obturation of canals. Orthograde placement of MTA is a challenging procedure in terms of length control and condensation especially in divergent irregular reverse architecture wide open apex. A novel technique with the help of finger plugger, sterilized paper point, and ultrasonic agitation for 3D compaction of MTA at apical reverse architecture was used. Thickening of the canal wall and complete apical closure were confirmed one year after the treatment. PMID:27313910

  19. Marginal adaptation of mineral trioxide aggregate (MTA) to root dentin surface with orthograde/retrograde application techniques: A microcomputed tomographic analysis

    PubMed Central

    Al Fouzan, Khalid; Awadh, Mohammed; Badwelan, Moahmmed; Gamal, Abeer; Geevarghese, Amrita; Babhair, Samar; Al-Rejaie, Mansour; Al Hezaimi, Khalid; Rotstein, Ilan

    2015-01-01

    Background: Achieving a good apical seal for root canals is known to be associated with good mineral trioxide aggregate (MTA) adaptation to dentin. Aims: This study aims to compare the marginal adaptation of MTA with root dentin between orthograde and retrograde application techniques using microcomputed tomography (micro-CT) analysis. Settings and Design: Fifty-two single-rooted human teeth were divided into four equal groups: (Group 1) Retrograde MTA (RMTA), (Group 2) Orthograde MTA (OMTA), (Group 3) Etched RMTA (ERMTA), and (Group 4) Etched OMTA (EOMTA). Materials and Methods: For Group 1, 3-mm retrograde cavities were prepared and filled with MTA. For Group 2, the apical 6 mm of the canals were filled with MTA and sealed with sealer cement and warm gutta-percha. In Groups 3 and 4, canals were treated the same as Groups 1 and 2, respectively, except that before placing the MTA, canals were irrigated with 17% ethylenediaminetetraacetic acid (EDTA). After 48 hours, all the teeth were analyzed using a micro-CT scanner. Statistical Analysis: Mean dentin-MTA contact and the mean length and width of each gap was analysed using one-way analysis of variance (ANOVA). Statistical significance was set at an α level of 5%. Results: No significant difference in gap volumes was observed in the dentin-MTA adaptation in both orthograde and retrograde application techniques. However, significant difference in the gap volumes was observed between RMTA and ERMTA (P = 0.045). Etching significantly improved the MTA-Dentin adaptation (P < 0.05). The type of application technique did not significantly improve the dentin-MTA adaptation, instead with the use of 17% EDTA, a significant improvement could be achieved. Conclusion: Within the limitations of the present study, it concludes that MTA adaptation to dentin tooth structure is not significantly different between an orthograde and retrograde approach. However, the use of EDTA significantly improved the MTA-Dentin adaptation. PMID

  20. Methanol:coenzyme M methyltransferase from Methanosarcina barkeri -- substitution of the corrinoid harbouring subunit MtaC by free cob(I)alamin.

    PubMed

    Sauer, K; Thauer, R K

    1999-05-01

    Methyl-coenzyme M formation from coenzyme M and methanol in Methanosarcina barkeri is catalysed by an enzyme system composed of three polypeptides MtaA, MtaB and MtaC, the latter of which harbours a corrinoid prosthetic group. We report here that MtaC can be substituted by free cob(I)alamin which is methylated with methanol in an MtaB-catalysed reaction and demethylated with coenzyme M in an MtaA-catalysed reaction. Methyl transfer from methanol to coenzyme M was found to proceed at a relatively high specific activity at micromolar concentrations of cob(I)alamin. This finding was surprising because the methylation of cob(I)alamin catalysed by MtaB alone and the demethylation of methylcob(III)alamin catalysed by MtaA alone exhibit apparent Km for cob(I)alamin and methylcob(III)alamin of above 1 mm. A possible explanation is that MtaA positively affects the MtaB catalytic efficiency and vice versa by decreasing the apparent Km for their corrinoid substrates. Activation of MtaA by MtaB was methanol-dependent. In the assay for methanol:coenzyme M methyltransferase activity cob(I)alamin could be substituted by cob(I)inamide which is devoid of the nucleotide loop. Substitution was, however, only possible when the assays were supplemented with imidazole: approximately 1 mm imidazole being required for half-maximal activity. Methylation of cob(I)inamide with methanol was found to be dependent on imidazole but not on the demethylation of methylcob(III)inamide with coenzyme M. The demethylation reaction was even inhibited by imidazole. The structure and catalytic mechanism of the MtaABC complex are compared with the cobalamin-dependent methionine synthase. PMID:10215883

  1. 10 CFR 820.12 - Classified, confidential, and controlled information

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 10 Energy 4 2014-01-01 2014-01-01 false Classified, confidential, and controlled information 820... § 820.12 Classified, confidential, and controlled information (a) General rule. The DOE Official in... prevent disclosure of classified, confidential, and controlled information, including Restricted Data...

  2. 10 CFR 820.12 - Classified, confidential, and controlled information

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 10 Energy 4 2012-01-01 2012-01-01 false Classified, confidential, and controlled information 820... § 820.12 Classified, confidential, and controlled information (a) General rule. The DOE Official in... prevent disclosure of classified, confidential, and controlled information, including Restricted Data...

  3. 10 CFR 820.12 - Classified, confidential, and controlled information

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 10 Energy 4 2010-01-01 2010-01-01 false Classified, confidential, and controlled information 820... § 820.12 Classified, confidential, and controlled information (a) General rule. The DOE Official in... prevent disclosure of classified, confidential, and controlled information, including Restricted Data...

  4. 10 CFR 820.12 - Classified, confidential, and controlled information

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 10 Energy 4 2013-01-01 2013-01-01 false Classified, confidential, and controlled information 820... § 820.12 Classified, confidential, and controlled information (a) General rule. The DOE Official in... prevent disclosure of classified, confidential, and controlled information, including Restricted Data...

  5. 10 CFR 820.12 - Classified, confidential, and controlled information

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 10 Energy 4 2011-01-01 2011-01-01 false Classified, confidential, and controlled information 820... § 820.12 Classified, confidential, and controlled information (a) General rule. The DOE Official in... prevent disclosure of classified, confidential, and controlled information, including Restricted Data...

  6. 15 CFR 30.60 - Confidentiality of Electronic Export Information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 15 Commerce and Foreign Trade 1 2013-01-01 2013-01-01 false Confidentiality of Electronic Export... § 30.60 Confidentiality of Electronic Export Information. (a) Confidential status. The EEI collected... in any form including but not limited to electronic transmission, paper printout, or...

  7. 15 CFR 30.60 - Confidentiality of Electronic Export Information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 1 2010-01-01 2010-01-01 false Confidentiality of Electronic Export... § 30.60 Confidentiality of Electronic Export Information. (a) Confidential status. The EEI collected... in any form including but not limited to electronic transmission, paper printout, or...

  8. 15 CFR 30.60 - Confidentiality of Electronic Export Information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 15 Commerce and Foreign Trade 1 2011-01-01 2011-01-01 false Confidentiality of Electronic Export... § 30.60 Confidentiality of Electronic Export Information. (a) Confidential status. The EEI collected... in any form including but not limited to electronic transmission, paper printout, or...

  9. 40 CFR 704.7 - Confidential business information claims.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Confidential business information... Provisions for Section 8(a) Information-Gathering Rules § 704.7 Confidential business information claims. (a) Any person submitting a notice under this rule may assert a business confidentiality claim...

  10. 19 CFR 210.5 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 3 2011-04-01 2011-04-01 false Confidential business information. 210.5 Section... business information. (a) Definition and submission. Confidential business information shall be defined and... law judge, or another section of this part states otherwise, confidential business information...

  11. 40 CFR 704.7 - Confidential business information claims.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Confidential business information... Provisions for Section 8(a) Information-Gathering Rules § 704.7 Confidential business information claims. (a) Any person submitting a notice under this rule may assert a business confidentiality claim...

  12. 19 CFR 210.5 - Confidential business information.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 3 2013-04-01 2013-04-01 false Confidential business information. 210.5 Section... business information. (a) Definition and submission. Confidential business information shall be defined and... law judge, or another section of this part states otherwise, confidential business information...

  13. 22 CFR 130.15 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false Confidential business information. 130.15... CONTRIBUTIONS, FEES AND COMMISSIONS § 130.15 Confidential business information. (a) Any person who is required... person considers to be confidential business information. No person, including any applicant or...

  14. 40 CFR 704.7 - Confidential business information claims.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Confidential business information... Provisions for Section 8(a) Information-Gathering Rules § 704.7 Confidential business information claims. (a) Any person submitting a notice under this rule may assert a business confidentiality claim...

  15. 22 CFR 1304.7 - Confidential commercial information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 2 2010-04-01 2010-04-01 true Confidential commercial information. 1304.7... § 1304.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential commercial information to the...

  16. 25 CFR 517.7 - Confidential commercial information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 2 2010-04-01 2010-04-01 false Confidential commercial information. 517.7 Section 517.7... INFORMATION ACT PROCEDURES § 517.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential...

  17. 19 CFR 143.4 - Confidentiality of data.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 2 2010-04-01 2010-04-01 false Confidentiality of data. 143.4 Section 143.4... TREASURY (CONTINUED) SPECIAL ENTRY PROCEDURES Automated Broker Interface § 143.4 Confidentiality of data. The electronic data received and exchanged by a service bureau shall be considered confidential,...

  18. 12 CFR 978.6 - Access to confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 12 Banks and Banking 7 2010-01-01 2010-01-01 false Access to confidential information. 978.6... OPERATIONS AND AUTHORITIES BANK REQUESTS FOR INFORMATION § 978.6 Access to confidential information. Each Bank shall ensure that access to the confidential information stored at its facility is limited...

  19. 40 CFR 91.7 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... (CONTINUED) CONTROL OF EMISSIONS FROM MARINE SPARK-IGNITION ENGINES General § 91.7 Treatment of confidential... 40 Protection of Environment 20 2010-07-01 2010-07-01 false Treatment of confidential information... part is entitled to confidential treatment as provided by part 2, subpart B, of this chapter. (b)...

  20. 33 CFR 1.07-35 - Request for confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... the information on the basis that the information is: (1) Confidential financial information, trade secrets, or other material exempt from disclosure by the Freedom of Information Act (5 U.S.C. 552); (2... for confidential treatment. (a) In addition to information treated as confidential under § 1.07-30,...

  1. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE (Eff. Jan. 10, 2011... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  2. 26 CFR 301.6111-2 - Confidential corporate tax shelters.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 26 Internal Revenue 18 2011-04-01 2011-04-01 false Confidential corporate tax shelters. 301.6111-2....6111-2 Confidential corporate tax shelters. (a) In general. (1) Under section 6111(d) and this section, a confidential corporate tax shelter is treated as a tax shelter subject to the requirements...

  3. 49 CFR 1104.14 - Protective orders to maintain confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ...-SERVICE-PLEADINGS, GENERALLY § 1104.14 Protective orders to maintain confidentiality. (a) Segregation of... 49 Transportation 8 2010-10-01 2010-10-01 false Protective orders to maintain confidentiality... on the outside “Confidential materials subject to a request for a protective order.” (b) Requests...

  4. 49 CFR 1104.14 - Protective orders to maintain confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ...-SERVICE-PLEADINGS, GENERALLY § 1104.14 Protective orders to maintain confidentiality. (a) Segregation of... 49 Transportation 8 2011-10-01 2011-10-01 false Protective orders to maintain confidentiality... on the outside “Confidential materials subject to a request for a protective order.” (b) Requests...

  5. 19 CFR 201.6 - Confidential business information.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 19 Customs Duties 3 2014-04-01 2014-04-01 false Confidential business information. 201.6 Section 201.6 Customs Duties UNITED STATES INTERNATIONAL TRADE COMMISSION GENERAL RULES OF GENERAL APPLICATION Miscellaneous § 201.6 Confidential business information. (a) Definitions—(1) Confidential business information is information which concerns...

  6. 15 CFR 30.60 - Confidentiality of Electronic Export Information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 15 Commerce and Foreign Trade 1 2012-01-01 2012-01-01 false Confidentiality of Electronic Export... § 30.60 Confidentiality of Electronic Export Information. (a) Confidential status. The EEI collected... in any form including but not limited to electronic transmission, paper printout, or...

  7. 48 CFR 452.224-70 - Confidentiality of Information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... Information. 452.224-70 Section 452.224-70 Federal Acquisition Regulations System DEPARTMENT OF AGRICULTURE... Confidentiality of Information. As prescribed in 424.104, insert a clause substantially as follows: Confidentiality of Information (FEB 1988) (a) Confidential information, as used in this clause, means—...

  8. 48 CFR 452.224-70 - Confidentiality of Information.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... Information. 452.224-70 Section 452.224-70 Federal Acquisition Regulations System DEPARTMENT OF AGRICULTURE... Confidentiality of Information. As prescribed in 424.104, insert a clause substantially as follows: Confidentiality of Information (FEB 1988) (a) Confidential information, as used in this clause, means—...

  9. 48 CFR 452.224-70 - Confidentiality of Information.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... Information. 452.224-70 Section 452.224-70 Federal Acquisition Regulations System DEPARTMENT OF AGRICULTURE... Confidentiality of Information. As prescribed in 424.104, insert a clause substantially as follows: Confidentiality of Information (FEB 1988) (a) Confidential information, as used in this clause, means—...

  10. 48 CFR 452.224-70 - Confidentiality of Information.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... Information. 452.224-70 Section 452.224-70 Federal Acquisition Regulations System DEPARTMENT OF AGRICULTURE... Confidentiality of Information. As prescribed in 424.104, insert a clause substantially as follows: Confidentiality of Information (FEB 1988) (a) Confidential information, as used in this clause, means—...

  11. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will...

  12. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will...

  13. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will...

  14. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will...

  15. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will...

  16. 40 CFR 94.4 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... (CONTINUED) CONTROL OF EMISSIONS FROM MARINE COMPRESSION-IGNITION ENGINES General Provisions for Emission Regulations for Compression-Ignition Marine Engines § 94.4 Treatment of confidential information. (a) Any... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must...

  17. 22 CFR 130.15 - Confidential business information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Confidential business information. 130.15... CONTRIBUTIONS, FEES AND COMMISSIONS § 130.15 Confidential business information. (a) Any person who is required... person considers to be confidential business information. No person, including any applicant or...

  18. 40 CFR 704.7 - Confidential business information claims.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidential business information... Provisions for Section 8(a) Information-Gathering Rules § 704.7 Confidential business information claims. (a) Any person submitting a notice under this rule may assert a business confidentiality claim...

  19. 5 CFR 2634.904 - Confidential filer defined.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 5 Administrative Personnel 3 2011-01-01 2011-01-01 false Confidential filer defined. 2634.904 Section 2634.904 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS EXECUTIVE BRANCH FINANCIAL DISCLOSURE, QUALIFIED TRUSTS, AND CERTIFICATES OF DIVESTITURE Confidential Financial Disclosure Reports § 2634.904 Confidential...

  20. 5 CFR 2634.904 - Confidential filer defined.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 5 Administrative Personnel 3 2010-01-01 2010-01-01 false Confidential filer defined. 2634.904 Section 2634.904 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS EXECUTIVE BRANCH FINANCIAL DISCLOSURE, QUALIFIED TRUSTS, AND CERTIFICATES OF DIVESTITURE Confidential Financial Disclosure Reports § 2634.904 Confidential...

  1. Confidentiality Revisited: A Response to Manhal-Baugus (1996).

    ERIC Educational Resources Information Center

    Doyle, Kevin

    1998-01-01

    Reviews the issues relating to confidentiality raised by Manhal-Baugus (1996), identifies problem areas from the 1996 article, and offers additional information about confidentiality not included in the article. Chemical dependency counselors are urged to consider the federal law covering confidentiality of alcohol- and drug-abuse patient records…

  2. 42 CFR 2a.7 - Effect of Confidentiality Certificate.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... agents carrying out such a project. (See 45 CFR 5.71 for confidentiality standards imposed on such DHHS... 42 Public Health 1 2011-10-01 2011-10-01 false Effect of Confidentiality Certificate. 2a.7 Section... PROTECTION OF IDENTITY-RESEARCH SUBJECTS § 2a.7 Effect of Confidentiality Certificate. (a) A...

  3. 40 CFR 86.1116-87 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany... submitter, in accordance with 40 CFR 2.204(c)(2)(i)(A). ... 40 Protection of Environment 19 2011-07-01 2011-07-01 false Treatment of confidential...

  4. 33 CFR 1.07-35 - Request for confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... treatment. 1.07-35 Section 1.07-35 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... for confidential treatment. (a) In addition to information treated as confidential under § 1.07-30, a request for confidential treatment of a document or portion thereof may be made by the person...

  5. 40 CFR 90.614 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Importation of Nonconforming Engines § 90.614 Treatment of confidential information. The provisions for treatment of confidential information described in § 90.4 apply to this subpart....

  6. 40 CFR 90.912 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Exclusion and Exemption of Nonroad Engines from Regulations § 90.912 Treatment of confidential information. The provisions for treatment of confidential information described in § 90.4 apply to this subpart....

  7. 40 CFR 92.517 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Remanufacturer Production Line Testing and Audit Programs § 92.517 Treatment of confidential information. Except... any claim of confidentiality made by the submitter. The provisions for treatment of...

  8. 40 CFR 91.516 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Testing Program § 91.516 Treatment of confidential information. Except for information required by § 91... submitter. The provisions for treatment of confidential information described in § 91.7 apply to...

  9. 40 CFR 85.1712 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany... submitter, in accordance with 40 CFR 2.204(c)(2)(i)(A). ... 40 Protection of Environment 18 2010-07-01 2010-07-01 false Treatment of confidential...

  10. 40 CFR 90.4 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this part is entitled to confidential treatment as provided by part 2, subpart B...

  11. 40 CFR 86.1116-87 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany... submitter, in accordance with 40 CFR 2.204(c)(2)(i)(A). ... 40 Protection of Environment 19 2010-07-01 2010-07-01 false Treatment of confidential...

  12. 40 CFR 94.4 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany... CFR part 2, subpart B. (e) Information provided without a claim of confidentiality at the time of... with 40 CFR 2.204(c)(2)(i)(A)....

  13. 40 CFR 85.1514 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany the information at... 40 Protection of Environment 18 2010-07-01 2010-07-01 false Treatment of confidential information... Vehicle Engines § 85.1514 Treatment of confidential information. (a) Any importer may assert that some...

  14. 40 CFR 89.7 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this part is entitled to confidential treatment as provided by part 2, subpart B...

  15. 12 CFR 1102.309 - Confidential treatment procedures.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 12 Banks and Banking 9 2013-01-01 2013-01-01 false Confidential treatment procedures. 1102.309... Description of Office, Procedures, Public Information § 1102.309 Confidential treatment procedures. (a) In... submission be afforded confidential treatment under 5 U.S.C. 552(b)(4) (i.e., trade secrets and commercial...

  16. 40 CFR 89.613 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Importation of Nonconforming Nonroad Engines § 89.613 Treatment of confidential information. The provisions for treatment of confidential information as described in § 89.7 apply....

  17. 40 CFR 91.7 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... (CONTINUED) CONTROL OF EMISSIONS FROM MARINE SPARK-IGNITION ENGINES General § 91.7 Treatment of confidential... part is entitled to confidential treatment as provided by part 2, subpart B, of this chapter. (b)...

  18. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.

    PubMed

    Zhang, Hong; Zhu, Xiaoxia; Li, Na; Li, Dianhe; Sha, Zhou; Zheng, Xiaokang; Wang, Haofei

    2015-07-01

    Metastasis-associated gene 1 (MTA1) is associated with cell growth, metastasis, and survival in non-small-cell lung cancer (NSCLC). Several previous reports have demonstrated that microRNAs affect gene expression through interaction between their seed region and the 3'-untranslated region of the target mRNA, resulting in post-transcriptional regulation. The aim of this study was to identify miRNAs that suppress malignancy in NSCLC cells by targeting MTA1. Two human NSCLC cell lines were analyzed for the expression of MTA1 by quantitative RT-PCR and western blotting after transfection with MTA1 mimics. A luciferase reporter assay was established to test the direct connection between MTA1 and its upstream miRNAs. Cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, 5-ethynyl-2'-deoxyuridine analysis, and colony formation assay. Cell migration and invasive capacity were evaluated by wound-healing assay and transwell assay. The miRNA/MTA1 axis was also probed by quantitative RT-PCR and western blotting in samples from eight NSCLC patients. Among the candidate miRNAs, miR-125a-3p was shown to post-transcriptionally regulate MTA1 in NSCLC cells. These data were reinforced by the luciferase reporter assay, in addition to the demonstration that MTA1 is inversely correlated with miR-125a-3p in NSCLC tissues. Furthermore, miR-125a-3p was found to inhibit NSCLC cell proliferation, migration, and invasion, through the same mechanisms of down-regulated MTA1. Our report demonstrates that miR-125a-3p inhibits the proliferation, migration, and invasion of NSCLC cells through down-regulation of MTA1, indicating the role of the miR-125a-3p/MTA1 axis in NSCLC, and may provide novel insight into the molecular mechanisms underpinning the disease and potential therapeutic targets. PMID:25998575

  19. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... regulation, Confidential Information is defined in the SBA Lender information portal and by notice issued from time to time. Access to the Lender information portal may be obtained by contacting the OCRM....

  20. Comparing the Coronal Seal of Different Thicknesses of MTA with Gutta-Percha after Post Space Preparation

    PubMed Central

    Frough Reyhani, Mohammad; Yavari, Hamidreza; Ghasemi, Negin; Rahimi, Saeed; Soroush Barhaghi, Mohammad Hosien; Mokhtari, Hadi; Sarikhani, Payman

    2015-01-01

    Introduction. The aim of this study was to compare the coronal seal of different thicknesses of MTA with gutta-percha after post space preparation. Materials and Methods. A total of 50 maxillary central incisors randomly divided into 5 experimental groups (n = 8). After preparation of the root canals with step back technique, in groups 1 and 2, post spaces were prepared and 4 or 5 mm gutta-percha remained in the apical, respectively. In groups 3, 4, and 5, there was 1-2 and 3 mm MTA in the apical, respectively. The ten teeth serve as control groups. The teeth were connected to a bacterial microleakage evaluation system. The study period was 120 days and the samples were evaluated on ten-day intervals; Meier-Kaplan technique was used for estimation of the mean time of microleakage to occur. Log-rank test was used for comparison of microleakage. Results. Number of samples exhibiting microleakage in MTA was less than those of gutta-percha at all intervals. Means of days with no microleakage were maximum and minimum with 3 mm MTA and 4 mm gutta-percha, respectively. Conclusion. Obturation of root canals using the MTA technique provides a proper seal with the minimum thickness of MTA in teeth requiring post space preparation. PMID:25984559

  1. 21 CFR 26.76 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 1 2011-04-01 2011-04-01 false Confidentiality. 26.76 Section 26.76 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT...

  2. 42 CFR 67.104 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 1 2011-10-01 2011-10-01 false Confidentiality. 67.104 Section 67.104 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES FELLOWSHIPS, INTERNSHIPS, TRAINING AGENCY FOR HEALTH CARE POLICY AND RESEARCH GRANTS AND CONTRACTS Peer Review of Contracts for...

  3. 42 CFR 67.104 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 67.104 Section 67.104 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES FELLOWSHIPS, INTERNSHIPS, TRAINING AGENCY FOR HEALTH CARE POLICY AND RESEARCH GRANTS AND CONTRACTS Peer Review of Contracts for...

  4. 42 CFR 67.104 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 67.104 Section 67.104 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES FELLOWSHIPS, INTERNSHIPS, TRAINING AGENCY FOR HEALTH CARE POLICY AND RESEARCH GRANTS AND CONTRACTS Peer Review of Contracts for...

  5. 42 CFR 67.104 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 67.104 Section 67.104 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES FELLOWSHIPS, INTERNSHIPS, TRAINING AGENCY FOR HEALTH CARE POLICY AND RESEARCH GRANTS AND CONTRACTS Peer Review of Contracts for...

  6. 29 CFR 1635.9 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... conducted in compliance with the regulations and protections provided for under 45 CFR part 46; (3) In... Relating to Labor (Continued) EQUAL EMPLOYMENT OPPORTUNITY COMMISSION GENETIC INFORMATION NONDISCRIMINATION ACT OF 2008 § 1635.9 Confidentiality. (a) Treatment of genetic information. (1) A covered entity...

  7. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS GRANTS FOR FAMILY PLANNING SERVICES Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal facts and circumstances obtained by the project staff about individuals receiving services must be...

  8. Medical confidentiality and the competent patient.

    PubMed

    Niveau, Gerard; Burkhardt, Sandra; Chiesa, Sarah

    2013-11-01

    Confidentiality is both a fundamental principle of medical ethics and a legal obligation. In exceptional situations not covered by legal provisions, doctors may want to waive confidentiality against the wishes of the patient. Swiss law calls for an authority to rule on such cases. In the Canton of Geneva this authority is the Commission for Professional Confidentiality. This paper concerns 41 cases managed by this commission. The study shows that the majority of these requests to the Commission concern the reporting of patients who are not incompetent but need the protection of a legal guardianship. In rare cases, there is another interest higher than confidentiality: public order or functioning of justice. The Commission found that the measure requested was justified in the majority of cases brought before it. This study focuses on exceptional cases but it throws into relief the conflict between the principle of autonomy on the one hand and the need for patient protection and social justice on the other. PMID:23300253

  9. 46 CFR 531.4 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... General Provisions § 531.4 Confidentiality. (a) All NSAs and amendments to NSAs filed with the Commission... NSAs to another agency of the Federal government of the United States. (c) Parties to a filed NSA may... NSA by either party will not, on its own, be considered a violation of these rules....

  10. 46 CFR 531.4 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... General Provisions § 531.4 Confidentiality. (a) All NSAs and amendments to NSAs filed with the Commission... NSAs to another agency of the Federal government of the United States. (c) Parties to a filed NSA may... NSA by either party will not, on its own, be considered a violation of these rules....

  11. 46 CFR 531.4 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... General Provisions § 531.4 Confidentiality. (a) All NSAs and amendments to NSAs filed with the Commission... NSAs to another agency of the Federal government of the United States. (c) Parties to a filed NSA may... NSA by either party will not, on its own, be considered a violation of these rules....

  12. 46 CFR 531.4 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... General Provisions § 531.4 Confidentiality. (a) All NSAs and amendments to NSAs filed with the Commission... NSAs to another agency of the Federal government of the United States. (c) Parties to a filed NSA may... NSA by either party will not, on its own, be considered a violation of these rules....

  13. 46 CFR 531.4 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... General Provisions § 531.4 Confidentiality. (a) All NSAs and amendments to NSAs filed with the Commission... NSAs to another agency of the Federal government of the United States. (c) Parties to a filed NSA may... NSA by either party will not, on its own, be considered a violation of these rules....

  14. 15 CFR 705.6 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... confidential information (trade secrets, commercial or financial information, or any other information... submitter and will not be considered. However, such information or material may be resubmitted as non... filing by a statement justifying non-disclosure and referring to the specific legal authority claimed....

  15. 40 CFR 1033.915 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ..., stamping, or some other method. (b) We will store your confidential information as described in 40 CFR part 2. Also, we will disclose it only as specified in 40 CFR part 2. This applies both to any... described in 40 CFR 2.204....

  16. 40 CFR 1042.915 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... your confidential information as described in 40 CFR part 2. Also, we will disclose it only as specified in 40 CFR part 2. This applies both to any information you send us and to any information we... available to the public without further notice to you, as described in 40 CFR 2.204....

  17. 40 CFR 1033.915 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ..., stamping, or some other method. (b) We will store your confidential information as described in 40 CFR part 2. Also, we will disclose it only as specified in 40 CFR part 2. This applies both to any... described in 40 CFR 2.204....

  18. 40 CFR 1042.915 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... your confidential information as described in 40 CFR part 2. Also, we will disclose it only as specified in 40 CFR part 2. This applies both to any information you send us and to any information we... available to the public without further notice to you, as described in 40 CFR 2.204....

  19. 16 CFR 1502.3 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 16 Commercial Practices 2 2012-01-01 2012-01-01 false Confidential information. 1502.3 Section... information. Whenever any participant desires or is required to submit information in any proceeding under this part 1502, and the participant believes that such information consists of trade secret or...

  20. Confidentiality of Accounting Academics: Consequences of Nonconformity

    ERIC Educational Resources Information Center

    Amponsah, Emmanuel B.; Boateng, Peter Agyekum; Onuoha, Luke N.

    2016-01-01

    This paper examined ways by which nonconformity to confidentiality among accounting academics could lead to increased-recruitment-and-legal-costs to their employing universities in Ghana that offered accounting degree programmes. With a cross-sectional design, data collected from 1,225 accountants analysed via Cronbach's alpha,…

  1. 38 CFR 1.462 - Confidentiality restrictions.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... Sickle Cell Anemia § 1.462 Confidentiality restrictions. (a) General. The patient records to which §§ 1..., infection with the HIV, or sickle cell anemia may be acknowledged only if the patient's written consent is... with the HIV, or sickle cell anemia. (2) Any answer to a request for a disclosure of patient...

  2. 40 CFR 710.58 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT TSCA CHEMICAL INVENTORY REGULATIONS Inventory Update Reporting for 2006 and Beyond § 710.58 Confidentiality. (a... Inventory File as of the time the report is submitted for that substance under this subpart. The...

  3. 10 CFR 430.75 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... OF ENERGY ENERGY CONSERVATION ENERGY CONSERVATION PROGRAM FOR CONSUMER PRODUCTS Certification and Enforcement § 430.75 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11, any person submitting... been deleted. In accordance with the procedures established at 10 CFR 1004.11, DOE shall make its...

  4. 10 CFR 430.75 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... OF ENERGY ENERGY CONSERVATION ENERGY CONSERVATION PROGRAM FOR CONSUMER PRODUCTS Certification and Enforcement § 430.75 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11, any person submitting... been deleted. In accordance with the procedures established at 10 CFR 1004.11, DOE shall make its...

  5. 41 CFR 60-742.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 41 Public Contracts and Property Management 1 2010-07-01 2010-07-01 true Confidentiality. 60-742.3 Section 60-742.3 Public Contracts and Property Management Other Provisions Relating to Public Contracts OFFICE OF FEDERAL CONTRACT COMPLIANCE PROGRAMS, EQUAL EMPLOYMENT OPPORTUNITY, DEPARTMENT OF LABOR 742-PROCEDURES FOR COMPLAINTS/CHARGES...

  6. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Confidentiality. 717.19 Section 717.19 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH...

  7. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Confidentiality. 717.19 Section 717.19 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH...

  8. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Confidentiality. 717.19 Section 717.19 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH...

  9. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Confidentiality. 717.19 Section 717.19 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH...

  10. 42 CFR 67.104 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Confidentiality. 67.104 Section 67.104 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES FELLOWSHIPS, INTERNSHIPS, TRAINING AGENCY FOR HEALTH CARE POLICY AND RESEARCH GRANTS AND CONTRACTS Peer Review of Contracts for...

  11. Peer Review Confidentiality: Is It Still Possible?

    ERIC Educational Resources Information Center

    Lee, Barbara A.

    This pamphlet analyzes the clash between higher education institutions' concerns for preserving the confidentiality of peer faculty review and the need for relevant evidence when a disappointed faculty member suspects that a negative tenure decision is infected with illegal bias. Until recently many institutions decided whether to give tenure to a…

  12. 42 CFR 2.63 - Confidential communications.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal... injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS Court Orders Authorizing Disclosure and Use §...

  13. 42 CFR 2.63 - Confidential communications.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal... injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS Court Orders Authorizing Disclosure and Use §...

  14. 42 CFR 2.63 - Confidential communications.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal... injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS Court Orders Authorizing Disclosure and Use §...

  15. 42 CFR 2.63 - Confidential communications.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal... injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS Court Orders Authorizing Disclosure and Use §...

  16. 45 CFR 1340.20 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 45 Public Welfare 4 2013-10-01 2013-10-01 false Confidentiality. 1340.20 Section 1340.20 Public Welfare Regulations Relating to Public Welfare (Continued) OFFICE OF HUMAN DEVELOPMENT SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES THE ADMINISTRATION FOR CHILDREN, YOUTH AND FAMILIES, CHILD ABUSE AND NEGLECT PREVENTION AND TREATMENT PROGRAM...

  17. 42 CFR 2.63 - Confidential communications.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... bodily injury, including circumstances which constitute suspected child abuse and neglect and verbal... injury, including homicide, rape, kidnapping, armed robbery, assault with a deadly weapon, or child abuse... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS Court Orders Authorizing Disclosure and Use §...

  18. 42 CFR 136a.57 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 136a.57 Section 136a.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  19. 42 CFR 50.310 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 50.310 Section 50.310 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS POLICIES OF GENERAL APPLICABILITY Abortions and Related Medical Services in Federally Assisted Programs of the Public Health...

  20. 42 CFR 136a.57 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 1 2011-10-01 2011-10-01 false Confidentiality. 136a.57 Section 136a.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  1. 42 CFR 136.57 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 136.57 Section 136.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  2. 42 CFR 136.57 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 136.57 Section 136.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  3. 42 CFR 50.310 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Confidentiality. 50.310 Section 50.310 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS POLICIES OF GENERAL APPLICABILITY Abortions and Related Medical Services in Federally Assisted Programs of the Public Health...

  4. 42 CFR 50.310 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 50.310 Section 50.310 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS POLICIES OF GENERAL APPLICABILITY Abortions and Related Medical Services in Federally Assisted Programs of the Public Health...

  5. 42 CFR 136a.57 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Confidentiality. 136a.57 Section 136a.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  6. 42 CFR 136a.57 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 136a.57 Section 136a.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  7. 42 CFR 136a.57 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 136a.57 Section 136a.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  8. 42 CFR 136.57 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Confidentiality. 136.57 Section 136.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  9. 42 CFR 50.310 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 1 2011-10-01 2011-10-01 false Confidentiality. 50.310 Section 50.310 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS POLICIES OF GENERAL APPLICABILITY Abortions and Related Medical Services in Federally Assisted Programs of the Public Health...

  10. 42 CFR 50.310 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Confidentiality. 50.310 Section 50.310 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GRANTS POLICIES OF GENERAL APPLICABILITY Abortions and Related Medical Services in Federally Assisted Programs of the Public Health...

  11. 42 CFR 136.57 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 1 2011-10-01 2011-10-01 false Confidentiality. 136.57 Section 136.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  12. 42 CFR 136.57 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Confidentiality. 136.57 Section 136.57 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES INDIAN HEALTH Abortions and Related Medical Services in Indian...

  13. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 2 2011-01-01 2011-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards... REGULATIONS COTTON CLASSING, TESTING, AND STANDARDS Cotton Fiber and Processing Tests Fiber and...

  14. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 2 2014-01-01 2014-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards... REGULATIONS COTTON CLASSING, TESTING, AND STANDARDS Cotton Fiber and Processing Tests Fiber and...

  15. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 2 2012-01-01 2012-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards... REGULATIONS COTTON CLASSING, TESTING, AND STANDARDS Cotton Fiber and Processing Tests Fiber and...

  16. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 2 2013-01-01 2013-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards... REGULATIONS COTTON CLASSING, TESTING, AND STANDARDS Cotton Fiber and Processing Tests Fiber and...

  17. 38 CFR 1.462 - Confidentiality restrictions.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Sickle Cell Anemia § 1.462 Confidentiality restrictions. (a) General. The patient records to which §§ 1..., infection with the HIV, or sickle cell anemia may be acknowledged only if the patient's written consent is... with the HIV, or sickle cell anemia. (2) Any answer to a request for a disclosure of patient...

  18. 38 CFR 1.462 - Confidentiality restrictions.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Sickle Cell Anemia § 1.462 Confidentiality restrictions. (a) General. The patient records to which §§ 1..., infection with the HIV, or sickle cell anemia may be acknowledged only if the patient's written consent is... with the HIV, or sickle cell anemia. (2) Any answer to a request for a disclosure of patient...

  19. 38 CFR 1.462 - Confidentiality restrictions.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Sickle Cell Anemia § 1.462 Confidentiality restrictions. (a) General. The patient records to which §§ 1..., infection with the HIV, or sickle cell anemia may be acknowledged only if the patient's written consent is... with the HIV, or sickle cell anemia. (2) Any answer to a request for a disclosure of patient...

  20. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 717.19 Section 717.19 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH OR THE ENVIRONMENT General Provisions...

  1. Client Confidentiality in Police Social Work Settings.

    ERIC Educational Resources Information Center

    Curtis, Patrick Almond; Lutkus, Anita M.

    1985-01-01

    Results of a survey that questioned police social workers regarding the protection of client confidentiality in police settings revealed several problems related to the unique character of the setting and to the identification of social workers with the goals and practices of police. Results raise questions about the protection of client…

  2. 7 CFR 987.67 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 987.67 Section 987.67 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... information. All data or other information constituting a trade secret or disclosing a trade position...

  3. 7 CFR 926.19 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 926.19 Section 926.19 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... RECORDKEEPING REQUIREMENTS APPLICABLE TO CRANBERRIES NOT SUBJECT TO THE CRANBERRY MARKETING ORDER §...

  4. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 2 2010-01-01 2010-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards, Inspections, Marketing Practices), DEPARTMENT OF AGRICULTURE COMMODITY STANDARDS AND STANDARD...

  5. 37 CFR 384.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Collective are public knowledge. The party claiming the benefit of this provision shall have the burden of proving that the disclosed information was public knowledge. (c) Use of Confidential Information. In no event shall the Collective or any other person or entity authorized to have access to...

  6. Ownership, Privacy, Confidentiality, and Security Data.

    ERIC Educational Resources Information Center

    Staman, E. Michael

    1986-01-01

    One of the areas most often neglected by those responsible for information systems in colleges and universities relates to ownership, privacy, confidentiality, and security of data. Background information and definitions are provided, and a suggested environment is described. Model recommendations for institutional policy are offered. (MLW)

  7. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... procedures in 40 CFR part 2, subpart B, including FIFRA confidentiality procedures at 40 CFR 2.307. To the extent that provisions in this section conflict with those in 40 CFR part 2, subpart B, the provisions in this section take precedence. The provisions of 40 CFR 2.308 do not apply to information to which...

  8. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... procedures in 40 CFR part 2, subpart B, including FIFRA confidentiality procedures at 40 CFR 2.307. To the extent that provisions in this section conflict with those in 40 CFR part 2, subpart B, the provisions in this section take precedence. The provisions of 40 CFR 2.308 do not apply to information to which...

  9. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... procedures in 40 CFR part 2, subpart B, including FIFRA confidentiality procedures at 40 CFR 2.307. To the extent that provisions in this section conflict with those in 40 CFR part 2, subpart B, the provisions in this section take precedence. The provisions of 40 CFR 2.308 do not apply to information to which...

  10. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... procedures in 40 CFR part 2, subpart B, including FIFRA confidentiality procedures at 40 CFR 2.307. To the extent that provisions in this section conflict with those in 40 CFR part 2, subpart B, the provisions in this section take precedence. The provisions of 40 CFR 2.308 do not apply to information to which...

  11. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... procedures in 40 CFR part 2, subpart B, including FIFRA confidentiality procedures at 40 CFR 2.307. To the extent that provisions in this section conflict with those in 40 CFR part 2, subpart B, the provisions in this section take precedence. The provisions of 40 CFR 2.308 do not apply to information to which...

  12. 42 CFR 456.213 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 4 2010-10-01 2010-10-01 false Confidentiality. 456.213 Section 456.213 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL ASSISTANCE PROGRAMS UTILIZATION CONTROL Utilization Control: Mental Hospitals Ur...

  13. 28 CFR 0.29f - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Confidentiality. 0.29f Section 0.29f Judicial Administration DEPARTMENT OF JUSTICE ORGANIZATION OF THE DEPARTMENT OF JUSTICE 4-Office of the... investigation, disclose the identity of an employee who submits a complaint to the OIG without the...

  14. 29 CFR 1641.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1641.3 Section 1641.3 Labor Regulations Relating to Labor (Continued) EQUAL EMPLOYMENT OPPORTUNITY COMMISSION PROCEDURES FOR COMPLAINTS/CHARGES OF EMPLOYMENT DISCRIMINATION BASED ON DISABILITY FILED AGAINST EMPLOYERS HOLDING GOVERNMENT CONTRACTS...

  15. 15 CFR 701.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 2 2010-01-01 2010-01-01 false Confidentiality. 701.5 Section 701.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF INDUSTRY AND SECURITY, DEPARTMENT OF COMMERCE NATIONAL SECURITY INDUSTRIAL BASE REGULATIONS REPORTING...

  16. 46 CFR 502.405 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... Alternative Dispute Resolution § 502.405 Confidentiality. (a) Except as provided in paragraphs (d) and (e) of this section, a neutral in a dispute resolution proceeding shall not voluntarily disclose or through discovery or compulsory process be required to disclose any dispute resolution communication or...

  17. 46 CFR 502.405 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... Alternative Dispute Resolution § 502.405 Confidentiality. (a) Except as provided in paragraphs (d) and (e) of this section, a neutral in a dispute resolution proceeding shall not voluntarily disclose or through discovery or compulsory process be required to disclose any dispute resolution communication or...

  18. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient receiving a device subject to tracking requirements under this part may refuse to release, or...

  19. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient receiving a device subject to tracking requirements under this part may refuse to release, or...

  20. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient receiving a device subject to tracking requirements under this part may refuse to release, or...

  1. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient receiving a device subject to tracking requirements under this part may refuse to release, or...

  2. The Law Clerk's Duty of Confidentiality.

    ERIC Educational Resources Information Center

    University of Pennsylvania Law Review, 1981

    1981-01-01

    Judges were surveyed for their views on their law clerks' responsibility for confidentiality. Background is outlined, results are presented, and guidelines for law clerk conduct are suggested. The questionnaire is appended. Available from: Executive Editor, University of Pennsylvania Law Review, 3400 Chestnut St., Philadelphia, PA 19104, $6.50.…

  3. Confidentiality of Library Records: Renewed Concerns.

    ERIC Educational Resources Information Center

    Schmidt, C. James

    1988-01-01

    Discusses the Federal Bureau of Investigation's Library Awareness Program and presents the American Library Association's policy on confidentiality of library records and suggested procedures for implementing the policy. Relevant state and federal legislation are summarized, and suggestions are offered for library administrators dealing with the…

  4. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality claims. 716.55 Section 716.55 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL... contained in a study, the disclosure of which would clearly be an unwarranted invasion of personal...

  5. 15 CFR 801.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 3 2010-01-01 2010-01-01 false Confidentiality. 801.5 Section 801.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF ECONOMIC ANALYSIS, DEPARTMENT OF COMMERCE SURVEY OF INTERNATIONAL TRADE IN SERVICES BETWEEN U.S....

  6. 28 CFR 42.603 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Confidentiality. 42.603 Section 42.603 Judicial Administration DEPARTMENT OF JUSTICE NONDISCRIMINATION; EQUAL EMPLOYMENT OPPORTUNITY; POLICIES AND PROCEDURES Procedures for Complaints of Employment Discrimination Filed Against Recipients of Federal Financial Assistance §...

  7. 28 CFR 42.603 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... EEOC, except in cases where the agency receives the same information from a source independent of EEOC... independent source information or information obtained by EEOC under the agency's investigative authority in a... Financial Assistance § 42.603 Confidentiality. When an agency receives information obtained by EEOC,...

  8. 12 CFR 1253.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... “commercial or financial information obtained from a person and privileged or confidential” as that phrase is... 12 Banks and Banking 10 2014-01-01 2014-01-01 false Confidential information. 1253.5 Section 1253.5 Banks and Banking FEDERAL HOUSING FINANCE AGENCY ENTERPRISES PRIOR APPROVAL FOR...

  9. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... proposed criteria for evaluating a safety approval is secret, as classified by the U.S. Government, or the...,” “Proprietary Commercial Information,” “Trade Secret,” or “Confidential Treatment Requested.” Where this...

  10. 42 CFR 456.213 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 4 2011-10-01 2011-10-01 false Confidentiality. 456.213 Section 456.213 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL ASSISTANCE PROGRAMS UTILIZATION CONTROL Utilization Control: Mental Hospitals Ur...

  11. 42 CFR 456.213 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 4 2012-10-01 2012-10-01 false Confidentiality. 456.213 Section 456.213 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL ASSISTANCE PROGRAMS UTILIZATION CONTROL Utilization Control: Mental Hospitals Ur...

  12. Efficacy of MTA and CEM Cement with Collagen Membranes for Treatment of Class II Furcation Defects

    PubMed Central

    Ghanbari, Habib Ollah; Taheri, Morteza; Abolfazli, Salman; Asgary, Saeed; Gharechahi, Maryam

    2014-01-01

    Objectives: This study aimed to compare the efficacy of MTA and CEM cement in Class II furcation defects in human mandibular molars. Materials and Methods: Forty furcation defects were treated in 16 patients with chronic periodontitis. The clinical parameters of probing depth (PD), vertical and horizontal clinical attachment levels (VCAL and HCAL), open vertical and horizontal furcation depths (OVFD and OHFD), and gingival margin level (GML) were measured at baseline and at 3- and 6-month (re-entry surgery) postoperatively. Data were analyzed at a significance level of P<0.05. Results: Use of MTA and CEM caused significant decreases in PD, VCAL, HCAL, OVFD and OHFD at re-entry, with no statistically significant differences between the two treatment options in soft and hard tissue parameters. Conclusion: Both treatment modalities caused significant gains in attachment levels and bone fills, proving efficacy for treatment of Class II furcation involvements. PMID:25628670

  13. [Repair of a root perforation by using MTA: a case report].

    PubMed

    Riccitiello, Francesco; Di Caprio, Maria Patrizia; D'Amora, Marilina; Pizza, Nunzia Luisa; Vallone, Gianfranco; D'Ambrosio, Colomba; Amato, Massimo

    2013-01-01

    Root perforations are accidental events that may occur during the treatment, causing tissue inflammation and alveolar bone loss of integrity of the periodontium. In such cases, the radiological evidence is fundamental in the formulation of the diagnosis, in the choice of therapy (surgical or non-surgical) and finally for the assessment of prognosis of the dental element. In non-surgical treatment of endodontic lesions, the material used for the repair of the defect root should have biocompatibility, antibacterial activity, ability to induce healing of periodontal tissues and radiopacity. The Mineral Trioxide Aggregate (MTA) is a silicate-based cement introduced in dental clinical practice with good radiopacity, biocompatibility and bone induction. This article describes the use of MTA in endodontic repair of a perforation of the middle third root and the success of non-surgical treatment was dimonstrated radiographicaly. PMID:24042428

  14. Breaching confidentiality to protect the public: evolving standards of medical confidentiality for military detainees.

    PubMed

    Wynia, Matthew K

    2007-08-01

    Confidentiality is a core value in medicine and public health yet, like other core values, it is not absolute. Medical ethics has typically allowed for breaches of confidentiality when there is a credible threat of significant harm to an identifiable third party. Medical ethics has been less explicit in spelling out criteria for allowing breaches of confidentiality to protect populations, instead tending to defer these decisions to the law. But recently, issues in military detention settings have raised the profile of decisions to breach medical confidentiality in efforts to protect the broader population. National and international ethics documents say little about the confidentiality of detainee medical records. But initial decisions to use detainee medical records to help craft coercive interrogations led to widespread condemnation, and might have contributed to detainee health problems, such as a large number of suicide attempts several of which have been successful. More recent military guidance seems to reflect lessons learned from these problems and does more to protect detainee records. For the public health system, this experience is a reminder of the importance of confidentiality in creating trustworthy, and effective, means to protect the public's health. PMID:17710687

  15. Antibacterial Activity of MTA Fillapex and AH 26 Root Canal Sealers at Different Time Intervals

    PubMed Central

    Jafari, Farnaz; Samadi Kafil, Hossein; Jafari, Sanaz; Aghazadeh, Mohammad; Momeni, Tahereh

    2016-01-01

    Introduction: The main goal of endodontic treatment is elimination of bacteria and their by-products from infected root canals. This study compared the antibacterial effect of two different sealers, AH 26 and MTA Fillapex, on 4 microorganisms 24, 48 and 72 h and 7 days after mixing. Methods and Materials: The microorganisms used in this study consisted of Lactobacillus acidophilus (ATCC 4356), Lactobacillus casei (ATCC 39392), Staphylococcus aureus (ATCC 25923) and Enterococcus faecalis (ATCC 29212). This test is based on the growth of bacteria and turbidity measurement technique using a spectrophotometer, and direct contact was conducted. Multiple comparisons were carried out using repeated-measures ANOVA followed by Tukey’s test and student’s t-test. The level of significance was set at 0.05. Results: The antibacterial activity in the indirect technique was more than the technique with both sealers. In the direct technique the antibacterial activity on all microorganisms were lower for MTA Fillapex sealer. In the indirect technique, both sealers exhibited similar antibacterial properties. Conclusion: The antibacterial effect of MTA Fillapex sealer was significantly less than that of AH 26 sealer in the direct technique. The antibacterial effects of both sealers were similar in the indirect technique. PMID:27471530

  16. Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies

    PubMed Central

    Yildiz, Esma; Tosun, Gul

    2014-01-01

    Objective: The aim of this study is to evaluate four different pulpotomy medicaments in primary molars. Materials and Methods: A total of 147 primary molars with deep caries were treated with four different pulpotomy medicaments (FC: formocresol, FS: ferric sulfate, CH: calcium hydroxide, and MTA: mineral trioxide aggregate) in this study. The criteria for tooth selection for inclusion were no clinical and radiographic evidence of pulp pathology. During 30 months of follow-up at 6-month intervals, clinical and radiographic success and failures were recorded. The differences between the groups were statistically analyzed using the Chi-square test and Kaplan-Meier analysis. Results: At 30 months, clinical success rates were 100%, 95.2%, 96.4%, and 85% in the FC, FS, MTA, and CH groups, respectively. In radiographic analysis, the MTA group had the highest (96.4%), and the CH group had the lowest success rate (85%). There were no clinical and radiographic differences between materials (P > 0.05). Conclusions: Although there were no differences between materials, only in the CH group did three teeth require extraction due to further clinical symptoms of radiographic failures during the 30-month follow-up period. None of the failed teeth in the other groups required extraction during the 30-month follow-up period. PMID:24966776

  17. Evaluation of the dentinal wall adaptation ability of MTA Fillapex using stereo electron microscope

    PubMed Central

    Demiriz, Levent; Koçak, Mustafa Murat; Koçak, Sibel; Sağlam, Baran Can; Türker, Sevinç Aktemur

    2016-01-01

    Background: An ideal root canal obturation requires a complete dentinal wall adaptation of sealer and Gutta-percha combinations without any gap formations. Aims: The aim of the study was to evaluate the dentinal wall adaptation ability of MTA Fillapex root canal sealer using stereo electron microscope (SEM). Methods: Twenty-four, single-rooted, human maxillary incisor teeth were used. All canals were prepared with a rotary nickel–titanium (Ni–Ti) instrument to a size F3 file. Teeth divided into two equal groups and one of the experimental groups was filled with AH Plus, and the other group was filled with MTA Fillapex using Gutta-percha single cone as a core material. The roots were prepared for SEM evaluation, and serial scanning electron photomicrographs were taken at ×50, ×100, ×500, and ×1000 magnifications. The gaps between the root canal sealer and canal walls were detected and measured in coronal, middle, and apical thirds. For each section, the highest value among the detected gap formations was recorded. Statistical Analysis: Mann–Whitney U-test, Freidman, and Wilcoxon tests were used. Results: The statistical analysis showed no significant difference between two sealers in terms of gap formation (P > 0.05). Conclusions: MTA Fillapex has a similar dentinal wall adaptation ability as AH Plus does. PMID:27217633

  18. Evaluation of Adhesion and Morphology of Human Osteoblasts to White MTA and Portland Cement

    PubMed Central

    Bidar, Maryam; Tavakkol Afshari, Jalil; Shahrami, Fatemeh

    2007-01-01

    INTRODUCTION: Osteoblasts and periodontal ligament cells are major cells for wound healing after root end resection. The interaction of osteoblasts with filling materials could play a critical role in healing of surgical lesion. Adhesion and spreading of cells on material surface are the initial phase for cellular function. The purpose of the present study was the evaluation of morphology and attachment of human osteoblasts in present of white MTA, Portland cement (PC) and IRM as root end filling and perforation repair materials. MATERIALS AND METHODS: The human osteoblasts (MG-63 cell line) were prepared from Iranian Pasteur Institute; Cellular Bank, were grown in RPMI 1640 medium. The testing materials were mixed according to the manufacture's instruction, inserted in to the wells of 24-well flat-bottomed plate, and condensed to disk of 1mm thickness and 1×1mm diameter. Cells were added to the materials after two weeks. During 1,3,7 days intervals, the disk of materials along with cells were grown on their surface, examined by a scanning electron microscope (SEM). We used of IRM as negative group. RESULTS: Results showed that after 7 days many of osteoblasts were attached on the surface of white MTA and PC and appeared partially round or flat. The cells appeared round with no attachment and spreading in conjunction with IRM. CONCLUSION: The results indicate that human osteoblasts have a favorable response to white MTA and Portland cement compared with IRM. PMID:24298287

  19. Sealing ability of MTA, Super EBA, Vitremer and amalgam as root-end filling materials.

    PubMed

    Pereira, Cecília Luiz; Cenci, Maximiliano Sérgio; Demarco, Flávio Fernando

    2004-01-01

    This study evaluated the root-end sealing ability of mineral trioxide aggregate (MTA Angelus), reinforced zinc oxide-eugenol cement (Super EBA), resin-modified glass ionomer (Vitremer) and zinc-free amalgam (GS-80) (control). The root canals of eighty human lower molars were accessed, cleansed, shaped and obturated. Apexes were resected and cavities were prepared. Teeth were divided into 4 groups of 40 cavities, root-end filled with the materials, and immersed in methylene blue for 72 h at 37 degrees C. Roots were then sectioned transversally at each millimeter and evaluated under magnification, observing the dye penetration in each section. Data were evaluated using Kruskal-Wallis test at a 5% level of significance, showing the differences among all materials (p < 0.001). The crescent order of microleakage was MTA < Vitremer < Super EBA < amalgam. Higher leakage levels were observed in the first millimeter sections of amalgam, Vitremer and MTA, when compared with the third millimeter section (p < 0.05). PMID:16089263

  20. IN VITRO SEALING ABILITY OF WHITE AND GRAY MINERAL TRIOXIDE AGGREGATE (MTA) AND WHITE PORTLAND CEMENT USED AS APICAL PLUGS

    PubMed Central

    Coneglian, Patrícia Zanatta Aranha; Orosco, Fernando Accorsi; Bramante, Clóvis Monteiro; de Moraes, Ivaldo Gomes; Garcia, Roberto Brandão; Bernardineli, Norberti

    2007-01-01

    This study evaluated the sealing ability of apical plugs made of white and gray MTA-Angelus® and white Portland cement placed via the root canal and having different thicknesses (2, 5 and 7 mm). Ninety extracted human single-rooted teeth were instrumented using a size 40 K-file to standardize the foraminal opening by the stepback technique. The teeth were assigned to 3 groups (n=30), according to the material used for fabrication of the apical plugs: A = gray MTA; B = white MTA; C = white Portland cement. The groups were subdivided into groups of 10 teeth each according to the apical plug thickness (2, 5 and 7 mm). Marginal apical dye leakage was assessed using 0.2% Rhodamine B solution in which the specimens were immersed for 72 hours at 37°C. The roots were sectioned longitudinally in a buccolingual direction for apical plug exposure, and digital photographs were taken and analyzed by Image Tool image-analysis software. Data were analyzed statistically by Kruskal-Wallis and Dunn's tests. Significance level was set at 5%. The least percent leakage was observed for 5- and 7-mm-thick plugs (p<0.05). No significant difference (p>0.05) was found between gray MTA and white Portland cement. Among the three materials analyzed, white MTA presented the highest marginal leakage (p<0.05). The findings of the present study showed that gray MTA and Portland cement had better sealing ability than white MTA when used as apical plugs. Dye leakage was smaller for 5- and 7-mm-thick plugs compared to 2-mm-thick plugs. PMID:19089127

  1. Methanol:coenzyme M methyltransferase from Methanosarcina barkeri--identification of the active-site histidine in the corrinoid-harboring subunit MtaC by site-directed mutagenesis.

    PubMed

    Sauer, K; Thauer, R K

    1998-05-01

    The enzyme system catalyzing the formation of methyl-coenzyme M from methanol and coenzyme M in Methanosarcina barkeri is composed of the three different polypeptides MtaA, MtaB and MtaC of which MtaC harbors a corrinoid prosthetic group. The heterologous expression of mtaA and mtaB in Escherichia coli has been described previously. We report here on the overproduction of the apoprotein of MtaC in E. coli, on its reconstitution to the active holoprotein with either cob(II)alamin or methyl-cob(III)alamin, and on the properties of the reconstituted corrinoid protein. Reconstituted MtaC was found to contain 1 mol bound cobamide/mol. EPR spectroscopic evidence is presented for a His residue as an axial ligand to Co2+ of the bound corrinoid. This active-site His was identified by site-directed mutagenesis as His136 in the MtaC sequence that contains four His residues. The reconstituted MtaC, in the cob(I)amide oxidation state, was methylated with methanol in the presence of MtaB and demethylated with coenzyme M in the presence of MtaA. In the presence of both MtaB and MtaA, methyl-coenzyme M was formed from methanol and coenzyme M at specific rates comparable to those determined for the enzyme system purified from M. barkeri. M. barkeri contains an isoenzyme of MtaA designated MtbA. The isoenzyme reacted with MtaC with only 2.5% of the activity of MtaA. PMID:9654068

  2. Informed consent and the limits of confidentiality.

    PubMed

    Haggerty, L A; Hawkins, J

    2000-06-01

    Investigators encounter many legal and ethical issues when they conduct research on partner abuse. Balancing abused women's rights to privacy with legally mandated reporting requirements involves considerable thought and planning. Failure to protect participants may result in escalation of abuse as well as loss of children to protective services. Various perspectives on maintaining participant privacy while conforming to legal mandates to report child abuse, homicidality, and suicidality are discussed. The role of confidentiality certificates in providing legal immunity for researchers and the method of obtaining the certificates are presented. In addition, the authors describe the strategies for participant protection that are implemented in a federally funded study of abuse, women's self-care, and pregnancy outcomes. The decision to clearly and specifically inform abused women of the limits of confidentiality allows participants to make informed decisions about disclosures, but may result in diminished recruitment. PMID:10826257

  3. A study of confidential unit exclusion.

    PubMed

    Kean, C A; Hsueh, Y; Querin, J J; Keating, L J; Allensworth, D D

    1990-10-01

    The effectiveness of the confidential unit exclusion (CUE) procedure recommended by the Food and Drug Administration has been questioned by the blood banking community. The purpose of this study was to determine whether donors were informing the blood center correctly regarding the disposition (transfuse or do not transfuse) of their donated blood. A letter explaining the confidential study and requesting permission to send the participant a questionnaire noting his or her self-exclusion choice was mailed to 230 donors who had chosen transfuse and 276 donors who had chosen do not transfuse. After consent was obtained, participants were sent a second packet and asked to indicate whether they had chosen correctly and, if not, to identify reasons for that incorrect choice. A seven-word terminology quiz made up of words from the CUE form was also enclosed. All participants who had chosen transfuse indicated that this was the correct choice. Approximately 50 percent of those who had chosen do not transfuse indicated that this was an incorrect choice; the most common reason was that "I was not paying attention." The most frequently misunderstood term was "confidential." Donors who chose do not transfuse had a significantly higher rate of error on the terminology quiz (p less than 0.01) than did those who chose transfuse. PMID:2219257

  4. Access control and confidentiality in radiology

    NASA Astrophysics Data System (ADS)

    Noumeir, Rita; Chafik, Adil

    2005-04-01

    A medical record contains a large amount of data about the patient such as height, weight and blood pressure. It also contains sensitive information such as fertility, abortion, psychiatric data, sexually transmitted diseases and diagnostic results. Access to this information must be carefully controlled. Information technology has greatly improved patient care. The recent extensive deployment of digital medical images made diagnostic images promptly available to healthcare decision makers, regardless of their geographic location. Medical images are digitally archived, transferred on telecommunication networks, and visualized on computer screens. However, with the widespread use of computing and communication technologies in healthcare, the issue of data security has become increasingly important. Most of the work until now has focused on the security of data communication to ensure its integrity, authentication, confidentiality and user accountability. The mechanisms that have been proposed to achieve the security of data communication are not specific to healthcare. Data integrity can be achieved with data signature. Data authentication can be achieved with certificate exchange. Data confidentiality can be achieved with encryption. User accountability can be achieved with audits. Although these mechanisms are essential to ensure data security during its transfer on the network, access control is needed in order to ensure data confidentiality and privacy within the information system application. In this paper, we present and discuss an access control mechanism that takes into account the notion of a care process. Radiology information is categorized and a model to enforce data privacy is proposed.

  5. Practical State Machine Replication with Confidentiality

    SciTech Connect

    Zhang, Haibin

    2016-01-01

    We study how to enable arbitrary randomized algorithms in Byzantine fault-tolerant (BFT) settings. We formalize a randomized BFT protocol and provide a simple and efficient construction that can be built on any existing BFT protocols while adding practically no overhead. We go one step further to revisit a confidential BFT protocol (Yin et al., SOSP '03). We show that their scheme is potentially susceptible to safety and confidentiality attacks. We then present a new protocol that is secure in the stronger model we formalize, by extending the idea of a randomized BFT protocol. Our protocol uses only efficient symmetric cryptography, while Yin et al.'s uses costly threshold signatures. We implemented and evaluated our protocols on microbenchmarks and real-world use cases. We show that our randomized BFT protocol is as efficient as conventional BFT protocols, and our confidential BFT protocol is two to three orders of magnitude faster than Yin et al.'s, which is less secure than ours.

  6. A Comparative Evaluation of Sealing Ability of New MTA Based Sealers with Conventional Resin Based Sealer: An In-vitro Study

    PubMed Central

    Jasuja, Purshottam; Verma, Kanika Gupta; Juneja, Suruchi; Mathur, Aditi; Walia, Rashmeet; Kakkar, Ashish; Singla, Metashi

    2016-01-01

    Introduction Root canal obturation is the most important step in the root canal treatment that aims to obtain a complete hermetic seal and to prevent the re-growth of microorganisms in the root canal system. To accomplish this, many endodontic obturation materials and sealers are being used. Aim To evaluate and compare the apical microleakage of a resin based sealer; Adseal with Mineral Trioxide Aggregate (MTA) based sealers; Pro root MTA and MTA Fillapex. Materials and Methods Total 75 extracted human single rooted teeth were taken and decoronated at cemento-enamel junction. The access cavities and biomechanical preparation were performed using endodontic rotary system. The teeth were randomly divided into five groups with n=15; Group I - Gutta-percha and Adseal sealer; Group II - Gutta-percha and MTA Fillapex; Group III- Gutta-percha and Pro root MTA; Group IV- Gutta-percha without sealer (positive control group); Group V- Root canal remained empty (negative control). All the specimens were stored at 370C with 100% humidity for one week. All root surfaces except the apical 2mm were covered with two layers of nail varnish and then immersed in an aqueous solution of 2% methylene blue dye for 72 hours. Roots were longitudinally split using a diamond disk. Linear apical dye penetration was measured under Stereomicroscope at 40X magnification. Statistical Analysis The data obtained was subjected to statistical analysis using paried t-test, ANOVA for interclass comparison, with SPSS statistical software (version 20.0). Results The intraobserver reliability was found to be insignificant in each of the triplicate study of all the three study samples. MTA Fillapex group showed maxmium apical microleakage followed by Pro root MTA and Adseal sealer. Conclusion The results concluded that Adseal sealer showed minimal dye penetration followed by Pro root MTA and MTA Fillapex. Thus, concluding that Adseal sealer is better in apical sealing than Pro root MTA and MTA Fillapex.

  7. Clinical outcome of direct pulp capping with MTA or calcium hydroxide: a systematic review and meta-analysis

    PubMed Central

    Zhu, Chenxi; Ju, Bin; Ni, Rong

    2015-01-01

    Direct pulp capping is one of the most common dental practices in endodontic therapy. This systematic review and meta-analysis aim to determine whether the effect of mineral trioxide aggregate (MTA) and calcium hydroxide for direct pulp capping is different, as measured by the clinical and radiographic analysis. The study list was obtained by searching PubMed, Springer Link, Scopus and Cochrane Database. Only those papers that met the inclusion criteria were analyzed. The results indicated that four studies met the inclusion criteria. Statistically significant difference was found between the success rates of MTA and calcium hydroxide treated teeth that needed direct pulp capping (P=0.002). Clinical assessments of the MTA versus calcium hydroxide for direct pulp capping suggested that MTA was superior to calcium hydroxide in direct pulp capping resulting in a lower failure rate (risk difference 0.1 [95% CI 0.04 to 0.16]). In conclusion, MTA has a higher clinical success rate for direct pulp capping comparing to calcium hydroxide, and might be a suitable replacement for calcium hydroxide. PMID:26770296

  8. The shear bond strength of MTA with three different types of adhesive systems: An in vitro study

    PubMed Central

    Tyagi, Nimish; Chaman, Chandrakar; Tyagi, Shashi Prabha; Singh, Udai Pratap; Sharma, Apoorv

    2016-01-01

    Aim: To evaluate the shear bond strength of MTA with three different types of adhesive systems- self-adhering flowable composite, etch and rinse adhesive system and self etch adhesive system. Methodology: MTA specimens (n = 60) were prepared using cylindrical acrylic blocks, having a central cavity with 4 mm diameter and 2 mm depth. MTA was mixed and placed in the prepared cavity, and was covered with a moist cotton pellet and temporary filling material. The specimens were divided into 3 groups which were further divided into 2 sub-groups (45 Minutes and 24 hours). After the application of bonding agents composite resin was placed over the MTA surface. The specimens were tested for shear bond strength and readings were statically analyzed. Result: After 24 hrs the mean value of etch and rinse group was significantly higher than self etch and the self adhering composite groups. Among the 45 minutes groups there were no significant difference. Conclusion: In single visit after 45 minutes self adhering flowable can be used successfully as a final restorative material in place of conventional flowable composite without using any alternative adhesive system over MTA. PMID:27099417

  9. Cytotoxicity and Initial Biocompatibility of Endodontic Biomaterials (MTA and Biodentine™) Used as Root-End Filling Materials

    PubMed Central

    Escobar-García, Diana María; Aguirre-López, Eva; Méndez-González, Verónica

    2016-01-01

    Objective. The aim of this study was to evaluate the cytotoxicity and cellular adhesion of Mineral Trioxide Aggregate (MTA) and Biodentine (BD) on periodontal ligament fibroblasts (PDL). Methods. PDL cells were obtained from nonerupted third molars and cultured; MTS cellular profusion test was carried out in two groups: MTA and BD, with respective controls at different time periods. Also, the LIVE/DEAD assay was performed at 24 h. For evaluation of cellular adhesion, immunocytochemistry was conducted to discern the expression of Integrin β1 and Vinculin at 12 h and 24 h. Statistical analysis was performed by the Kruskal-Wallis and Mann-Whitney U tests. Results. MTA and BD exhibited living cells up to 7 days. More expressions of Integrin β1 and Vinculin were demonstrated in the control group, followed by BD and MTA, which also showed cellular loss and morphological changes. There was a significant difference in the experimental groups cultured for 5 and 7 days compared with the control, but there was no significant statistical difference between both cements. Conclusions. Neither material was cytotoxic during the time evaluated. There was an increase of cell adhesion through the expression of focal contacts observed in the case of BD, followed by MTA, but not significantly. PMID:27595108

  10. The emergency physician and patient confidentiality: a review.

    PubMed

    Larkin, G L; Moskop, J; Sanders, A; Derse, A

    1994-12-01

    Confidentiality is a promise rooted in tradition, law, and medical ethics. Emergency physicians treat a variety of patients to whom confidentiality is of vital importance: employees, celebrities, victims of violence or disaster, minors, students, criminals, drug abusers, and patients with STDs. EDs should develop methods of ensuring confidentiality for all patients. Although confidentiality is an important principle that should be respected and guarded, it is not absolute. Various laws mandate disclosure of certain patient information; in addition, an overriding moral duty may occasionally require a breach of confidentiality. As Beauchamp and Childress noted, "the therapeutic role may sometimes have to yield to one's role as citizen and as protector of the interests of others." In general, however, circumstances requiring a breach of confidentiality are rare. PMID:7978601

  11. 48 CFR 30.202-4 - Privileged and confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... REGULATION GENERAL CONTRACTING REQUIREMENTS COST ACCOUNTING STANDARDS ADMINISTRATION CAS Program Requirements 30.202-4 Privileged and confidential information. See 48 CFR 9903.202-4 (FAR appendix)....

  12. 48 CFR 30.202-4 - Privileged and confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... REGULATION GENERAL CONTRACTING REQUIREMENTS COST ACCOUNTING STANDARDS ADMINISTRATION CAS Program Requirements 30.202-4 Privileged and confidential information. See 48 CFR 9903.202-4 (FAR appendix)....

  13. 48 CFR 30.202-4 - Privileged and confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... REGULATION GENERAL CONTRACTING REQUIREMENTS COST ACCOUNTING STANDARDS ADMINISTRATION CAS Program Requirements 30.202-4 Privileged and confidential information. See 48 CFR 9903.202-4 (FAR appendix)....

  14. 48 CFR 30.202-4 - Privileged and confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... REGULATION GENERAL CONTRACTING REQUIREMENTS COST ACCOUNTING STANDARDS ADMINISTRATION CAS Program Requirements 30.202-4 Privileged and confidential information. See 48 CFR 9903.202-4 (FAR appendix)....

  15. 48 CFR 30.202-4 - Privileged and confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... REGULATION GENERAL CONTRACTING REQUIREMENTS COST ACCOUNTING STANDARDS ADMINISTRATION CAS Program Requirements 30.202-4 Privileged and confidential information. See 48 CFR 9903.202-4 (FAR appendix)....

  16. 50 CFR 229.11 - Confidential fisheries data.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... ADMINISTRATION, DEPARTMENT OF COMMERCE MARINE MAMMALS AUTHORIZATION FOR COMMERCIAL FISHERIES UNDER THE MARINE MAMMAL PROTECTION ACT OF 1972 General Provisions § 229.11 Confidential fisheries data. (a)...

  17. The evaluation of interfaces between MTA and two types of GIC (conventional and resin modified) under an SEM: An in vitro study

    PubMed Central

    Patil, Anuradha; Aggarwal, Shalini; Kumar, Tanaya; Bhargava, Karan; Rai, Vinay

    2016-01-01

    Context: Mineral trioxide aggregate (MTA) is a biocompatible repair material that is often used along with glass ionomer cement (GIC) in many clinical situations. Aims: In this study, the interface of GIC and MTA was examined, and the effect of time on this interface was tested. Materials and Methods: Forty 9-mm hollow cylindrical glass molds were filled with MTA and then according to the group either conventional GIC or resin-modified GIC (RMGIC) is filled immediately or after 45 min. The specimens were then sectioned, carbon coated, and examined using a scanning electron microscope (SEM) and the elemental analysis was done. Statistical Analysis: Observational study, no statistical analysis done. Results: The SEM showed that both the groups underwent adhesive separation and gap formation at the interface. The specimens in which GIC was condensed over freshly mixed MTA (group IIA and group IIB) also showed cohesive separation in MTA; however, it was more in the GIC condensed after 45 min over MTA groups (group IA and group IB). The results were better for conventional GIC than RMGIC. Conclusions: GIC can be applied over freshly mixed MTA with minimal effects on the MTA, but this effect decreases with time. PMID:27217640

  18. Evidence, Interpretation, and Qualification from Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children with ADHD (MTA): Part II--Supporting Details

    ERIC Educational Resources Information Center

    Swanson, James; Arnold, L. Eugene; Kraemer, Helena; Hechtman, Lily; Molina, Brooke; Hinshaw, Stephen; Vitiello, Benedetto; Jensen, Peter; Steinhoff, Ken; Lerner, Marc; Greenhill, Laurence; Abikoff, Howard; Wells, Karen; Epstein, Jeffery; Elliott, Glen; Newcorn, Jeffrey; Hoza, Betsy; Wigal, Timothy

    2008-01-01

    Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and…

  19. Treatment of horizontal root fractures using MTA as apical plug: report of 3 cases.

    PubMed

    Kusgoz, Adem; Yildirim, Tahsin; Tanriver, Mehmet; Yesilyurt, Cemal

    2009-05-01

    Root fractures are rare occurrences through all dental injuries. They comprise only 0.5% to 7.0% of traumas affecting the permanent teeth. Generally the cervical and middle thirds of the roots are affected. The healing of these lesions depends on the health of the pulp, dentine, cementum, and alveolar bone. These case reports describe the management and 2-year follow-up of 3 maxillary central incisors with horizontal root fractures treated with mineral trioxide aggregate (MTA) as apical plug. PMID:19426911

  20. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence

    PubMed Central

    Sheridan, Christine Moore; Grogan, Tristan R.; Nguyen, Hao G.; Galet, Colette; Rettig, Matthew B.; Hsieh, Andrew C.; Ruggero, Davide

    2015-01-01

    Attempts to identify biomarkers to detect prostate tumorigenesis, and thus minimize prostate cancer progression and inform treatment decisions have primarily focused on alterations at the DNA and mRNA levels, ignoring alterations at the level of protein synthesis control. We have previously shown that the PI3K-AKT-mTOR pathway, frequently deregulated in prostate cancer, specifically induces the synthesis of proteins that contribute to metastasis, most notably YB-1 and MTA1, without altering mRNA levels thereby demonstrating the importance of translation control in driving the expression of these genes in cancer. Here, we analyze genomic sequencing and mRNA expression databases, as well as protein expression employing an annotated tissue microarray generated from 332 prostate cancer patients with 15 years of clinical follow-up to determine the combined prognostic capability of YB-1 and MTA1 alterations in forecasting prostate cancer outcomes. Remarkably, protein abundance, but not genomic or transcriptional alterations of YB-1 and MTA1, is predictive of disease recurrence, exhibiting a dose-dependent effect on time to PSA recurrence, an indicator of tumor relapse. Moreover, high protein levels of YB-1 and MTA1 are associated with a 3-fold increased risk for requiring future hormone therapy or radiation therapy. Importantly, YB-1 and MTA1 protein levels significantly increase the predictive capacity of a clinical model for prostate cancer recurrence. These findings demonstrate that protein abundance of YB-1 and MTA1, irrespective of DNA or mRNA status, can predict for prostate cancer relapse and uncover a vast underappreciated repository of biomarkers regulated at the level of protein expression. PMID:25797255